drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Amiodarone	Acenocoumarol	0.256	-1.331	None	21954 (9815/12139)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#B4D1E6	395.145793930947	0
Digoxin	Furosemide	0.271	1.489	Moderate	36441 (22435/14006)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#F9BCBC	655.894501076689	0
Mesalazine	Azathioprine	0.283	-1.277	Moderate	3176 (1452/1724)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B4D1E6	57.1642088696678	0
Trimethoprim	Leucovorin	0.522	-2.113	Major	4550 (1535/3015)		#B1CFE5	81.8945687522004	0
Omeprazole	Diazepam	0.223	1.656	Moderate	253473 (162337/91136)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F8BABA	4562.21143413769	1
Acetylsalicylic acid	Gliclazide	0.257	-1.648	None	36543 (14436/22107)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	657.730379321243	0
Haloperidol	Biperiden	0.409	-1.401	Moderate	3437 (1493/1944)		#B4D1E6	61.8618973189698	0
Rivastigmine	Quetiapine	0.266	1.364	Moderate	6577 (3912/2665)		#F9BCBC	118.378149161148	0
Allopurinol	Acenocoumarol	0.23	-2.675	None	18923 (5428/13495)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	340.591411977558	0
Digoxin	Spironolactone	0.294	1.356	Minor	10201 (6053/4148)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#F9BCBC	183.605823261801	0
Acetaminophen	Acenocoumarol	0.178	1.078	None	98427 (52844/45583)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	1771.56850957644	1
Acetylsalicylic acid	Glyburide	0.241	-1.532	Moderate	22535 (9298/13237)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#B4D1E6	405.603100402381	0
Omeprazole	Alprazolam	0.201	2.126	Moderate	167507 (116550/50957)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B9B9	3014.92605010436	1
Digoxin	Carvedilol	0.258	-1.247	Moderate	6134 (2841/3293)	Digoxin may increase the bradycardic activities of Carvedilol.	#B4D1E6	110.404677961758	0
Pravastatin	Fenofibrate	0.715	-2.161	Major	7022 (2334/4688)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#B1CFE5	126.387617973176	0
Acetylsalicylic acid	Insulin aspart	0.219	-1.423	Moderate	16312 (7023/9289)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B4D1E6	293.596528678218	0
Acetylsalicylic acid	Ibuprofen	0.092	-1.134	Major	133691 (65077/68614)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B4D1E6	2406.27841561548	1
Donepezil	Quetiapine	0.28	1.731	Moderate	5690 (3702/1988)		#F8BABA	102.413207956048	0
Prednisone	Acetylsalicylic acid	0.116	-1.301	Moderate	49297 (22314/26983)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#B4D1E6	887.287155115873	1
Risperidone	Donepezil	0.235	1.938	Moderate	4958 (3351/1607)		#F8BABA	89.2380817304196	0
Omeprazole	Clonazepam	0.183	1.511	Moderate	47811 (29604/18207)		#F9BCBC	860.540928925594	1
Trazodone	Rivastigmine	0.233	1.509	Moderate	4027 (2492/1535)		#F9BCBC	72.4811930472771	0
Digoxin	Amiodarone	0.26	-1.152	Major	4526 (2186/2340)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#B4D1E6	81.4625974005404	0
Acetylsalicylic acid	Acenocoumarol	0.141	-1.795	None	22193 (8317/13876)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	399.447508641227	1
Warfarin	Amiodarone	0.26	-1.465	Major	2218 (939/1279)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B4D1E6	39.9213524159078	0
Acetylsalicylic acid	Insulin detemir	0.236	-1.128	Moderate	9894 (4830/5064)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B4D1E6	178.080189721818	0
Spironolactone	Enalapril	0.258	-1.176	Major	17416 (8322/9094)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#B4D1E6	313.467210854576	1.63197702255035e-303
Fenofibrate	Atorvastatin	0.306	-2.786	Major	9217 (2568/6649)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#AFCEE4	165.894997843743	0
Diltiazem	Atorvastatin	0.337	-1.637	Moderate	8863 (3515/5348)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#B2D0E5	159.523420406759	0
Bisoprolol	Gliclazide	0.233	-1.548	None	11797 (4838/6959)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	212.331918147188	0
Carbamazepine	Levetiracetam	0.344	-1.208	Moderate	1845 (869/976)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	33.2077976588593	0
Indomethacin	Methotrexate	0.233	1.463	Major	4369 (2672/1697)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F9BCBC	78.6367848084315	0
Galantamine	Quetiapine	0.276	1.357	Moderate	2588 (1536/1052)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#F9BCBC	46.5809107539988	0
Trazodone	Donepezil	0.251	1.998	Moderate	4164 (2842/1322)		#F8BABA	74.9470295130027	0
Galantamine	Risperidone	0.236	1.575	Moderate	2495 (1569/926)		#F8BABA	44.9070217663165	0
Diltiazem	Simvastatin	0.306	-1.152	Major	12317 (5947/6370)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B4D1E6	221.691297433154	4.19941886740397e-155
Entacapone	Apomorphine	0.153	-1.375	Moderate	41 (18/23)		#B4D1E6	0.737951059085761	7.99388869344626e-87
Valproic acid	Carbamazepine	0.375	-1.451	Moderate	1609 (685/924)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#B4D1E6	28.9600793675363	0
Levofloxacin	Acenocoumarol	0.072	-1.344	None	13841 (6153/7688)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	249.121478263562	1
Simvastatin	Fenofibrate	0.256	-2.128	Major	11273 (3786/7487)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#B1CFE5	202.900543635946	1
Omeprazole	Methotrexate	0.22	1.657	Major	18918 (12119/6799)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F8BABA	340.501417945962	7.32528124468801e-145
Fluvoxamine	Clomipramine	0.296	-1.122	Major	813 (398/415)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#B4D1E6	14.6330295374811	0
Trazodone	Galantamine	0.242	1.431	Moderate	1930 (1170/760)		#F9BCBC	34.7376961959883	0
Simvastatin	Amiodarone	0.226	-1.424	Major	9893 (4258/5635)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#B4D1E6	178.062190915498	1.24683338785829e-10
Simvastatin	Colchicine	0.094	-4.29	Major	7401 (1484/5917)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#ABCBE2	133.20916556814	1
Prednisone	Acenocoumarol	0.118	-1.2	None	16020 (7573/8447)		#B4D1E6	288.340877233022	1
Bisoprolol	Repaglinide	0.239	-1.389	Moderate	6035 (2634/3401)		#B4D1E6	108.62279613616	0
Methotrexate	Hydroxychloroquine	0.222	3.815	Minor	1618 (1301/317)		#F5B4B4	29.1220686244088	0
Ciprofloxacin	Acenocoumarol	0.073	-1.414	None	15642 (6758/8884)		#B4D1E6	281.537328444378	1
Lamotrigine	Carbamazepine	0.346	1.022	Moderate	949 (497/452)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#F9BCBC	17.0808671968875	0
Bisoprolol	Salmeterol	0.202	-1.692	Moderate	9631 (3744/5887)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#B2D0E5	173.346503659877	1
Levothyroxine	Acenocoumarol	0.217	2.406	None	11065 (7982/3083)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	199.15679192156	4.21406872883696e-24
Bisoprolol	Formoterol	0.158	-1.355	Moderate	11619 (5143/6476)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B4D1E6	209.128130622377	1
Omeprazole	Cilostazol	0.158	-3.838	Major	6107 (1337/4770)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#ACCCE3	109.91871019114	1
Bisoprolol	Ibuprofen	0.083	-1.002	Moderate	44276 (22921/21355)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	796.915148587346	1
Pentoxifylline	Acenocoumarol	0.242	-2.233	None	3921 (1275/2646)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	70.5733195774456	2.16728395203784e-132
Repaglinide	Gliclazide	0.16	-1.196	None	3663 (1735/1928)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	65.9296275471011	0
Simvastatin	Gemfibrozil	0.148	-2.106	Major	9848 (3330/6518)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#B1CFE5	177.252244631136	1
Fluvoxamine	Olanzapine	0.324	-1.794	Moderate	779 (292/487)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#B2D0E5	14.0210701226295	0
Carvedilol	Insulin aspart	0.207	-1.795	Moderate	2127 (797/1330)		#B2D0E5	38.2834610408638	0
Mesalazine	Mercaptopurine	0.209	-1.201	Moderate	218 (103/115)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	3.92373977757795	7.93510437405501e-252
Diltiazem	Amiodarone	0.275	-1.256	Major	2341 (1080/1261)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B4D1E6	42.1352055931651	0
Bisoprolol	Salbutamol	0.109	-1.182	Moderate	18777 (8946/9831)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	337.96358625496	1
Propafenone	Acenocoumarol	0.234	1.42	None	1893 (1144/749)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F9BCBC	34.0717403621792	0
Fenofibrate	Rosuvastatin	0.343	-3.296	Major	1857 (457/1400)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#AECDE3	33.4237833346892	1.56453781371145e-304
Repaglinide	Carvedilol	0.246	-1.732	Moderate	2169 (831/1338)		#B2D0E5	39.0394109062687	0
Bisoprolol	Insulin aspart	0.199	-1.378	Moderate	4708 (2064/2644)		#B4D1E6	84.7383801506284	7.2943465890988e-130
Digoxin	Verapamil	0.306	1.401	Moderate	1788 (1075/713)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#F9BCBC	32.1818656986669	0
Atenolol	Gliclazide	0.225	-1.276	None	5054 (2312/2742)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	90.9659671370595	8.14165647070298e-129
Phenytoin	Lamotrigine	0.349	-1.516	Moderate	436 (181/255)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#B4D1E6	7.8474795551559	2.11881228979233e-300
Atenolol	Ibuprofen	0.101	1.223	Moderate	29717 (16884/12833)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F9BCBC	534.870527386624	1
Acetylsalicylic acid	Ginkgo biloba	0.173	1.318	Moderate	6721 (3942/2779)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F9BCBC	120.969977271107	6.37243802078536e-74
Spironolactone	Losartan	0.256	1.185	Major	6013 (3370/2643)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#F9BCBC	108.226822397139	1.11288592684745e-129
Gliclazide	Carvedilol	0.233	-1.646	None	3168 (1252/1916)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	57.0202184191144	1.80684625556989e-253
Bisoprolol	Glyburide	0.206	-1.577	Moderate	4850 (1967/2883)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	87.2942106479498	4.38751334033111e-29
Citalopram	Acenocoumarol	0.238	1.616	None	10373 (6585/3788)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F8BABA	186.701617948698	1
Propranolol	Primidone	0.175	-1.213	Moderate	502 (236/266)	The metabolism of Propranolol can be increased when combined with Primidone.	#B4D1E6	9.03540077222079	1.90322569306078e-306
Ramipril	Spironolactone	0.298	-1.518	Major	3317 (1376/1941)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#B4D1E6	59.70204056067	1.36651759695669e-165
Acetaminophen	Warfarin	0.165	-1.02	Minor	9005 (4622/4383)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	162.07925090408	1
Digoxin	Hydrochlorothiazide	0.222	1.692	Moderate	7473 (4823/2650)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F8BABA	134.505079623119	2.22400016446154e-08
Trazodone	Acenocoumarol	0.193	1.308	None	5502 (3216/2286)		#F9BCBC	99.0294323680453	3.32985813764979e-44
Acetylsalicylic acid	Methylprednisolone	0.125	-1.002	Moderate	9378 (4856/4522)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#B4D1E6	168.792805661129	1
Cyclosporine	Sulfamethoxazole	0.264	-2.219	Major	588 (192/396)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	10.583298115669	6.8790159158599e-237
Atorvastatin	Gemfibrozil	0.179	-2.578	Major	5508 (1622/3886)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#B1CFE5	99.1374252059603	1
Salmeterol	Carvedilol	0.225	-1.974	Major	3297 (1163/2134)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#B2D0E5	59.3420644342867	2.25563090484226e-39
Tacrolimus	Atorvastatin	0.259	-1.613	Moderate	3822 (1529/2293)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#B2D0E5	68.7914377518483	0.00344905519450148
Furosemide	Ibuprofen	0.138	1.522	Moderate	44911 (27880/17031)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F9BCBC	808.344390600015	1
Acetylsalicylic acid	Glipizide	0.257	-1.327	Moderate	1916 (858/1058)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#B4D1E6	34.48571290752	0
Atorvastatin	Colchicine	0.122	-5.374	Major	3465 (578/2887)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#A8C8E1	62.3658638959064	1
Phenytoin	Omeprazole	0.26	-1.236	Moderate	4869 (2266/2603)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B4D1E6	87.636187968014	1
Fluoxetine	Clomipramine	0.252	1.745	Major	2290 (1494/796)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F8BABA	41.2172664708877	2.14454915396751e-234
Simvastatin	Clarithromycin	0.047	1.35	Major	20838 (12340/8498)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	375.059126078758	1
Atenolol	Glyburide	0.242	-1.199	Moderate	3150 (1490/1660)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	56.6962399053695	4.32061962797015e-140
Ranitidine	Acenocoumarol	0.201	-1.067	None	6645 (3336/3309)		#B4D1E6	119.602067990851	1
Acetylsalicylic acid	Insulin glulisine	0.172	-1.581	Moderate	2260 (915/1345)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#B2D0E5	40.6773022813127	5.3299936669079e-169
Carbamazepine	Risperidone	0.278	-1.482	Moderate	1260 (530/730)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#B4D1E6	22.6784959621478	2.00293350000547e-159
Acetylsalicylic acid	Dexamethasone	0.134	-1.904	Moderate	5853 (2113/3740)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#B2D0E5	105.347013386072	1
Glyburide	Carvedilol	0.229	-1.774	Moderate	1793 (677/1116)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	32.2718597302627	2.48571627624848e-152
Hydrocortisone	Acetylsalicylic acid	0.106	1.021	Moderate	8206 (4295/3911)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#F9BCBC	147.698204655067	1
Fluoxetine	Risperidone	0.274	1.029	Moderate	2940 (1545/1395)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F9BCBC	52.9164905783448	1
Ibuprofen	Acenocoumarol	0.085	-1.064	None	22709 (11419/11290)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	408.734892701916	1
Carvedilol	Insulin detemir	0.247	-1.249	Moderate	1225 (567/658)		#B4D1E6	22.048537740977	6.13034764645298e-260
Tacrolimus	Nifedipine	0.293	-2.152	Moderate	834 (278/556)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#B1CFE5	15.0110044701835	6.63183180309049e-107
Cholestyramine	Ursodeoxycholic acid	0.249	1.543	None	516 (322/194)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F8BABA	9.2873840606891	2.87986989024967e-281
Topiramate	Carbamazepine	0.32	-1.033	Moderate	876 (447/429)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	15.7669543355885	1.17468955734869e-159
Salbutamol	Carvedilol	0.12	-1.428	Major	5777 (2482/3295)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#B4D1E6	103.979104105816	1
Donepezil	Sertraline	0.341	2.558	Minor	2690 (1973/717)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F7B9B9	48.4167889985536	2.52633728322502e-307
Paroxetine	Risperidone	0.239	1.447	Moderate	4528 (2757/1771)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F9BCBC	81.4985950131787	1
Valproic acid	Acetylsalicylic acid	0.266	-1.301	Moderate	4547 (2058/2489)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B4D1E6	81.8405723332429	1
Propranolol	Rizatriptan	0.279	3.777	Moderate	2233 (1792/441)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F5B4B4	40.1913345106952	0
Repaglinide	Glyburide	0.148	-1.199	None	1732 (819/913)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B4D1E6	31.1739325447936	5.65930132147295e-197
Warfarin	Acetylsalicylic acid	0.152	-2.334	Major	2352 (742/1610)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#B1CFE5	42.3331924626759	1
Diltiazem	Amlodipine	0.207	-1.27	Moderate	3872 (1776/2096)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#B4D1E6	69.6913780678065	1
Cyclosporine	Ursodeoxycholic acid	0.338	-2.138	Minor	227 (76/151)		#B1CFE5	4.08572903445044	7.12505261738337e-114
Digoxin	Levothyroxine	0.253	2.93	Moderate	4401 (3341/1060)		#F7B7B7	79.2127466106448	1.28420217731889e-05
Mitomycin	Vinblastine	1	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Vinblastine is combined with Mitomycin.	#1E61A5	0.0179988063191649	0.476240778400811
Formoterol	Carvedilol	0.161	-1.787	Major	3031 (1139/1892)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#B2D0E5	54.5543819533888	1
Bisoprolol	Insulin detemir	0.21	-1.034	Moderate	2542 (1296/1246)		#B4D1E6	45.7529656633172	1.57889444747083e-74
Carbamazepine	Simvastatin	0.231	1.178	Moderate	4015 (2244/1771)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	72.2652073714471	1
Trimethoprim	Rifampicin	0.599	-1.49	Moderate	842 (353/489)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B4D1E6	15.1549949207369	7.70275161282797e-170
Amiodarone	Levofloxacin	0.136	-1.523	Major	3444 (1426/2018)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	61.987888963204	1
Omeprazole	Midazolam	0.183	1.517	Moderate	5246 (3253/1993)		#F9BCBC	94.4217379503391	1
Omeprazole	Ketazolam	0.19	2.244	None	9528 (6737/2791)		#F7B9B9	171.492626609003	1
Azithromycin	Acenocoumarol	0.064	-1.133	None	9536 (4645/4891)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B4D1E6	171.636617059557	1
Tramadol	Citalopram	0.158	3.528	Major	21795 (17250/4545)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F6B6B6	392.283983726199	1
Topiramate	Lithium cation	0.244	1.604	Moderate	755 (478/277)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F8BABA	13.5890987709695	1.43302217666653e-276
Moxifloxacin	Acenocoumarol	0.066	-1.395	None	3465 (1509/1956)		#B4D1E6	62.3658638959064	1
Warfarin	Propafenone	0.194	1.366	Moderate	363 (216/147)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F9BCBC	6.53356669385686	1.23699687898532e-247
Haloperidol	Lithium cation	0.263	-1.374	Major	558 (245/313)	Lithium may increase the neurotoxic activities of Haloperidol.	#B4D1E6	10.043333926094	9.435058194061e-135
Methimazole	Acenocoumarol	0.215	1.655	None	1618 (1036/582)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F8BABA	29.1220686244088	2.57032818613286e-119
Cyclosporine	Omeprazole	0.261	-1.312	Moderate	3034 (1367/1667)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B4D1E6	54.6083783723463	1
Allopurinol	Warfarin	0.207	-2.642	Moderate	1275 (369/906)	Allopurinol may increase the anticoagulant activities of Warfarin.	#AFCEE4	22.9484780569353	2.54977847056019e-98
Mirtazapine	Rivastigmine	0.253	2.124	Moderate	1725 (1200/525)		#F7B9B9	31.0479409005595	3.83258775467643e-300
Torasemide	Ibuprofen	0.122	1.832	Moderate	21883 (14517/7366)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F8BABA	393.867878682286	1
Pyridostigmine	Prednisone	0.306	-1.261	Moderate	1010 (465/545)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#B4D1E6	18.1787943823566	7.44447638226972e-125
Metformin	Glucosamine	0.106	1.154	None	5034 (2788/2246)		#F9BCBC	90.6059910106762	1
Clozapine	Clonazepam	0.258	-2.138	Moderate	242 (81/161)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#B1CFE5	4.35571112923791	4.05304168283742e-128
Verapamil	Atorvastatin	0.288	-1.098	Moderate	2198 (1088/1110)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	39.5613762895245	1.894705210009e-35
Trihexyphenidyl	Haloperidol	0.401	-1.55	Moderate	227 (93/134)		#B2D0E5	4.08572903445044	1.0645831218799e-118
Ibuprofen	Carvedilol	0.087	-1.195	Moderate	10740 (5088/5652)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B4D1E6	193.307179867831	1
Omeprazole	Itraconazole	0.113	1.553	Moderate	14846 (9287/5559)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	267.210278614322	1
Fluvastatin	Acenocoumarol	0.235	-1.552	None	1436 (588/848)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B2D0E5	25.8462858743208	4.04117986429491e-19
Methotrexate	Acetylsalicylic acid	0.179	-1.033	Major	3228 (1647/1581)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B4D1E6	58.1001467982643	1
Fluconazole	Simvastatin	0.061	1.312	Major	8307 (4862/3445)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	149.516084093303	1
Glimepiride	Gemfibrozil	0.218	-2.605	Moderate	1112 (325/787)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#AFCEE4	20.0146726269114	3.72091467604943e-64
Atenolol	Salbutamol	0.098	1.023	Moderate	7671 (4019/3652)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#F9BCBC	138.068843274314	1
Fenofibrate	Acenocoumarol	0.21	-1.904	None	2338 (844/1494)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	42.0812091742076	1
Paroxetine	Acenocoumarol	0.221	1.757	None	5932 (3880/2052)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	106.768919085286	1
Citalopram	Carvedilol	0.267	1.347	Moderate	3432 (2031/1401)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#F9BCBC	61.771903287374	1
Spironolactone	Tolevamer	0.223	-1.61	Moderate	624 (250/374)		#B2D0E5	11.2312551431589	2.30611994247396e-148
Propranolol	Ibuprofen	0.138	2.017	Moderate	14980 (10254/4726)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F8BABA	269.62211866109	1
Cyclosporine	Allopurinol	0.25	-3.189	Moderate	658 (166/492)		#AECDE3	11.8432145580105	6.58550448307621e-98
Methotrexate	Naproxen	0.174	1.85	Major	4791 (3189/1602)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F8BABA	86.2322810751191	1
Fluoxetine	Lithium cation	0.248	1.268	Major	851 (491/360)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	15.3169841776093	4.6842787373368e-59
Atenolol	Repaglinide	0.212	-1.14	Moderate	1876 (911/965)		#B4D1E6	33.7657606547534	1.13600489980767e-07
Spironolactone	Eplerenone	0.096	-4.161	Major	589 (121/468)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#ACCCE3	10.6012969219881	2.09726166714462e-61
Sucralfate	Lansoprazole	0.309	1.598	Moderate	1460 (923/537)		#F8BABA	26.2782572259808	6.12395357942576e-94
Carbamazepine	Atorvastatin	0.238	-1.097	Moderate	2018 (999/1019)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B4D1E6	36.3215911520748	1
Phenytoin	Furosemide	0.279	1.005	Minor	1280 (665/615)	Phenytoin may decrease the diuretic activities of Furosemide.	#F9BCBC	23.0384720885311	4.34875123856346e-83
Norfloxacin	Acenocoumarol	0.063	2.055	None	4906 (3378/1528)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	88.3021438018231	1
Amiodarone	Flecainide	0.128	-1.413	Major	671 (290/381)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#B4D1E6	12.0771990401597	3.02007596067916e-91
Gemfibrozil	Acenocoumarol	0.203	-1.988	None	2432 (854/1578)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#B2D0E5	43.7730969682091	1
Folic acid	Phenytoin	0.217	-1.311	Moderate	659 (297/362)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#B4D1E6	11.8612133643297	8.3630567044663e-24
Fluvoxamine	Lithium cation	0.28	-1.306	Major	197 (89/108)	Lithium may increase the serotonergic activities of Fluvoxamine.	#B4D1E6	3.54576484487549	2.99477430316978e-91
Sertraline	Carvedilol	0.257	1.371	Moderate	2482 (1479/1003)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#F9BCBC	44.6730372841673	1
Omeprazole	Flurazepam	0.167	1.767	Moderate	3603 (2361/1242)		#F8BABA	64.8496991679512	1
Amitriptyline	Duloxetine	0.247	5.408	Major	4364 (3724/640)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#F3AFAF	78.5467907768357	1.85379782554769e-141
Propranolol	Paroxetine	0.239	2.643	Moderate	3970 (2937/1033)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F7B7B7	71.4552610870847	1
Citalopram	Propranolol	0.227	2.414	Moderate	4105 (2964/1141)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F7B9B9	73.885099940172	1
Donepezil	Solifenacin	0.263	-1.073	Moderate	693 (347/346)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B4D1E6	12.4731727791813	8.22046475642554e-43
Cyclosporine	Sirolimus	0.156	-3.048	Moderate	46 (12/34)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#AFCEE4	0.827945090681586	5.56772387449527e-46
Glimepiride	Repaglinide	0.155	-1.192	None	898 (426/472)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B4D1E6	16.1629280746101	1.46284361094976e-104
Spironolactone	Irbesartan	0.239	-1.027	Major	1331 (681/650)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B4D1E6	23.9564112108085	7.14208618966076e-25
Propranolol	Sertraline	0.242	2.269	Moderate	3056 (2168/888)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F7B9B9	55.004352111368	1
Propranolol	Escitalopram	0.229	1.94	None	2599 (1757/842)		#F8BABA	46.7788976235096	1
Haloperidol	Carbamazepine	0.261	-1.478	Moderate	584 (246/338)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#B4D1E6	10.5113028903923	1.01016808879155e-37
Amitriptyline	Carbamazepine	0.315	1.702	Moderate	1257 (813/444)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F8BABA	22.6244995431903	2.52283939755776e-25
Triamcinolone	Acetylsalicylic acid	0.072	-1.464	Moderate	3626 (1536/2090)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#B4D1E6	65.263671713292	1
Digoxin	Propafenone	0.243	1.625	Moderate	547 (348/199)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F8BABA	9.84534705658321	7.35706308581028e-167
Atenolol	Salmeterol	0.166	-1.459	Moderate	2776 (1178/1598)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#B4D1E6	49.9646863420018	1
Phenytoin	Dexamethasone	0.376	-1.701	Moderate	444 (172/272)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#B2D0E5	7.99147000570922	1.01724339063179e-84
Atorvastatin	Clarithromycin	0.065	-1.113	Major	6943 (3413/3530)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	124.965712273962	1
Atenolol	Formoterol	0.121	-1.238	Moderate	3359 (1562/1797)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B4D1E6	60.4579904260749	1
Mirtazapine	Donepezil	0.313	2.964	Moderate	1621 (1234/387)		#F7B7B7	29.1760650433663	5.23645288552297e-200
Tramadol	Paroxetine	0.137	4.096	Major	15804 (12881/2923)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	284.453135068082	1
Lorazepam	Phenytoin	0.256	-1.095	Moderate	1368 (678/690)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B4D1E6	24.6223670446176	1
Indomethacin	Bisoprolol	0.093	-2.08	Moderate	2446 (834/1612)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#B1CFE5	44.0250802566774	1
Phenytoin	Quetiapine	0.256	-1.363	Major	544 (240/304)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#B4D1E6	9.79135063762571	8.36298943150776e-68
Donepezil	Tolterodine	0.314	1.45	Moderate	594 (362/232)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#F9BCBC	10.691290953584	8.41902377045374e-76
Galantamine	Sertraline	0.333	2.049	Moderate	1048 (721/327)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#F8BABA	18.8627490224848	2.65704063158337e-86
Digoxin	Telmisartan	0.216	1.405	Moderate	1228 (739/489)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#F9BCBC	22.1025341599345	5.22840637345263e-44
Digoxin	Alprazolam	0.201	2.281	Moderate	4605 (3272/1333)		#F7B9B9	82.8845030997544	1
Ranolazine	Simvastatin	0.252	-2.265	Major	1031 (332/699)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#B1CFE5	18.556769315059	1
Alendronic acid	Ibuprofen	0.113	11.397	Moderate	43869 (40561/3308)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#EB9E9E	789.589634415446	1
Indomethacin	Atenolol	0.101	-1.656	Moderate	1699 (669/1030)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#B2D0E5	30.5799719362612	1
Fluconazole	Fentanyl	0.33	1.026	Major	1776 (932/844)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#F9BCBC	31.9658800228369	1
Prazosin	Nadolol	0.443	-1.23	Moderate	30 (14/16)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B4D1E6	0.539964189574947	1.37047409944388e-29
Clodronic acid	Estramustine	0.667	-Inf	None	1 (0/1)	The serum concentration of Estramustine can be increased when it is combined with Clodronic Acid.	#1E61A5	0.0179988063191649	1
Cyclosporine	Atorvastatin	0.285	-1.949	Major	745 (265/480)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	13.4091107077779	2.35090022300949e-20
Levothyroxine	Iron	0.131	10.47	Moderate	8806 (8088/718)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#EDA1A1	158.497488446566	1
Fluoxetine	Acenocoumarol	0.219	1.68	None	3276 (2109/1167)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F8BABA	58.9640895015843	1
Indomethacin	Losartan	0.099	-1.258	Moderate	2386 (1100/1286)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B4D1E6	42.9451518775275	1
Digoxin	Methimazole	0.244	2.284	Moderate	764 (543/221)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F7B9B9	13.751088027842	3.22127600821626e-81
Lovastatin	Acenocoumarol	0.241	1.064	None	1197 (639/558)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#F9BCBC	21.5445711640404	0.0248387015975431
Indomethacin	Furosemide	0.168	-1.215	Moderate	2885 (1355/1530)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B4D1E6	51.9265562307908	1
Sumatriptan	Ergotamine	0.377	2.906	Major	425 (322/103)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B7B7	7.64949268564509	4.19911668891384e-96
Propranolol	Gliclazide	0.211	-1.213	None	1415 (665/750)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	25.4683109416184	1
Spironolactone	Cholestyramine	0.24	-1.237	Moderate	475 (221/254)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#B4D1E6	8.54943300160333	7.95801832020078e-38
Methotrexate	Amoxicillin	0.078	1.588	Major	6392 (4032/2360)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F8BABA	115.048369992102	1
Tramadol	Escitalopram	0.157	3.015	Major	9149 (6993/2156)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F7B7B7	164.67107901404	1
Fenofibrate	Fluvastatin	0.307	-2.521	Major	585 (175/410)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#B1CFE5	10.5293016967115	6.99217548878494e-11
Phenytoin	Topiramate	0.354	-1.67	Moderate	268 (105/163)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#B2D0E5	4.8236800935362	4.87164907626414e-36
Sulfasalazine	Azathioprine	0.286	1.298	Moderate	151 (88/63)		#F9BCBC	2.7178197541939	1.79026834429801e-94
Phenytoin	Oxcarbazepine	0.309	-1.695	Moderate	188 (73/115)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#B2D0E5	3.383775588003	1.16170752433926e-72
Cyclosporine	Carvedilol	0.348	-2.086	Moderate	288 (98/190)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#B1CFE5	5.1836562199195	8.85663977913637e-57
Folic acid	Phenobarbital	0.158	1.016	Moderate	515 (269/246)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#F9BCBC	9.26938525436993	1.72773964555686e-14
Sertraline	Rasagiline	0.303	-1.011	Major	675 (348/327)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	12.1491942654363	6.22799030984926e-17
Cyclosporine	Nifedipine	0.299	-2.135	Moderate	188 (63/125)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#B1CFE5	3.383775588003	2.34042391523476e-47
Dextropropoxyphene	Naltrexone	0.415	-5.164	None	29 (5/24)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#A9C9E1	0.521965383255782	1.64898021175495e-28
Pravastatin	Colchicine	0.116	-4.086	Major	854 (178/676)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#ACCCE3	15.3709805965668	1
Simvastatin	Itraconazole	0.058	1.167	Major	4886 (2720/2166)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	87.9421676754398	1
Pravastatin	Gemfibrozil	0.191	-2.045	Major	1346 (464/882)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#B2D0E5	24.226393305596	1
Paroxetine	Carvedilol	0.245	1.432	Moderate	2251 (1365/886)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F9BCBC	40.5153130244402	1
Galantamine	Tolterodine	0.298	1.215	Moderate	330 (187/143)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#F9BCBC	5.93960608532442	3.05346491154021e-62
Spironolactone	Captopril	0.307	1.068	Major	866 (463/403)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F9BCBC	15.5869662723968	1.18245926205735e-12
Lidocaine	Bisoprolol	0.1	1.859	Moderate	2211 (1474/737)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F8BABA	39.7953607716736	1
Atenolol	Insulin aspart	0.192	-1.178	Moderate	1307 (624/683)		#B4D1E6	23.5244398591485	1
Zolmitriptan	Ergotamine	0.316	2.991	Major	426 (325/101)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F7B7B7	7.66749149196425	2.80031054944275e-71
Ranolazine	Diltiazem	0.293	-1.595	Major	283 (114/169)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#B2D0E5	5.09366218832367	1.94727295201997e-70
Carvedilol	Escitalopram	0.251	1.065	None	1517 (810/707)		#F9BCBC	27.3041891861732	1
Galantamine	Solifenacin	0.275	-1.275	Moderate	343 (157/186)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#B4D1E6	6.17359056747356	1.61581525981113e-28
Cyclosporine	Tacrolimus	0.108	-1.36	Major	249 (110/139)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	4.48170277347206	5.81837116433715e-61
Tramadol	Carbamazepine	0.227	1.428	Moderate	2207 (1337/870)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F9BCBC	39.723365546397	1
Phenytoin	Acenocoumarol	0.279	-1.398	None	591 (257/334)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	10.6372945346265	1.32271170507057e-28
Fluconazole	Atorvastatin	0.085	-1.211	Major	3069 (1444/1625)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B4D1E6	55.2383365935171	1
Fluoxetine	Propranolol	0.237	3.002	Moderate	2398 (1831/567)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F7B7B7	43.1611375533575	1
Ezetimibe	Cholestyramine	0.159	-1.15	Moderate	389 (188/201)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	7.00153565815515	1.12706359744367e-51
Lovastatin	Diltiazem	0.315	1.222	Major	618 (351/267)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F9BCBC	11.1232623052439	1.1655318723967e-35
Hydrocortisone	Acenocoumarol	0.108	1.03	None	2062 (1084/978)		#F9BCBC	37.1135386301181	1
Carvedilol	Insulin glulisine	0.179	-2.424	Moderate	283 (87/196)		#B1CFE5	5.09366218832367	1.22694729789796e-33
Spironolactone	Telmisartan	0.21	1.015	Major	958 (500/458)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#F9BCBC	17.24285645376	1
Propranolol	Salbutamol	0.122	1.182	Major	3487 (1952/1535)		#F9BCBC	62.761837634928	1
Bisoprolol	Glipizide	0.215	-1.389	Moderate	520 (227/293)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	9.35937928596575	1.20603140428412e-23
Fentanyl	Amiodarone	0.215	1.68	Major	1404 (904/500)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#F8BABA	25.2703240721075	0.00220097762931891
Ergotamine	Rizatriptan	0.324	3.129	Major	393 (303/90)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F7B7B7	7.07353088343181	2.52129786952443e-59
Methotrexate	Phenylbutazone	0.162	-1.435	Major	56 (24/32)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#B4D1E6	1.00793315387324	9.63301891714032e-39
Clozapine	Haloperidol	0.191	-2.029	Major	101 (35/66)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#B2D0E5	1.81787943823566	2.77437208892341e-44
Tramadol	Fluoxetine	0.152	5.257	Major	11088 (9422/1666)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#F4B1B1	199.570764466901	1
Ciprofloxacin	Iron	0.26	1.412	Moderate	4020 (2424/1596)		#F9BCBC	72.355201403043	1
Enalapril	Tizanidine	0.087	-1.007	Major	2673 (1381/1292)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	48.1108092911278	1
Ibuprofen	Lithium cation	0.086	1.284	Moderate	3196 (1854/1342)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F9BCBC	57.5241849960511	1
Pyridostigmine	Fludrocortisone	0.301	-1.703	Moderate	31 (12/19)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#B2D0E5	0.557962995894112	8.99057615271417e-24
Escitalopram	Rasagiline	0.292	1.049	Major	581 (308/273)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#F9BCBC	10.4573064714348	4.49366727705213e-16
Atenolol	Diltiazem	0.201	-1.124	Major	1243 (608/635)	Diltiazem may increase the hypotensive activities of Atenolol.	#B4D1E6	22.372516254722	1
Amitriptyline	Fluoxetine	0.227	5.598	Major	4537 (3891/646)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#F3AFAF	81.6605842700512	1
Diltiazem	Cilostazol	0.196	-6.08	Major	286 (43/243)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#A6C7E0	5.14765860728116	5.30634761761233e-16
Phenytoin	Diazepam	0.204	-1.296	Moderate	1109 (503/606)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B4D1E6	19.9606762079539	1
Alprazolam	Clarithromycin	0.123	2.804	Moderate	10049 (7547/2502)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F7B7B7	180.870004701288	1
Bisoprolol	Insulin glulisine	0.18	-1.644	Moderate	637 (252/385)		#B2D0E5	11.465239625308	0.186517262740087
Omeprazole	Halazepam	0.158	2.195	Moderate	2363 (1660/703)		#F7B9B9	42.5311793321867	1
Citalopram	Rasagiline	0.261	1.153	Major	802 (444/358)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F9BCBC	14.4350426679703	1
Phenytoin	Ciprofloxacin	0.085	-1.514	Moderate	1023 (425/598)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#B4D1E6	18.4127788645057	1
Erythromycin	Simvastatin	0.051	1.574	Major	3887 (2444/1443)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F8BABA	69.961360162594	1
Cyclosporine	Methotrexate	0.148	-1.076	Moderate	194 (97/97)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#B4D1E6	3.49176842591799	4.96206599686034e-56
Levofloxacin	Iron	0.231	1.193	Moderate	2533 (1424/1109)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#F9BCBC	45.5909764064447	1
Mirtazapine	Galantamine	0.307	2.436	Moderate	735 (532/203)		#F7B9B9	13.2291226445862	2.57848201827098e-94
Warfarin	Levofloxacin	0.092	-1.427	Major	1005 (432/573)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#B4D1E6	18.0888003507607	1
Verapamil	Lithium cation	0.255	-4.386	Moderate	132 (26/106)	Verapamil may increase the neurotoxic activities of Lithium.	#ABCBE2	2.37584243412977	5.44802967015009e-13
Levothyroxine	Warfarin	0.199	2.088	Moderate	948 (656/292)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F7B9B9	17.0628683905683	1
Carbamazepine	Aripiprazole	0.237	-1.158	Moderate	301 (145/156)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#B4D1E6	5.41764070206864	1.2714448852979e-42
Fluvoxamine	Mirtazapine	0.262	1.145	Major	442 (244/198)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F9BCBC	7.95547239307089	2.70739530533478e-21
Prednisone	Warfarin	0.142	-1.184	Moderate	1363 (649/714)	Prednisone may increase the anticoagulant activities of Warfarin.	#B4D1E6	24.5323730130218	1
Ciprofloxacin	Rasagiline	0.07	-1.731	Major	1041 (399/642)		#B2D0E5	18.7367573782507	1
Ceftazidime	Tobramycin	0.867	-1.614	Moderate	5 (2/3)		#B2D0E5	0.0899940315958246	1.48685891066214e-06
Atenolol	Insulin detemir	0.202	-1.068	Moderate	837 (420/417)		#B4D1E6	15.065000889141	1
Fluoxetine	Carvedilol	0.248	1.314	Moderate	1349 (790/559)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F9BCBC	24.2803897245535	1
Alprazolam	Carbamazepine	0.193	1.57	Moderate	1667 (1047/620)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F8BABA	30.0040101340479	1
Repaglinide	Gemfibrozil	0.195	-2.215	Major	829 (271/558)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#B1CFE5	14.9210104385877	1
Cloxacillin	Acenocoumarol	0.051	-1.26	None	2412 (1111/1301)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	43.4131208418258	1
Propranolol	Glyburide	0.222	-1.151	Moderate	830 (401/429)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	14.9390092449069	1
Carbamazepine	Sertraline	0.225	1.47	Moderate	932 (571/361)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F9BCBC	16.7748874894617	1
Furosemide	Gentamicin	0.114	1.624	Major	695 (442/253)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#F8BABA	12.5091703918196	2.95256263324377e-34
Torasemide	Indomethacin	0.143	-1.012	Moderate	1362 (702/660)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	24.5143742067026	1
Methotrexate	Ibuprofen	0.117	1.913	Major	5377 (3619/1758)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F8BABA	96.7795815781497	1
Ciprofloxacin	Warfarin	0.099	-1.572	Major	1216 (494/722)		#B2D0E5	21.8865484841045	1
Rosuvastatin	Gemfibrozil	0.191	-2.941	Major	672 (180/492)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#AFCEE4	12.0951978464788	1
Digoxin	Rabeprazole	0.178	1.565	Moderate	1138 (714/424)		#F8BABA	20.4826415912097	1
Amitriptyline	Salbutamol	0.139	2.787	Moderate	6306 (4729/1577)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F7B7B7	113.500472648654	1
Propranolol	Salmeterol	0.176	-1.136	Major	1334 (649/685)		#B4D1E6	24.010407629766	1
Ceftazidime	Amikacin	0.833	-2.152	Moderate	3 (1/2)		#B1CFE5	0.0539964189574947	0.00282040622138154
Pioglitazone	Gemfibrozil	0.214	-2.51	Major	330 (99/231)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#B1CFE5	5.93960608532442	3.43273313046008e-14
Raloxifene	Estriol	0.193	39.115	None	517 (505/12)		#C64C4C	9.30538286700826	5.13268095471303e-204
Warfarin	Pentoxifylline	0.205	-2.768	Moderate	318 (89/229)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#AFCEE4	5.72362040949444	0.0654401131172871
Propranolol	Formoterol	0.152	1.086	Major	1670 (900/770)		#F9BCBC	30.0580065530054	1
Diclofenac	Alendronic acid	0.105	10.069	Moderate	17170 (15719/1451)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#EDA1A1	309.039504500062	1
Fluconazole	Alprazolam	0.148	2.986	Major	5236 (3993/1243)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F7B7B7	94.2417498871475	1
Clarithromycin	Acenocoumarol	0.06	-1.016	None	3122 (1606/1516)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B4D1E6	56.1922733284329	1
Spironolactone	Lisinopril	0.193	-1.204	Major	1265 (597/668)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B4D1E6	22.7684899937436	1
Imipramine	Fluoxetine	0.299	1.973	Major	381 (259/122)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F8BABA	6.85754520760183	2.10758925317909e-18
Bisoprolol	Verapamil	0.15	1.04	Major	966 (510/456)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#F9BCBC	17.3868469043133	1
Imipramine	Duloxetine	0.18	2.15	Major	275 (192/83)	Duloxetine may increase the serotonergic activities of Imipramine.	#F7B9B9	4.94967173777035	1.81491056686223e-38
Ziprasidone	Carbamazepine	0.246	-1.584	Minor	89 (36/53)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#B2D0E5	1.60189376240568	3.31536521526143e-26
Glimepiride	Pregabalin	0.144	-1.21	None	971 (457/514)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B4D1E6	17.4768409359091	1
Methotrexate	Flurbiprofen	0.16	1.102	Major	94 (51/43)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#F9BCBC	1.6918877940015	9.24489646497968e-38
Carbamazepine	Acenocoumarol	0.218	-1.175	None	730 (349/381)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#B4D1E6	13.1391286129904	1
Fluoxetine	Carbamazepine	0.214	1.548	Moderate	717 (448/269)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F8BABA	12.9051441308412	1
Cyclosporine	Pravastatin	0.346	-2.681	Major	220 (63/157)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#AFCEE4	3.95973739021628	0.000132567363907054
Mirtazapine	Rasagiline	0.296	1.106	Major	416 (226/190)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#F9BCBC	7.4875034287726	5.59315932542099e-14
Propranolol	Phenobarbital	0.247	1.043	Moderate	261 (138/123)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F9BCBC	4.69768844930204	3.97057747179708e-19
Bisoprolol	Terbutaline	0.071	-1.063	Moderate	2219 (1116/1103)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	39.9393512222269	1
Digoxin	Indapamide	0.203	1.534	Moderate	713 (444/269)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#F8BABA	12.8331489055646	1
Phenytoin	Gabapentin	0.296	-1.254	Moderate	444 (205/239)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B4D1E6	7.99147000570922	1
Warfarin	Ranitidine	0.189	-1.247	Moderate	652 (302/350)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B4D1E6	11.7352217200955	1
Digoxin	Diazepam	0.175	1.9	Moderate	3537 (2375/1162)		#F8BABA	63.6617779508863	1
Theophylline	Ciprofloxacin	0.189	-2.576	Major	774 (228/546)		#B1CFE5	13.9310760910336	1
Spironolactone	Perindopril	0.298	-1.241	Major	336 (156/180)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B4D1E6	6.04759892323941	9.8407080770455e-10
Olanzapine	Rivastigmine	0.257	1.334	Moderate	431 (254/177)		#F9BCBC	7.75748552356008	8.72574234634868e-17
Carbamazepine	Midazolam	0.157	-1.464	Moderate	144 (61/83)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B4D1E6	2.59182810995975	6.39127866027906e-14
Acetaminophen	Isoniazid	0.175	-1.272	Moderate	2424 (1111/1313)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B4D1E6	43.6291065176557	1
Primidone	Acenocoumarol	0.189	-1.99	None	208 (73/135)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#B2D0E5	3.7437517143863	2.73765205695518e-12
Fluoxetine	Nortriptyline	0.303	2.438	Major	308 (223/85)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F7B9B9	5.54363234630279	6.57491885860459e-33
Levofloxacin	Methotrimeprazine	0.182	-1.154	Moderate	854 (412/442)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#B4D1E6	15.3709805965668	1
Fludrocortisone	Acetylsalicylic acid	0.217	-1.511	Moderate	363 (151/212)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B4D1E6	6.53356669385686	1
Haloperidol	Propranolol	0.205	1.251	Moderate	685 (393/292)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#F9BCBC	12.329182328628	1
Trazodone	Warfarin	0.201	1.1	Minor	463 (251/212)	Trazodone may decrease the anticoagulant activities of Warfarin.	#F9BCBC	8.33344732577335	1
Cyclosporine	Simvastatin	0.24	-1.409	Major	702 (304/398)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	12.6351620360538	1
Sumatriptan	Lithium cation	0.171	-2.213	None	107 (35/72)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#B1CFE5	1.92587227615065	1
Nabumetone	Acenocoumarol	0.076	1.255	None	543 (312/231)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	9.77335183130655	1
Venlafaxine	Metoclopramide	0.106	3.59	Moderate	4337 (3445/892)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F6B6B6	78.0608230062182	1
Methotrexate	Diclofenac	0.141	1.524	Major	2524 (1568/956)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F9BCBC	45.4289871495722	1
Tramadol	Rasagiline	0.119	1.148	Major	988 (546/442)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#F9BCBC	17.7828206433349	1
Galantamine	Methotrimeprazine	0.219	1.301	Moderate	168 (98/70)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#F9BCBC	3.02379946161971	3.66856940290084e-35
Duloxetine	Ciprofloxacin	0.101	2.202	Major	3120 (2194/926)		#F7B9B9	56.1562757157945	1
Enalapril	Rifampicin	0.105	-1.77	None	1000 (378/622)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#B2D0E5	17.9988063191649	1
Chlorthalidone	Digoxin	0.221	1.493	Moderate	464 (286/178)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#F9BCBC	8.35144613209252	1
Venlafaxine	Rasagiline	0.256	1.229	Major	367 (209/158)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#F9BCBC	6.60556191913352	8.12937377836445e-06
Acitretin	Methotrexate	0.12	-1.77	Major	82 (31/51)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#B2D0E5	1.47590211817152	4.3050888627552e-22
Moxifloxacin	Amiodarone	0.144	-1.372	Major	794 (349/445)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	14.2910522174169	1
Indomethacin	Carvedilol	0.099	-2.098	Moderate	652 (221/431)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#B1CFE5	11.7352217200955	1
Citalopram	Oxycodone	0.221	2.38	Moderate	1136 (817/319)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F7B9B9	20.4466439785713	1
Galantamine	Paroxetine	0.276	2.152	Moderate	683 (477/206)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F7B9B9	12.2931847159896	1
Naproxen	Acenocoumarol	0.069	-1.105	None	4014 (1980/2034)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	72.247208565128	1
Propranolol	Repaglinide	0.207	-1.113	Moderate	588 (289/299)		#B4D1E6	10.583298115669	1
Duloxetine	Nortriptyline	0.258	2.72	Major	212 (158/54)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F7B7B7	3.81574693966296	4.66778078879906e-43
Atorvastatin	Bezafibrate	0.223	-1.801	None	353 (132/221)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#B2D0E5	6.35357863066521	1
Phenobarbital	Acenocoumarol	0.264	-1.168	None	367 (176/191)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B4D1E6	6.60556191913352	0.010757521730213
Trospium	Solifenacin	0.162	1.273	Moderate	154 (89/65)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F9BCBC	2.7718161731514	4.334234139962e-25
Theophylline	Pentoxifylline	0.251	-2.887	Moderate	221 (60/161)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#AFCEE4	3.97773619653545	1
Citalopram	Clarithromycin	0.104	3.176	Major	5883 (4551/1332)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F6B6B6	105.886977575647	1
Phenytoin	Alprazolam	0.236	1.268	Moderate	714 (412/302)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#F9BCBC	12.8511477118837	1
Fluvoxamine	Duloxetine	0.184	1.549	Major	264 (165/99)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F8BABA	4.75168486825954	0.000107741053169144
Cyclosporine	Ciprofloxacin	0.123	-1.695	Moderate	582 (226/356)		#B2D0E5	10.475305277754	1
Glipizide	Carvedilol	0.243	-1.703	Moderate	155 (60/95)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	2.78981497947056	1.43534734197096e-15
Enalapril	Lithium cation	0.177	-1.001	Moderate	971 (503/468)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B4D1E6	17.4768409359091	1
Lovastatin	Verapamil	0.363	1.695	Major	288 (186/102)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F8BABA	5.1836562199195	1.33289176886815e-30
Fluvoxamine	Clozapine	0.305	-6.814	Moderate	22 (3/19)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#A5C6DF	0.395973739021628	1.2849116121255e-09
Betamethasone	Acetylsalicylic acid	0.071	-1.03	Moderate	955 (488/467)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B4D1E6	17.1888600348025	1
Rosiglitazone	Gemfibrozil	0.248	-3.012	Moderate	171 (45/126)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#AFCEE4	3.0777958805772	3.8391005844539e-07
Trospium	Tolterodine	0.238	1.455	Moderate	118 (72/46)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#F9BCBC	2.12385914566146	5.38362310371088e-25
Phenytoin	Levodopa	0.33	-1.435	Moderate	168 (72/96)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B4D1E6	3.02379946161971	3.08508504866107e-17
Fluvastatin	Gemfibrozil	0.246	-2.192	Major	410 (135/275)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#B1CFE5	7.37951059085761	1
Repaglinide	Glipizide	0.148	-1.506	None	144 (60/84)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#B4D1E6	2.59182810995975	2.41968217355029e-17
Dexamethasone	Acenocoumarol	0.136	-1.621	None	955 (381/574)		#B2D0E5	17.1888600348025	1
Phenytoin	Fluoxetine	0.246	-1.257	Moderate	271 (125/146)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B4D1E6	4.87767651249369	1
Phenytoin	Sertraline	0.264	1.075	Moderate	371 (199/172)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#F9BCBC	6.67755714441018	1
Omeprazole	Ketoconazole	0.155	-1.046	Moderate	1489 (755/734)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B4D1E6	26.8002226092366	1
Fluvoxamine	Carbamazepine	0.231	-1.219	Moderate	128 (60/68)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#B4D1E6	2.30384720885311	4.09785048140277e-12
Spironolactone	Quinapril	0.268	-1.297	Major	225 (102/123)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#B4D1E6	4.04973142181211	0.00447311323366201
Ranolazine	Amiodarone	0.253	-3.391	Major	137 (33/104)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#AECDE3	2.46583646572559	1.95964543622657e-08
Phenytoin	Prednisone	0.122	-1.34	Moderate	640 (285/355)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B4D1E6	11.5192360442655	1
Azathioprine	Acenocoumarol	0.263	1.012	None	468 (244/224)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#F9BCBC	8.42344135736918	1
Alendronic acid	Naproxen	0.099	12.098	Moderate	12671 (11767/904)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#EB9C9C	228.062874870139	1
Ziprasidone	Chlorpromazine	0.264	-2.152	Major	33 (11/22)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B1CFE5	0.593960608532442	4.25175975636842e-16
Olanzapine	Donepezil	0.293	1.84	Moderate	444 (295/149)		#F8BABA	7.99147000570922	4.1134133113265e-11
Glyburide	Glucosamine	0.178	1.076	None	669 (359/310)		#F9BCBC	12.0412014275213	1
Celecoxib	Acenocoumarol	0.09	1.132	None	1302 (715/587)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	23.4344458275527	1
Metoprolol	Ibuprofen	0.104	1.188	Moderate	1394 (782/612)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	25.0903360089159	1
Warfarin	Fenofibrate	0.22	-2.274	Major	274 (88/186)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#B1CFE5	4.93167293145119	1
Simvastatin	Rifampicin	0.08	-1.736	Major	839 (321/518)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#B2D0E5	15.1009985017794	1
Salbutamol	Clomipramine	0.103	1.791	Moderate	1724 (1135/589)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F8BABA	31.0299420942403	1
Salbutamol	Rasagiline	0.111	-1.66	Moderate	707 (278/429)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#B2D0E5	12.7251560676496	1
Atenolol	Terbutaline	0.076	1.15	Moderate	1318 (729/589)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#F9BCBC	23.7224267286594	1
Diazepam	Clarithromycin	0.228	2.339	Moderate	7813 (5591/2222)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F7B9B9	140.624673771635	1
Cyclosporine	Fluconazole	0.294	-1.626	Moderate	221 (88/133)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#B2D0E5	3.97773619653545	1
Disopyramide	Bisoprolol	0.249	1.527	Major	74 (46/28)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#F9BCBC	1.3319116676182	9.95183438215094e-42
Ergotamine	Almotriptan	0.284	2.989	Major	156 (119/37)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#F7B7B7	2.80781378578973	6.65995089179622e-16
Metoprolol	Gliclazide	0.252	-1.398	None	223 (97/126)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	4.01373380917378	0.0195174970466844
Atorvastatin	Itraconazole	0.087	-1.348	Major	1570 (697/873)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B4D1E6	28.2581259210889	1
Prednisone	Phenobarbital	0.114	-1.08	Moderate	591 (295/296)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	10.6372945346265	1
Gliclazide	Glucosamine	0.127	1.118	None	901 (492/409)		#F9BCBC	16.2169244935676	1
Ciprofloxacin	Methotrexate	0.082	1.267	Moderate	1399 (807/592)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F9BCBC	25.1803300405117	1
Acarbose	Digoxin	0.262	1.556	Moderate	254 (159/95)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F8BABA	4.57169680506789	4.63705021925074e-23
Erythromycin	Atorvastatin	0.077	1.117	Major	1464 (799/665)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	26.3502524512574	1
Clozapine	Diazepam	0.203	-2.256	Major	223 (72/151)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#B1CFE5	4.01373380917378	1
Donepezil	Methotrimeprazine	0.185	2.02	Moderate	257 (176/81)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#F8BABA	4.62569322402538	6.58141641852918e-27
Oxycodone	Sertraline	0.211	2.849	Moderate	870 (656/214)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F7B7B7	15.6589614976735	1
Amitriptyline	Rasagiline	0.217	-1.21	Major	272 (128/144)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#B4D1E6	4.89567531881286	1
Doxycycline	Amoxicillin	0.307	1.103	Moderate	5258 (2854/2404)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F9BCBC	94.6377236261691	1
Prazosin	Propranolol	0.324	-2.062	Moderate	35 (12/23)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#B2D0E5	0.629958221170772	6.83123063529842e-08
Cyclosporine	Ezetimibe	0.26	-2.327	Moderate	136 (43/93)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B1CFE5	2.44783765940643	9.98984884659549e-07
Rivastigmine	Methotrimeprazine	0.198	1.638	Moderate	221 (141/80)		#F8BABA	3.97773619653545	2.62260499050595e-21
Metoprolol	Glyburide	0.263	-1.614	Moderate	150 (60/90)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	2.69982094787474	1.51799216980866e-05
Cyclosporine	Sevelamer	0.132	-1.95	Moderate	45 (16/29)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#B2D0E5	0.809946284362421	1.01228604508796e-18
Indomethacin	Acenocoumarol	0.096	-1.956	None	899 (319/580)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	16.1809268809293	1
Atenolol	Glipizide	0.23	-1.345	Moderate	207 (92/115)	Atenolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	3.72575290806714	0.0159313066706293
Simvastatin	Fusidic acid	0.045	-1.001	None	969 (502/467)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	17.4408433232708	1
Citalopram	Warfarin	0.212	1.876	Moderate	803 (537/266)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F8BABA	14.4530414742894	1
Azithromycin	Lovastatin	0.052	1.517	Moderate	1395 (865/530)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F9BCBC	25.1083348152351	1
Atenolol	Verapamil	0.21	1.091	Major	476 (257/219)	Verapamil may increase the hypotensive activities of Atenolol.	#F9BCBC	8.5674318079225	1
Lidocaine	Carvedilol	0.077	1.266	Moderate	444 (256/188)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#F9BCBC	7.99147000570922	1
Diclofenac	Lithium cation	0.068	1.234	Moderate	1180 (673/507)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F9BCBC	21.2385914566146	1
Warfarin	Ibuprofen	0.1	-1.135	Major	1907 (928/979)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B4D1E6	34.3237236506475	1
Indomethacin	Alendronic acid	0.155	5.469	Moderate	1900 (1624/276)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#F3AFAF	34.1977320064133	1
Sertraline	Clarithromycin	0.102	3.091	Moderate	3824 (2940/884)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F7B7B7	68.8274353644866	1
Fluconazole	Diazepam	0.228	2.604	Moderate	4509 (3323/1186)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F7B7B7	81.1566176931146	1
Omeprazole	Triazolam	0.174	1.943	Moderate	612 (414/198)		#F8BABA	11.0152694673289	1
Ticlopidine	Acetylsalicylic acid	0.125	-2.341	Moderate	235 (74/161)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#B1CFE5	4.22971948500375	1
Phenytoin	Mirtazapine	0.225	-1.026	Moderate	254 (130/124)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#B4D1E6	4.57169680506789	1
Clozapine	Fluoxetine	0.281	-2.613	Moderate	72 (21/51)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#AFCEE4	1.29591405497987	0.383212297905283
Flutamide	Acenocoumarol	0.297	-10.893	None	89 (8/81)		#99BDDA	1.60189376240568	1
Methylprednisolone	Clarithromycin	0.525	1.369	Major	1783 (1062/721)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F9BCBC	32.091871667071	1
Propranolol	Ergotamine	0.269	3.478	Moderate	460 (363/97)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F6B6B6	8.27945090681586	4.67281421111373e-06
Disopyramide	Atenolol	0.273	1.039	Major	36 (19/17)	Disopyramide may increase the bradycardic activities of Atenolol.	#F9BCBC	0.647957027489937	4.51441231793356e-18
Phenytoin	Midazolam	0.199	-1.764	Moderate	66 (25/41)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#B2D0E5	1.18792121706488	8.14506632001548e-10
Ciprofloxacin	Sevelamer	0.145	-1.739	Moderate	416 (159/257)		#B2D0E5	7.4875034287726	1
Erythromycin	Acenocoumarol	0.058	1.264	None	977 (563/414)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#F9BCBC	17.5848337738241	1
Oxycodone	Escitalopram	0.216	1.904	Moderate	561 (377/184)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F8BABA	10.0973303450515	1
Terbutaline	Carvedilol	0.071	-1.338	Major	673 (300/373)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B4D1E6	12.113196652798	1
Methylphenidate	Carbamazepine	0.243	-1.731	None	227 (87/140)		#B2D0E5	4.08572903445044	1
Fluconazole	Acenocoumarol	0.071	-1.076	None	1164 (582/582)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B4D1E6	20.950610555508	1
Phenytoin	Vigabatrin	0.409	-1.076	Minor	20 (10/10)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.359976126383298	1.71850341820162e-14
Dihydroergotamine	Sumatriptan	0.399	2.572	Major	162 (119/43)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B9B9	2.91580662370472	7.22964270468154e-08
Fluvoxamine	Nortriptyline	0.334	-1.858	Major	30 (11/19)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B2D0E5	0.539964189574947	2.659363745243e-05
Dextromethorphan	Paroxetine	0.11	3.659	Major	4315 (3441/874)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F6B6B6	77.6648492671966	1
Rifampicin	Atorvastatin	0.107	-2.577	Major	455 (134/321)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#B1CFE5	8.18945687522003	1
Acenocoumarol	Cholestyramine	0.122	-1.12	None	351 (172/179)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	6.31758101802688	1
Alprazolam	Itraconazole	0.135	2.547	Major	2693 (1973/720)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F7B9B9	48.4707854175111	1
Metronidazole	Acenocoumarol	0.067	-1.25	None	1111 (514/597)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#B4D1E6	19.9966738205922	1
Olanzapine	Galantamine	0.302	1.257	Moderate	207 (119/88)		#F9BCBC	3.72575290806714	6.36142330421831e-06
Clozapine	Lamotrigine	0.251	-1.202	Moderate	36 (17/19)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#B4D1E6	0.647957027489937	5.42751912567824e-16
Diclofenac	Warfarin	0.104	-1.275	Major	1062 (486/576)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B4D1E6	19.1147323109531	1
Theophylline	Verapamil	0.269	-1.506	Moderate	108 (45/63)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#B4D1E6	1.94387108246981	1.57972227474777e-05
Trospium	Rivastigmine	0.234	-1.162	Moderate	52 (25/27)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#B4D1E6	0.935937928596575	4.1155592401735e-05
Warfarin	Fluvastatin	0.166	-1.532	Minor	143 (59/84)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#B4D1E6	2.57382930364058	1
Fluconazole	Haloperidol	0.452	1.093	Major	618 (334/284)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#F9BCBC	11.1232623052439	1
Rosuvastatin	Colchicine	0.129	-4.443	Moderate	277 (54/223)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#ABCBE2	4.98566935040868	1
Phenytoin	Trimethoprim	0.144	-1.979	Moderate	159 (56/103)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#B2D0E5	2.86181020474722	1
Cyclosporine	Ibuprofen	0.106	-1.413	Moderate	974 (421/553)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	17.5308373548666	1
Trospium	Quetiapine	0.199	1.109	Moderate	136 (74/62)		#F9BCBC	2.44783765940643	1
Moxifloxacin	Warfarin	0.096	-1.74	Major	280 (107/173)		#B2D0E5	5.03966576936618	1
Pimozide	Sertraline	0.277	-1.291	Major	99 (45/54)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#B4D1E6	1.78188182559733	0.0135815165881328
Paroxetine	Rasagiline	0.233	1.347	Major	409 (242/167)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#F9BCBC	7.36151178453845	1
Phenytoin	Hydrocortisone	0.179	-1.418	Moderate	197 (85/112)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#B4D1E6	3.54576484487549	1
Spironolactone	Eprosartan	0.234	1.087	Major	308 (166/142)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#F9BCBC	5.54363234630279	1
Gentamicin	Cefonicid	0.633	1.374	Moderate	57 (34/23)		#F9BCBC	1.0259319601924	1.25263012589937e-16
Eplerenone	Tolevamer	0.21	-5.297	None	77 (13/64)		#A8C8E1	1.3859080865757	8.14853346896162e-07
Zolmitriptan	Dihydroergotamine	0.335	2.943	Major	175 (133/42)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F7B7B7	3.14979110585386	7.16555695634172e-05
Clonidine	Labetalol	0.465	-Inf	Major	3 (0/3)	Clonidine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#1E61A5	0.0539964189574947	1
Cyclosporine	Danazol	0.404	-1.076	Moderate	14 (7/7)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#B4D1E6	0.251983288468309	4.42183046859957e-09
Rifampicin	Leflunomide	0.132	1.267	Major	78 (45/33)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#F9BCBC	1.40390689289486	5.06968362019111e-15
Trospium	Flavoxate	0.151	-Inf	Moderate	5 (0/5)		#1E61A5	0.0899940315958246	1
Metoclopramide	Levodopa	0.095	1.532	Moderate	1131 (704/427)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F9BCBC	20.3566499469755	1
Fluorouracil	Acenocoumarol	0.059	-2.216	None	153 (50/103)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#B1CFE5	2.75381736683223	1
Erythromycin	Alprazolam	0.1	3.06	Moderate	2172 (1666/506)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F7B7B7	39.0934073252262	1
Tobramycin	Furosemide	0.113	-1.345	Major	99 (44/55)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#B4D1E6	1.78188182559733	0.0488029206989898
Chlorpropamide	Acetylsalicylic acid	0.279	-1.125	None	90 (44/46)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	1.61989256872484	2.04052398205195e-11
Folic acid	Primidone	0.154	-1.524	Moderate	116 (48/68)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#B4D1E6	2.08786153302313	1
Verapamil	Carvedilol	0.207	-1.052	Major	263 (133/130)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#B4D1E6	4.73368606194037	1
Fluconazole	Clonazepam	0.149	1.987	None	1161 (791/370)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F8BABA	20.8966141365505	1
Diltiazem	Propranolol	0.22	1.219	Major	467 (265/202)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F9BCBC	8.40544255105001	1
Levothyroxine	Raloxifene	0.183	25.849	Moderate	2132 (2058/74)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#D87373	38.3734550724596	2.14702234502463e-47
Bisoprolol	Rifampicin	0.128	-2.35	Moderate	363 (114/249)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#B1CFE5	6.53356669385686	1
Fenofibrate	Ursodeoxycholic acid	0.247	-1.035	None	255 (130/125)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B4D1E6	4.58969561138705	1
Ropinirole	Ciprofloxacin	0.092	-1.23	Moderate	373 (174/199)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B4D1E6	6.71355475704851	1
Verapamil	Colchicine	0.119	-2.69	Major	175 (50/125)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#AFCEE4	3.14979110585386	1
Clonidine	Clomipramine	0.286	-3.228	Major	20 (5/15)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#AECDE3	0.359976126383298	0.000174374834280635
Diltiazem	Tacrolimus	0.174	-1.506	Moderate	288 (120/168)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B4D1E6	5.1836562199195	1
Ibuprofen	Nadolol	0.154	2.341	Moderate	1675 (1199/476)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F7B9B9	30.1480005846012	1
Phenytoin	Megestrol acetate	0.25	-1.004	Moderate	116 (60/56)		#B4D1E6	2.08786153302313	2.01169253298463e-09
Trospium	Oxybutynin	0.276	1.027	Moderate	40 (21/19)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#F9BCBC	0.719952252766596	2.71803909710526e-08
Lidocaine	Atenolol	0.071	2.023	Moderate	648 (444/204)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F8BABA	11.6632264948189	1
Pimozide	Escitalopram	0.202	1.111	Major	101 (55/46)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F9BCBC	1.81787943823566	1.65669521276563e-06
Trazodone	Ginkgo biloba	0.168	2.082	Moderate	512 (354/158)		#F7B9B9	9.21538883541244	1
Naproxen	Lithium cation	0.069	1.602	Major	885 (560/325)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F8BABA	15.9289435924609	1
Duloxetine	Rasagiline	0.31	1.516	Major	200 (124/76)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#F9BCBC	3.59976126383298	1
Zolmitriptan	Escitalopram	0.176	4.471	Major	860 (712/148)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#F5B2B2	15.4789734344818	1
Fluoxetine	Dextromethorphan	0.12	3.984	Major	2897 (2349/548)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F5B4B4	52.1425419066207	1
Eletriptan	Ergotamine	0.212	3.074	Major	56 (43/13)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#F7B7B7	1.00793315387324	3.95486276878812e-07
Sotalol	Gliclazide	0.211	-1.51	None	125 (52/73)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	2.24985078989561	1
Hydrocortisone	Phenobarbital	0.099	-1.064	Moderate	173 (87/86)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B4D1E6	3.11379349321553	1
Phenytoin	Paramethasone	0.017	-Inf	None	1 (0/1)	The metabolism of Paramethasone can be increased when combined with Phenytoin.	#1E61A5	0.0179988063191649	1
Acenocoumarol	Etoricoxib	0.074	-1.008	None	866 (447/419)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	15.5869662723968	1
Pregabalin	Pioglitazone	0.169	1.156	Moderate	350 (194/156)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#F9BCBC	6.29958221170772	1
Itraconazole	Budesonide	0.269	1.139	Major	2083 (1147/936)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#F9BCBC	37.4915135628205	1
Prednisone	Rifampicin	0.289	-1.508	Moderate	550 (229/321)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B4D1E6	9.8993434755407	1
Sotalol	Levofloxacin	0.082	-1.362	Major	213 (94/119)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	3.83374574598213	1
Oxycodone	Paroxetine	0.181	2.905	Moderate	726 (550/176)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F7B7B7	13.0671333877137	1
Testosterone	Acenocoumarol	0.173	-34.787	None	200 (6/194)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#548ABC	3.59976126383298	1
Gemfibrozil	Ursodeoxycholic acid	0.234	-1.463	None	236 (100/136)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B4D1E6	4.24771829132292	1
Atomoxetine	Fluoxetine	0.21	-1.383	Major	144 (63/81)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#B4D1E6	2.59182810995975	1
Hydrochlorothiazide	Lithium cation	0.148	1.529	Major	529 (329/200)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F9BCBC	9.52136854283824	1
Sertraline	Cilostazol	0.22	-2.459	Moderate	230 (70/160)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#B1CFE5	4.13972545340793	1
Lovastatin	Warfarin	0.188	1.018	Moderate	132 (69/63)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#F9BCBC	2.37584243412977	1
Colestipol	Ursodeoxycholic acid	0.225	2.117	None	59 (41/18)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F7B9B9	1.06192957283073	3.63607032190549e-22
Disopyramide	Labetalol	0.016	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Labetalol.	#1E61A5	0.0179988063191649	1
Triamcinolone	Acenocoumarol	0.081	-1.586	None	574 (232/342)		#B2D0E5	10.3313148272007	1
Cyclosporine	Azithromycin	0.095	-1.333	Moderate	412 (184/228)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B4D1E6	7.41550820349594	1
Levothyroxine	Cholestyramine	0.115	4.873	Moderate	643 (540/103)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F4B1B1	11.573232463223	1
Rizatriptan	Escitalopram	0.167	5.244	Major	890 (756/134)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F4B1B1	16.0189376240568	1
Warfarin	Methimazole	0.225	1.189	Moderate	98 (55/43)	Methimazole may decrease the anticoagulant activities of Warfarin.	#F9BCBC	1.76388301927816	1
Ergotamine	Nadolol	0.203	2.082	Moderate	81 (56/25)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F7B9B9	1.45790331185236	3.80040917511719e-05
Clozapine	Sertraline	0.305	-2.017	Major	69 (24/45)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#B2D0E5	1.24191763602238	1
Fluoxetine	Oxycodone	0.183	3.216	Moderate	562 (436/126)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F6B6B6	10.1153291513707	1
Dihydroergotamine	Rizatriptan	0.366	3.062	Major	146 (112/34)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F7B7B7	2.62782572259808	1
Norfloxacin	Iron	0.268	3.948	None	1401 (1134/267)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F5B4B4	25.21632765315	1
Cyclosporine	Amiodarone	0.188	-1.998	Moderate	100 (35/65)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#B2D0E5	1.79988063191649	1
Cyclophosphamide	Acenocoumarol	0.171	-1.6	None	97 (39/58)		#B2D0E5	1.745884212959	1
Theophylline	Clarithromycin	0.444	-1.032	Moderate	429 (219/210)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#B4D1E6	7.72148791092175	1
Rifabutin	Clarithromycin	0.476	-1.383	Moderate	64 (28/36)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#B4D1E6	1.15192360442655	0.00238426680365205
Galantamine	Oxybutynin	0.267	-1.187	Moderate	61 (29/32)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#B4D1E6	1.09792718546906	0.047226157633134
Phenytoin	Amiodarone	0.307	-1.187	Moderate	143 (68/75)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#B4D1E6	2.57382930364058	1
Cyclosporine	Metoclopramide	0.128	-1.316	Moderate	289 (130/159)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#B4D1E6	5.20165502623866	1
Diazepam	Itraconazole	0.225	2.037	Moderate	2499 (1716/783)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F8BABA	44.9790169915931	1
Propranolol	Maprotiline	0.231	2.338	Minor	116 (83/33)		#F7B9B9	2.08786153302313	3.99375677106954e-05
Trospium	Tiotropium	0.265	-2.539	Moderate	84 (25/59)	Trospium may increase the anticholinergic activities of Tiotropium.	#B1CFE5	1.51189973080985	1
Fluoxetine	Clarithromycin	0.108	4.726	Moderate	3219 (2690/529)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F5B2B2	57.9381575413919	1
Ziprasidone	Donepezil	0.363	1.472	Moderate	62 (38/24)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#F9BCBC	1.11592599178822	9.55694144056937e-09
Lorazepam	Clozapine	0.208	-1.517	Major	147 (61/86)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#B4D1E6	2.64582452891724	1
Losartan	Lithium cation	0.207	-1.002	Moderate	309 (160/149)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#B4D1E6	5.56163115262196	1
Valsartan	Lithium cation	0.157	-1.201	Moderate	237 (112/125)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#B4D1E6	4.26571709764208	1
Moclobemide	Clomipramine	0.271	1.461	None	18 (11/7)	Moclobemide may increase the serotonergic activities of Clomipramine.	#F9BCBC	0.323978513744968	1.57449155171587e-08
Indomethacin	Propranolol	0.18	1.481	Moderate	568 (349/219)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F9BCBC	10.2233219892857	1
Azithromycin	Warfarin	0.075	-1.227	Moderate	625 (292/333)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#B4D1E6	11.2492539494781	1
Donepezil	Oxybutynin	0.257	1.319	Moderate	104 (61/43)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#F9BCBC	1.87187585719315	1
Procainamide	Amiodarone	0.083	-Inf	Major	5 (0/5)	Amiodarone may increase the QTc-prolonging activities of Procainamide.	#1E61A5	0.0899940315958246	0.0546349304924012
Fentanyl	Rifampicin	0.211	-1.231	Major	193 (90/103)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B4D1E6	3.47376961959883	1
Citalopram	Rizatriptan	0.159	6.431	Major	1275 (1114/161)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#F2ACAC	22.9484780569353	1
Paroxetine	Rizatriptan	0.171	6.493	Major	1158 (1013/145)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#F2ACAC	20.842617717593	1
Digoxin	Clarithromycin	0.106	1.342	Major	985 (582/403)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#F9BCBC	17.7288242243774	1
Methotrexate	Sulfamethoxazole	0.231	1.011	Moderate	238 (124/114)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F9BCBC	4.28371590396125	1
Zolmitriptan	Paroxetine	0.166	6.026	Major	1130 (979/151)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#F2AEAE	20.3386511406564	1
Trimethoprim	Methotrexate	0.217	1.122	Major	267 (146/121)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F9BCBC	4.80568128721703	1
Citalopram	Zolmitriptan	0.15	5.75	Major	1193 (1027/166)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#F3AFAF	21.4725759387637	1
Fludrocortisone	Acenocoumarol	0.183	-1.339	None	101 (45/56)		#B4D1E6	1.81787943823566	1
Trospium	Risperidone	0.223	1.21	Moderate	99 (56/43)		#F9BCBC	1.78188182559733	1
Losartan	Rifampicin	0.102	-1.555	Moderate	291 (119/172)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#B2D0E5	5.23765263887699	1
Clozapine	Flunitrazepam	0.279	1.046	None	17 (9/8)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#F9BCBC	0.305979707425803	7.05502338235655e-09
Cyclosporine	Colchicine	0.138	-3.389	Major	83 (20/63)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#AECDE3	1.49390092449069	1
Sotalol	Ibuprofen	0.109	1.057	Moderate	622 (331/291)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#F9BCBC	11.1952575305206	1
Lovastatin	Carbamazepine	0.194	1.539	None	162 (101/61)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F8BABA	2.91580662370472	1
Amitriptyline	Rivastigmine	0.19	1.688	Moderate	307 (198/109)		#F8BABA	5.52563353998363	1
Sumatriptan	Paroxetine	0.173	4.957	Major	874 (736/138)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F4B1B1	15.7309567229501	1
Glycopyrronium	Rivastigmine	0.213	-4.102	None	77 (16/61)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#ACCCE3	1.3859080865757	1
Rivastigmine	Oxybutynin	0.214	-1.304	Moderate	73 (33/40)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#B4D1E6	1.31391286129904	1
Minocycline	Amoxicillin	0.245	1.113	Moderate	1879 (1024/855)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F9BCBC	33.8197570737109	1
Repaglinide	Glucosamine	0.138	1.067	None	348 (186/162)		#F9BCBC	6.26358459906939	1
Dapsone	Rifampicin	0.468	-Inf	Moderate	5 (0/5)	The metabolism of Dapsone can be increased when combined with Rifampicin.	#1E61A5	0.0899940315958246	1
Diltiazem	Midazolam	0.276	1.002	Moderate	133 (69/64)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#F9BCBC	2.39384124044893	1
Metoprolol	Salmeterol	0.176	-1.456	Moderate	160 (68/92)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B4D1E6	2.87980901106639	1
Verapamil	Eplerenone	0.305	-1.858	Moderate	90 (33/57)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#B2D0E5	1.61989256872484	1
Biperiden	Rivastigmine	0.215	1.458	Moderate	131 (80/51)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#F9BCBC	2.3578436278106	1
Pantoprazole	Itraconazole	0.174	1.463	Moderate	968 (592/376)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	17.4228445169516	1
Lovastatin	Gemfibrozil	0.182	-1.252	Major	251 (116/135)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	4.51770038611039	1
Atorvastatin	Fusidic acid	0.063	-1.323	None	379 (170/209)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	6.8215475949635	1
Propranolol	Terbutaline	0.119	1.205	Major	519 (293/226)		#F9BCBC	9.34138047964659	1
Pravastatin	Bezafibrate	0.21	-1.227	None	107 (50/57)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B4D1E6	1.92587227615065	1
Bupropion	Rasagiline	0.281	-1.329	Major	76 (34/42)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#B4D1E6	1.36790928025653	1
Lovastatin	Colchicine	0.125	-2.717	Major	141 (40/101)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#AFCEE4	2.53783169100225	1
Diltiazem	Carbamazepine	0.192	1.127	Major	208 (114/94)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#F9BCBC	3.7437517143863	1
Warfarin	Gemfibrozil	0.172	-2.325	Major	177 (56/121)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#B1CFE5	3.18578871849219	1
Methotrexate	Cholestyramine	0.13	1.056	None	94 (50/44)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.6918877940015	1
Phenytoin	Methylprednisolone	0.162	-1.049	Moderate	158 (80/78)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B4D1E6	2.84381139842806	1
Fluoxetine	Ergotamine	0.17	5.406	Major	518 (442/76)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#F3AFAF	9.32338167332743	1
Warfarin	Paroxetine	0.201	2.036	Moderate	453 (311/142)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F8BABA	8.15345926258171	1
Dihydroergotamine	Almotriptan	0.357	3.522	Major	91 (72/19)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#F6B6B6	1.63789137504401	0.000890344711239688
Cyclosporine	Fluvastatin	0.292	-1.383	Moderate	64 (28/36)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	1.15192360442655	1
Fluconazole	Tacrolimus	0.347	1.227	Major	420 (239/181)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#F9BCBC	7.55949865404926	1
Metoprolol	Salbutamol	0.109	1.019	Moderate	348 (182/166)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#F9BCBC	6.26358459906939	1
Glyburide	Nadolol	0.223	-1.721	Moderate	91 (35/56)	Nadolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	1.63789137504401	1
Warfarin	Phenobarbital	0.2	1.084	Major	65 (35/30)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#F9BCBC	1.16992241074572	3.63303266355611e-06
Zolmitriptan	Fluoxetine	0.165	7.187	Major	882 (781/101)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#F1ABAB	15.8749471735035	1
Prednisone	Primidone	0.12	-1.761	Moderate	174 (66/108)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#B2D0E5	3.13179229953469	1
Erythromycin	Lincomycin	0.591	1.084	Moderate	52 (28/24)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#F9BCBC	0.935937928596575	1
Methylprednisolone	Phenobarbital	0.099	1.056	Moderate	141 (75/66)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F9BCBC	2.53783169100225	1
Ziprasidone	Pimozide	0.29	-1.076	Major	12 (6/6)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#B4D1E6	0.215985675829979	7.4877718622384e-06
Spironolactone	Benazepril	0.474	-1.363	Major	34 (15/19)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#B4D1E6	0.611959414851607	0.0610096660655407
Fluvoxamine	Imipramine	0.252	1.104	Major	35 (19/16)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#F9BCBC	0.629958221170772	0.00404132554722258
Spironolactone	Fosinopril	0.266	-1.204	Major	89 (42/47)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#B4D1E6	1.60189376240568	1
Selegiline	Escitalopram	0.274	-1.18	Major	65 (31/34)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#B4D1E6	1.16992241074572	1
Erythromycin	Levofloxacin	0.492	1.367	Moderate	882 (525/357)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	15.8749471735035	1
Chlorpromazine	Donepezil	0.16	-1.816	Moderate	43 (16/27)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#B2D0E5	0.773948671724091	1
Cyclosporine	Repaglinide	0.253	-2.032	Major	78 (27/51)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#B2D0E5	1.40390689289486	1
Tizanidine	Lisinopril	0.101	1.19	Major	447 (251/196)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F9BCBC	8.04546642466672	1
Warfarin	Norfloxacin	0.085	2.096	Major	358 (248/110)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F7B9B9	6.44357266226104	1
Repaglinide	Clarithromycin	0.078	1.027	Moderate	720 (378/342)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#F9BCBC	12.9591405497987	1
Digoxin	Methotrexate	0.156	1.761	Moderate	275 (180/95)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F8BABA	4.94967173777035	1
Metoprolol	Repaglinide	0.248	-1.345	Moderate	81 (36/45)		#B4D1E6	1.45790331185236	1
Prednisone	Itraconazole	0.395	1.206	Moderate	1307 (738/569)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F9BCBC	23.5244398591485	1
Fluvastatin	Colchicine	0.153	-4.912	Major	128 (23/105)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#A9C9E1	2.30384720885311	1
Amiodarone	Clarithromycin	0.12	-1.124	Major	681 (333/348)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	12.2571871033513	1
Lidocaine	Propranolol	0.112	3.044	Moderate	419 (321/98)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F7B7B7	7.5414998477301	1
Ofloxacin	Acenocoumarol	0.058	-1.993	None	174 (61/113)		#B2D0E5	3.13179229953469	1
Fluvoxamine	Acenocoumarol	0.219	1.277	None	235 (136/99)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#F9BCBC	4.22971948500375	1
Moxifloxacin	Iron	0.257	1.275	Moderate	510 (295/215)		#F9BCBC	9.17939122277411	1
Leflunomide	Acenocoumarol	0.215	1.239	None	168 (96/72)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	3.02379946161971	1
Sucralfate	Levofloxacin	0.371	-1.211	Moderate	406 (191/215)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	7.30751536558095	1
Almotriptan	Escitalopram	0.193	5.361	Major	467 (398/69)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#F3AFAF	8.40544255105001	1
Propranolol	Glipizide	0.154	-1.159	Moderate	81 (39/42)	Propranolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	1.45790331185236	1
Fluvoxamine	Phenytoin	0.327	-4.124	Moderate	29 (6/23)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#ACCCE3	0.521965383255782	1
Colestipol	Levothyroxine	0.139	2.597	Moderate	129 (95/34)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F7B9B9	2.32184601517227	1
Cyclosporine	Phenobarbital	0.208	-2.767	Moderate	25 (7/18)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#AFCEE4	0.449970157979123	0.308142996949329
Sertraline	Propafenone	0.215	2.802	Moderate	281 (211/70)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F7B7B7	5.05766457568534	1
Erythromycin	Citalopram	0.091	3.208	Major	1144 (887/257)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F6B6B6	20.5906344291247	1
Trospium	Galantamine	0.26	1.472	Moderate	31 (19/12)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#F9BCBC	0.557962995894112	0.000757506727372683
Clarithromycin	Quetiapine	0.107	1.714	Major	1243 (806/437)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F8BABA	22.372516254722	1
Atenolol	Insulin glulisine	0.164	-1.524	Moderate	145 (60/85)		#B4D1E6	2.60982691627891	1
Propranolol	Propafenone	0.207	1.325	Moderate	114 (67/47)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F9BCBC	2.0518639203848	1
Atenolol	Ergotamine	0.167	2.6	Moderate	319 (235/84)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B7B7	5.74161921581361	1
Lovastatin	Clarithromycin	0.056	1.891	Major	613 (411/202)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F8BABA	11.0332682736481	1
Methylergometrine	Nitroglycerin	0.894	-1.291	Moderate	22 (10/12)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#B4D1E6	0.395973739021628	1
Valproic acid	Nimodipine	0.285	1.166	Minor	124 (69/55)		#F9BCBC	2.23185198357645	1
Amikacin	Furosemide	0.131	1.102	Major	59 (32/27)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#F9BCBC	1.06192957283073	0.0777543413296436
Sucralfate	Ciprofloxacin	0.362	1.051	Moderate	618 (328/290)		#F9BCBC	11.1232623052439	1
Fluconazole	Amitriptyline	0.175	4.071	Moderate	1259 (1025/234)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F5B4B4	22.6604971558286	1
Sucralfate	Levothyroxine	0.1	5.264	Minor	713 (606/107)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#F4B1B1	12.8331489055646	1
Dihydroergotamine	Propranolol	0.287	3.253	Moderate	225 (175/50)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F6B6B6	4.04973142181211	1
Clarithromycin	Solifenacin	0.113	1.224	Major	774 (440/334)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F9BCBC	13.9310760910336	1
Propranolol	Verapamil	0.217	1.212	Major	182 (103/79)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F9BCBC	3.27578275008801	1
Cyclosporine	Verapamil	0.379	-2.51	Moderate	40 (12/28)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#B1CFE5	0.719952252766596	1
Metoprolol	Formoterol	0.129	-1.031	Moderate	186 (95/91)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#B4D1E6	3.34777797536467	1
Carbamazepine	Oxybutynin	0.236	1.321	None	92 (54/38)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#F9BCBC	1.65589018136317	1
Carbamazepine	Verapamil	0.201	1.328	Major	119 (70/49)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F9BCBC	2.14185795198062	1
Phenytoin	Aprepitant	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Aprepitant.	#1E61A5	0.0179988063191649	1
Citalopram	Clozapine	0.26	-1.883	Major	66 (24/42)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#B2D0E5	1.18792121706488	1
Erythromycin	Diazepam	0.192	2.404	Moderate	1639 (1182/457)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F7B9B9	29.5000435571113	1
Fluoxetine	Warfarin	0.197	1.74	Moderate	270 (176/94)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	4.85967770617453	1
Meloxicam	Acenocoumarol	0.102	1.054	None	382 (203/179)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	6.875544013921	1
Glimepiride	Glucosamine	0.165	1.141	None	245 (135/110)		#F9BCBC	4.4097075481954	1
Torasemide	Gentamicin	0.147	1.859	Major	153 (102/51)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F8BABA	2.75381736683223	1
Terbinafine	Acenocoumarol	0.081	-1.549	None	422 (173/249)		#B2D0E5	7.59549626668759	1
Eletriptan	Paroxetine	0.212	4.77	Major	233 (195/38)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#F4B1B1	4.19372187236542	1
Metoprolol	Sertraline	0.236	1.726	Moderate	180 (117/63)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F8BABA	3.23978513744968	1
Ziprasidone	Galantamine	0.363	-1.076	Moderate	26 (13/13)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#B4D1E6	0.467968964298288	0.0302246151044572
Ampicillin	Acenocoumarol	0.038	-1.855	None	79 (29/50)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	1.42190569921403	1
Ramipril	Tizanidine	0.097	-1.11	Major	321 (158/163)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B4D1E6	5.77761682845194	1
Trospium	Donepezil	0.261	2.614	Moderate	61 (45/16)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#F7B7B7	1.09792718546906	6.35922664446097e-07
Metoprolol	Paroxetine	0.224	1.453	Moderate	182 (111/71)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F9BCBC	3.27578275008801	1
Biperiden	Donepezil	0.24	2.162	Moderate	143 (100/43)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F7B9B9	2.57382930364058	1
Citalopram	Sumatriptan	0.177	4.78	Major	774 (648/126)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#F4B1B1	13.9310760910336	1
Lansoprazole	Itraconazole	0.177	1.537	Moderate	613 (382/231)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F8BABA	11.0332682736481	1
Phenobarbital	Dexamethasone	0.197	-1.452	Moderate	94 (40/54)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.6918877940015	1
Disopyramide	Omeprazole	0.228	1.457	None	95 (58/37)		#F9BCBC	1.70988660032067	1
Nortriptyline	Carbamazepine	0.264	1.148	Moderate	38 (21/17)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#F9BCBC	0.683954640128267	0.873725532729264
Lovastatin	Fenofibrate	0.199	-1.099	Major	192 (95/97)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B4D1E6	3.45577081327966	1
Chlorpromazine	Rivastigmine	0.18	-1.435	Moderate	42 (18/24)		#B4D1E6	0.755949865404926	1
Gentamicin	Cefuroxime	0.546	1.288	Moderate	167 (97/70)		#F9BCBC	3.00580065530054	1
Paroxetine	Almotriptan	0.167	5.809	Major	551 (475/76)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#F2AEAE	9.91734228185987	1
Carbamazepine	Metronidazole	0.147	1.216	Moderate	277 (157/120)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F9BCBC	4.98566935040868	1
Duloxetine	Flecainide	0.191	2.622	Moderate	256 (189/67)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F7B7B7	4.60769441770622	1
Fluoxetine	Rasagiline	0.231	1.068	Major	159 (85/74)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#F9BCBC	2.86181020474722	1
Sotalol	Glyburide	0.222	-1.336	Moderate	65 (29/36)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	1.16992241074572	1
Metronidazole	Phenobarbital	0.042	-1.178	Moderate	132 (63/69)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#B4D1E6	2.37584243412977	1
Simvastatin	Ketoconazole	0.061	-1.044	Major	398 (202/196)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B4D1E6	7.16352491502764	1
Phenytoin	Theophylline	0.217	-1.865	Moderate	41 (15/26)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B2D0E5	0.737951059085761	1
Disopyramide	Propranolol	0.486	-2.152	Major	9 (3/6)	Disopyramide may increase the bradycardic activities of Propranolol.	#B1CFE5	0.161989256872484	1
Fluconazole	Rifabutin	0.297	-1.614	Moderate	25 (10/15)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#B2D0E5	0.449970157979123	1
Fluoxetine	Rizatriptan	0.165	9.104	Major	896 (813/83)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#EEA4A4	16.1269304619718	1
Imipramine	Carbamazepine	0.268	1.943	Moderate	68 (46/22)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#F8BABA	1.22391882970321	0.000282625627929655
Gentamicin	Cefazolin	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Sumatriptan	Escitalopram	0.159	3.768	Major	465 (373/92)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F5B4B4	8.36944493841168	1
Hydroxyzine	Donepezil	0.13	2.12	Moderate	456 (317/139)		#F7B9B9	8.2074556815392	1
Dihydroergotamine	Atenolol	0.159	2.43	Moderate	253 (183/70)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B9B9	4.55369799874872	1
Gliclazide	Nadolol	0.222	-1.84	None	103 (38/65)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	1.85387705087399	1
Chlorpromazine	Levofloxacin	0.32	-1.847	Moderate	163 (60/103)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#B2D0E5	2.93380543002388	1
Paroxetine	Propafenone	0.223	2.775	Moderate	287 (215/72)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F7B7B7	5.16565741360033	1
Omeprazole	Quazepam	0.138	2.212	Moderate	240 (169/71)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F7B9B9	4.31971351659958	1
Ramipril	Lithium cation	0.184	-1.751	Moderate	134 (51/83)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#B2D0E5	2.4118400467681	1
Metoprolol	Indomethacin	0.132	-1.96	Moderate	79 (28/51)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#B2D0E5	1.42190569921403	1
Rivastigmine	Clomipramine	0.217	1.859	Moderate	132 (88/44)		#F8BABA	2.37584243412977	1
Diclofenac	Rifampicin	0.277	-1.51	Moderate	536 (223/313)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B4D1E6	9.64736018707239	1
Trihexyphenidyl	Rivastigmine	0.181	-1.159	Moderate	27 (13/14)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#B4D1E6	0.485967770617453	0.460312174743181
Ranitidine	Itraconazole	0.256	1.316	Moderate	720 (422/298)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	12.9591405497987	1
Salmeterol	Nadolol	0.202	-1.786	Major	125 (47/78)		#B2D0E5	2.24985078989561	1
Indomethacin	Warfarin	0.088	-1.894	Major	138 (50/88)	Indomethacin may increase the anticoagulant activities of Warfarin.	#B2D0E5	2.48383527204476	1
Diazepam	Rifampicin	0.218	-1.027	Minor	477 (244/233)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B4D1E6	8.58543061424166	1
Cyclosporine	Diltiazem	0.281	-1.402	Moderate	76 (33/43)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B4D1E6	1.36790928025653	1
Digoxin	Cholestyramine	0.143	1.274	Moderate	128 (74/54)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	2.30384720885311	1
Salbutamol	Nadolol	0.155	1.064	Major	311 (166/145)		#F9BCBC	5.59762876526029	1
Chlorpromazine	Propranolol	0.24	1.069	Moderate	86 (46/40)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F9BCBC	1.54789734344818	1
Terbutaline	Clomipramine	0.094	1.386	Moderate	274 (164/110)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F9BCBC	4.93167293145119	1
Mirtazapine	Clonidine	0.195	-2.152	Moderate	27 (9/18)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#B1CFE5	0.485967770617453	1
Phenytoin	Clarithromycin	0.056	-1.228	Moderate	227 (106/121)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B4D1E6	4.08572903445044	1
Fluvoxamine	Tramadol	0.149	2.82	Major	589 (443/146)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F7B7B7	10.6012969219881	1
Dihydroergotamine	Fluoxetine	0.165	4.833	Major	341 (286/55)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F4B1B1	6.13759295483524	1
Donepezil	Glycopyrronium	0.274	-3.093	None	62 (16/46)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#AFCEE4	1.11592599178822	1
Sotalol	Repaglinide	0.247	-2.017	Moderate	46 (16/30)		#B2D0E5	0.827945090681586	1
Prednisone	Ketoconazole	0.429	-1.991	Moderate	248 (87/161)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#B2D0E5	4.4637039671529	1
Propranolol	Hydralazine	0.26	1.166	Minor	142 (79/63)	Hydralazine may increase the hypotensive activities of Propranolol.	#F9BCBC	2.55583049732142	1
Theophylline	Carbamazepine	0.213	-1.49	Moderate	62 (26/36)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#B4D1E6	1.11592599178822	1
Atropine	Galantamine	0.349	-2.152	Moderate	3 (1/2)	The therapeutic efficacy of Atropine can be decreased when used in combination with Galantamine.	#B1CFE5	0.0539964189574947	1
Fluoxetine	Sumatriptan	0.187	5.993	Major	566 (490/76)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#F2AEAE	10.1873243766473	1
Haloperidol	Glycopyrronium	0.23	-4.363	Moderate	91 (18/73)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#ABCBE2	1.63789137504401	1
Citalopram	Metoprolol	0.247	2.297	Moderate	243 (173/70)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F7B9B9	4.37370993555707	1
Fluvoxamine	Amitriptyline	0.211	1.975	Major	175 (119/56)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F8BABA	3.14979110585386	1
Imipramine	Salbutamol	0.128	1.645	Moderate	313 (200/113)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F8BABA	5.63362637789862	1
Clozapine	Midazolam	0.26	-4.304	Major	10 (2/8)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#ABCBE2	0.179988063191649	1
Dextromethorphan	Memantine	0.102	2.895	Minor	576 (436/140)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#F7B7B7	10.367312439839	1
Rifampicin	Acenocoumarol	0.141	-1.447	None	197 (84/113)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#B4D1E6	3.54576484487549	1
Doxycycline	Acenocoumarol	0.087	-1.491	None	458 (192/266)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#B4D1E6	8.24345329417753	1
Clonazepam	Itraconazole	0.131	1.786	None	561 (369/192)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F8BABA	10.0973303450515	1
Metoprolol	Escitalopram	0.263	1.662	Minor	145 (93/52)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F8BABA	2.60982691627891	1
Triazolam	Telithromycin	0.583	-Inf	Major	2 (0/2)	The serum concentration of Triazolam can be increased when it is combined with Telithromycin.	#1E61A5	0.0359976126383298	1
Clozapine	Carbamazepine	0.245	-1.614	Major	20 (8/12)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#B2D0E5	0.359976126383298	0.063780486644745
Digoxin	Hydroxychloroquine	0.211	1.733	Moderate	106 (69/37)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F8BABA	1.90787346983148	1
Erythromycin	Methylprednisolone	0.529	1.779	Moderate	408 (268/140)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F8BABA	7.34351297821928	1
Itraconazole	Acenocoumarol	0.061	-1.236	None	490 (228/262)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B4D1E6	8.81941509639081	1
Cyclosporine	Digoxin	0.113	-2.005	Moderate	63 (22/41)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#B2D0E5	1.13392479810739	1
Ergotamine	Frovatriptan	0.296	3.408	Major	28 (22/6)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#F6B6B6	0.503966576936618	0.0898881364486509
Warfarin	Cholestyramine	0.14	-1.369	Moderate	50 (22/28)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.899940315958246	1
Allopurinol	Azathioprine	0.15	-3.481	Major	144 (34/110)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#AECDE3	2.59182810995975	1
Carbamazepine	Clarithromycin	0.111	1.061	Major	364 (194/170)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F9BCBC	6.55156550017603	1
Warfarin	Azathioprine	0.258	1.186	Moderate	66 (37/29)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F9BCBC	1.18792121706488	1
Fluoxetine	Propafenone	0.225	2.285	Moderate	166 (118/48)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F7B9B9	2.98780184898138	1
Ticlopidine	Phenytoin	0.379	-1.383	Moderate	16 (7/9)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#B4D1E6	0.287980901106639	0.00280965604595939
Ranolazine	Digoxin	0.202	-2.51	Moderate	60 (18/42)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#B1CFE5	1.07992837914989	1
Phenytoin	Warfarin	0.305	-1.076	Moderate	52 (26/26)	Phenytoin may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.935937928596575	1
Galantamine	Biperiden	0.159	1.215	Moderate	60 (34/26)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#F9BCBC	1.07992837914989	1
Imipramine	Moclobemide	0.086	-1.076	None	4 (2/2)	Moclobemide may increase the serotonergic activities of Imipramine.	#B4D1E6	0.0719952252766596	1
Fluconazole	Carbamazepine	0.12	1.636	Moderate	265 (169/96)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F8BABA	4.7696836745787	1
Metformin	Cimetidine	0.104	-1.572	Moderate	64 (26/38)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#B2D0E5	1.15192360442655	1
Carbamazepine	Bupropion	0.198	-1.225	Moderate	77 (36/41)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#B4D1E6	1.3859080865757	1
Ciprofloxacin	Tizanidine	0.252	-1.146	Major	599 (290/309)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B4D1E6	10.7812849851798	1
Theophylline	Phenobarbital	0.139	-1.572	Moderate	32 (13/19)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#B2D0E5	0.575961802213277	1
Erythromycin	Sertraline	0.098	3.447	Moderate	744 (586/158)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F6B6B6	13.3911119014587	1
Fluoxetine	Almotriptan	0.151	7.278	Major	415 (368/47)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#F1ABAB	7.46950462245344	1
Alfuzosin	Itraconazole	0.089	-54.332	Major	103 (2/101)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	1.85387705087399	1
Doxycycline	Rifampicin	0.644	-1.754	Moderate	121 (46/75)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B2D0E5	2.17785556461895	1
Propranolol	Clonidine	0.416	-4.662	Major	16 (3/13)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#ABCBE2	0.287980901106639	1
Fluoxetine	Trimipramine	0.356	1.704	Major	17 (11/6)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#F8BABA	0.305979707425803	0.127280104367026
Carbamazepine	Warfarin	0.239	-1.592	Moderate	62 (25/37)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#B2D0E5	1.11592599178822	1
Citalopram	Almotriptan	0.17	5.981	Major	513 (444/69)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#F2AEAE	9.2333876417316	1
Metoprolol	Prazosin	0.56	1.239	Moderate	7 (4/3)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#F9BCBC	0.125991644234154	0.0158912704479388
Cyclosporine	Indomethacin	0.156	-2.066	Moderate	73 (25/48)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	1.31391286129904	1
Colestipol	Acenocoumarol	0.155	-1.336	None	65 (29/36)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	1.16992241074572	1
Lisinopril	Lithium cation	0.151	-1.255	Moderate	143 (66/77)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#B4D1E6	2.57382930364058	1
Bisoprolol	Epinephrine	0.077	-1.037	Moderate	269 (137/132)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	4.84167889985536	1
Fluconazole	Tolterodine	0.181	1.58	Moderate	297 (187/110)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F8BABA	5.34564547679198	1
Risperidone	Itraconazole	0.132	1.121	None	364 (199/165)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F9BCBC	6.55156550017603	1
Megestrol acetate	Phenobarbital	0.219	1.001	Moderate	54 (28/26)		#F9BCBC	0.971935541234905	1
Erythromycin	Digoxin	0.095	1.93	Moderate	320 (216/104)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F8BABA	5.75961802213277	1
Dihydroergotamine	Frovatriptan	0.436	1.673	Major	14 (9/5)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#F8BABA	0.251983288468309	1
Fluvastatin	Cholestyramine	0.21	-1.334	Moderate	56 (25/31)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#B4D1E6	1.00793315387324	1
Citalopram	Selegiline	0.235	1.975	Major	100 (68/32)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#F8BABA	1.79988063191649	1
Cyclosporine	Rosuvastatin	0.182	-1.829	Major	54 (20/34)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#B2D0E5	0.971935541234905	1
Trospium	Ipratropium	0.139	1.451	Moderate	146 (89/57)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F9BCBC	2.62782572259808	1
Theophylline	Propafenone	0.369	-2.286	Moderate	25 (8/17)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#B1CFE5	0.449970157979123	1
Bisoprolol	Ergotamine	0.142	2.539	Moderate	347 (254/93)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F7B9B9	6.24558579275022	1
Citalopram	Pimozide	0.268	1.075	Major	69 (37/32)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F9BCBC	1.24191763602238	1
Miglitol	Glucosamine	0.179	1.084	None	39 (21/18)		#F9BCBC	0.701953446447432	1
Metoprolol	Fluoxetine	0.224	2.38	Moderate	146 (105/41)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F7B9B9	2.62782572259808	1
Doxycycline	Insulin aspart	0.067	-1.695	Moderate	206 (80/126)		#B2D0E5	3.70775410174797	1
Dihydroergotamine	Bisoprolol	0.119	1.726	Moderate	240 (156/84)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	4.31971351659958	1
Sucralfate	Norfloxacin	0.29	1.448	Moderate	220 (134/86)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F9BCBC	3.95973739021628	1
Sulfasalazine	Mercaptopurine	0.198	2.091	Moderate	13 (9/4)		#F7B9B9	0.233984482149144	1.72278442597672e-06
Venlafaxine	Almotriptan	0.16	7.531	Major	355 (316/39)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#F0A9A9	6.38957624330354	1
Cyclosporine	Rifabutin	0.067	-3.228	None	4 (1/3)	The metabolism of Cyclosporine can be increased when combined with Rifabutin.	#AECDE3	0.0719952252766596	1
Nabumetone	Alendronic acid	0.139	13.322	Moderate	552 (516/36)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#E89898	9.93534108817903	1
Tacrolimus	Itraconazole	0.458	-1.137	Major	216 (105/111)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#B4D1E6	3.88774216493962	1
Nabumetone	Methotrexate	0.137	2.169	Major	90 (63/27)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#F7B9B9	1.61989256872484	1
Mefenamic acid	Acenocoumarol	0.112	-1.399	None	23 (10/13)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.413972545340793	1
Primidone	Nifedipine	0.158	-2.286	Major	25 (8/17)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#B1CFE5	0.449970157979123	1
Rifampicin	Gliclazide	0.109	-2.563	None	115 (34/81)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#B1CFE5	2.06986272670397	1
Doxycycline	Cloxacillin	0.598	-1.143	Moderate	460 (223/237)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#B4D1E6	8.27945090681586	1
Sotalol	Formoterol	0.124	1.07	Major	114 (61/53)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	2.0518639203848	1
Cyclosporine	Norfloxacin	0.096	1.452	Moderate	123 (75/48)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F9BCBC	2.21385317725728	1
Ketoconazole	Atorvastatin	0.101	-1.715	Major	179 (69/110)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	3.22178633113052	1
Tacrolimus	Metronidazole	0.2	-1.019	Moderate	259 (133/126)		#B4D1E6	4.66169083666371	1
Aprepitant	Dexamethasone	0.581	3.253	Moderate	9 (7/2)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#F6B6B6	0.161989256872484	2.57562954061943e-08
Metoprolol	Diltiazem	0.293	-1.235	Major	58 (27/31)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#B4D1E6	1.04393076651156	1
Allopurinol	Mercaptopurine	0.318	-2.6	Major	41 (12/29)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#AFCEE4	0.737951059085761	1
Amitriptyline	Terbutaline	0.152	3.304	Moderate	788 (615/173)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F6B6B6	14.183059379502	1
Isoniazid	Acenocoumarol	0.139	-2.243	None	145 (47/98)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#B1CFE5	2.60982691627891	1
Clonidine	Carvedilol	0.289	-2.797	Major	18 (5/13)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#AFCEE4	0.323978513744968	1
Paroxetine	Selegiline	0.24	1.48	Major	70 (43/27)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#F9BCBC	1.25991644234154	1
Amitriptyline	Donepezil	0.213	3.366	Moderate	305 (239/66)		#F6B6B6	5.4896359273453	1
Theophylline	Primidone	0.129	-5.917	Moderate	13 (2/11)	The metabolism of Theophylline can be increased when combined with Primidone.	#A6C7E0	0.233984482149144	1
Trospium	Biperiden	0.223	-1.435	Moderate	21 (9/12)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#B4D1E6	0.377974932702463	1
Erythromycin	Repaglinide	0.093	-1.021	Moderate	191 (98/93)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#B4D1E6	3.4377720069605	1
Lovastatin	Tacrolimus	0.073	1.022	Moderate	105 (55/50)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#F9BCBC	1.88987466351232	1
Phenytoin	Methotrexate	0.173	-1.399	Moderate	46 (20/26)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#B4D1E6	0.827945090681586	1
Clozapine	Alprazolam	0.206	-1.614	Major	65 (26/39)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#B2D0E5	1.16992241074572	1
Hydroxyzine	Rivastigmine	0.142	1.534	Moderate	273 (170/103)		#F8BABA	4.91367412513202	1
Cyclosporine	Diclofenac	0.105	-1.763	Moderate	248 (94/154)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	4.4637039671529	1
Cyclosporine	Fluoxetine	0.206	1.66	Moderate	117 (75/42)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F8BABA	2.10586033934229	1
Colestipol	Warfarin	0.189	-1.345	Minor	18 (8/10)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.323978513744968	1
Eplerenone	Clarithromycin	0.107	-2.616	Major	199 (58/141)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#AFCEE4	3.58176245751382	1
Theophylline	Norfloxacin	0.188	1.334	Moderate	151 (89/62)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F9BCBC	2.7178197541939	1
Fluvastatin	Bezafibrate	0.135	-3.873	None	23 (5/18)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#ACCCE3	0.413972545340793	1
Doxycycline	Phenobarbital	0.061	-1.322	Moderate	78 (35/43)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.40390689289486	1
Telmisartan	Lithium cation	0.197	-1.106	Moderate	73 (36/37)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B4D1E6	1.31391286129904	1
Paroxetine	Pimozide	0.199	1.287	Major	62 (36/26)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#F9BCBC	1.11592599178822	1
Doxycycline	Isotretinoin	0.241	-1.545	Major	95 (39/56)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#B2D0E5	1.70988660032067	1
Hydroxyzine	Galantamine	0.117	1.859	Moderate	216 (144/72)		#F8BABA	3.88774216493962	1
Phenytoin	Tacrolimus	0.165	-2.536	Major	47 (14/33)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#B1CFE5	0.845943897000751	1
Erythromycin	Lovastatin	0.084	1.825	Major	163 (108/55)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F8BABA	2.93380543002388	1
Ticlopidine	Carbamazepine	0.285	-1.691	Moderate	18 (7/11)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#B2D0E5	0.323978513744968	1
Alprazolam	Ketoconazole	0.147	1.954	Major	304 (206/98)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F8BABA	5.47163712102613	1
Irbesartan	Lithium cation	0.212	1.027	Moderate	80 (42/38)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#F9BCBC	1.43990450553319	1
Ibandronate	Iron	0.167	7.291	Moderate	283 (251/32)		#F1ABAB	5.09366218832367	1
Chlorpromazine	Galantamine	0.143	1.317	Moderate	29 (17/12)	The metabolism of Galantamine can be decreased when combined with Chlorpromazine.	#F9BCBC	0.521965383255782	0.358407431901781
Warfarin	Hydrocortisone	0.108	1.225	Moderate	146 (83/63)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#F9BCBC	2.62782572259808	1
Clozapine	Flurazepam	0.104	-2.69	Major	7 (2/5)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#AFCEE4	0.125991644234154	1
Indapamide	Lithium cation	0.174	-1.324	Major	58 (26/32)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B4D1E6	1.04393076651156	1
Erythromycin	Methylergometrine	0.921	3.485	None	19 (15/4)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#F6B6B6	0.341977320064133	1
Methotrexate	Cloxacillin	0.071	1.943	Major	340 (230/110)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F8BABA	6.11959414851607	1
Prazosin	Bisoprolol	0.277	-1.614	Moderate	30 (12/18)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B2D0E5	0.539964189574947	1
Rifampicin	Clarithromycin	0.542	-1.351	Moderate	212 (94/118)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B4D1E6	3.81574693966296	1
Almotriptan	Sertraline	0.158	5.678	Major	327 (281/46)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#F3AFAF	5.88560966636693	1
Fluconazole	Phenytoin	0.123	-1.332	Moderate	94 (42/52)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#B4D1E6	1.6918877940015	1
Verapamil	Midazolam	0.267	1.638	Moderate	58 (37/21)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F8BABA	1.04393076651156	1
Minocycline	Cloxacillin	0.549	-1.364	Moderate	220 (97/123)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#B4D1E6	3.95973739021628	1
Morphine	Rifampicin	0.362	-2.726	Moderate	53 (15/38)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#AFCEE4	0.95393673491574	1
Fluconazole	Lovastatin	0.066	2.107	Major	245 (170/75)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F7B9B9	4.4097075481954	1
Clomipramine	Rasagiline	0.233	1.785	Major	73 (48/25)	Rasagiline may increase the serotonergic activities of Clomipramine.	#F8BABA	1.31391286129904	1
Fentanyl	Ketoconazole	0.231	-1.779	Major	69 (26/43)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B2D0E5	1.24191763602238	1
Fluoxetine	Cilostazol	0.183	-1.766	Moderate	103 (39/64)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#B2D0E5	1.85387705087399	1
Phenytoin	Fludrocortisone	0.307	1.062	Moderate	15 (8/7)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#F9BCBC	0.269982094787474	0.544164660242924
Piroxicam	Bisoprolol	0.093	1.055	Moderate	126 (67/59)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#F9BCBC	2.26784959621478	1
Pregabalin	Rosiglitazone	0.187	1.097	Moderate	109 (59/50)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#F9BCBC	1.96186988878898	1
Alprazolam	Cimetidine	0.148	1.108	Moderate	57 (31/26)		#F9BCBC	1.0259319601924	1
Atorvastatin	Josamycin	0.07	1.246	None	302 (173/129)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F9BCBC	5.4356395083878	1
Erythromycin	Fluoxetine	0.109	5.003	Moderate	683 (576/107)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F4B1B1	12.2931847159896	1
Labetalol	Glyburide	0.15	-2.959	Moderate	15 (4/11)	Labetalol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	0.269982094787474	1
Pioglitazone	Glucosamine	0.153	1.215	None	90 (51/39)		#F9BCBC	1.61989256872484	1
Esomeprazole	Itraconazole	0.204	1.779	Moderate	405 (266/139)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F8BABA	7.28951655926179	1
Duloxetine	Propafenone	0.19	2.714	Moderate	98 (73/25)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F7B7B7	1.76388301927816	1
Repaglinide	Nadolol	0.203	-1.248	Moderate	54 (25/29)		#B4D1E6	0.971935541234905	1
Fluvoxamine	Doxepin	0.278	1.394	Major	10 (6/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#F9BCBC	0.179988063191649	0.73912913355327
Rifampicin	Nifedipine	0.118	-1.925	Major	53 (19/34)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#B2D0E5	0.95393673491574	1
Colestipol	Fluvastatin	0.186	-1.183	Moderate	21 (10/11)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.377974932702463	1
Fluconazole	Midazolam	0.283	1.555	Major	131 (82/49)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F8BABA	2.3578436278106	1
Diltiazem	Rifampicin	0.166	-1.237	Major	86 (40/46)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#B4D1E6	1.54789734344818	1
Triamcinolone	Phenobarbital	0.052	1.046	Moderate	68 (36/32)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#F9BCBC	1.22391882970321	1
Atropine	Donepezil	0.062	-2.152	Moderate	3 (1/2)	The therapeutic efficacy of Atropine can be decreased when used in combination with Donepezil.	#B1CFE5	0.0539964189574947	1
Warfarin	Clarithromycin	0.079	-1.005	Major	236 (122/114)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B4D1E6	4.24771829132292	1
Erythromycin	Amiodarone	0.106	1.064	Major	178 (95/83)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#F9BCBC	3.20378752481135	1
Prazosin	Carvedilol	0.28	-2.152	Moderate	12 (4/8)	Prazosin may increase the antihypertensive activities of Carvedilol.	#B1CFE5	0.215985675829979	1
Doxycycline	Carbamazepine	0.098	-1.449	Moderate	115 (49/66)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#B4D1E6	2.06986272670397	1
Erythromycin	Moxifloxacin	0.566	1.843	Major	340 (226/114)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F8BABA	6.11959414851607	1
Warfarin	Metronidazole	0.123	-1.435	Major	119 (51/68)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#B4D1E6	2.14185795198062	1
Formoterol	Nadolol	0.145	-1.094	Major	117 (58/59)		#B4D1E6	2.10586033934229	1
Atenolol	Prazosin	0.255	1.69	Moderate	31 (20/11)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F8BABA	0.557962995894112	0.297983657696977
Disulfiram	Isoniazid	0.237	-5.226	Moderate	41 (7/34)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#A9C9E1	0.737951059085761	1
Trospium	Haloperidol	0.2	1.743	Moderate	46 (30/16)		#F8BABA	0.827945090681586	1
Metoprolol	Verapamil	0.217	-1.345	Major	27 (12/15)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#B4D1E6	0.485967770617453	1
Cyclosporine	Naproxen	0.099	1.083	Moderate	236 (127/109)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	4.24771829132292	1
Piroxicam	Methotrexate	0.14	1.394	Major	40 (24/16)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#F9BCBC	0.719952252766596	1
Warfarin	Dexamethasone	0.156	-1.435	Moderate	91 (39/52)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.63789137504401	1
Glyburide	Oxprenolol	0.276	2.014	None	19 (13/6)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#F8BABA	0.341977320064133	0.00252583477584125
Capecitabine	Acenocoumarol	0.157	-1.143	None	66 (32/34)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#B4D1E6	1.18792121706488	1
Fluconazole	Eplerenone	0.081	-2.938	Moderate	97 (26/71)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#AFCEE4	1.745884212959	1
Labetalol	Gliclazide	0.176	-1.076	None	28 (14/14)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	0.503966576936618	1
Galantamine	Glycopyrronium	0.171	-3.945	None	28 (6/22)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#ACCCE3	0.503966576936618	1
Clonidine	Bisoprolol	0.267	-1.183	Major	42 (20/22)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	0.755949865404926	1
Methylprednisolone	Rifampicin	0.288	-1.019	Moderate	111 (57/54)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B4D1E6	1.99786750142731	1
Estradiol	Phenobarbital	0.175	6.772	Moderate	58 (51/7)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#F2ACAC	1.04393076651156	1
Donepezil	Clomipramine	0.228	2.954	Moderate	117 (89/28)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#F7B7B7	2.10586033934229	1
Galantamine	Maprotiline	0.343	2.324	Moderate	21 (15/6)		#F7B9B9	0.377974932702463	1
Fluconazole	Rifampicin	0.5	-1.238	Major	114 (53/61)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#B4D1E6	2.0518639203848	1
Fluconazole	Everolimus	0.185	-2.92	Major	26 (7/19)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#AFCEE4	0.467968964298288	1
Fluconazole	Fluvastatin	0.111	1.128	Moderate	166 (91/75)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	2.98780184898138	1
Isotretinoin	Minocycline	0.232	-1.31	Major	51 (23/28)	The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.	#B4D1E6	0.917939122277411	1
Trazodone	Itraconazole	0.134	2.612	Moderate	461 (340/121)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F7B7B7	8.29744971313503	1
Warfarin	Cloxacillin	0.05	-1.317	Moderate	149 (67/82)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#B4D1E6	2.68182214155557	1
Metronidazole	Lithium cation	0.047	1.859	Moderate	156 (104/52)		#F8BABA	2.80781378578973	1
Pseudoephedrine	Clomipramine	0.092	1.746	None	190 (124/66)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F8BABA	3.41977320064133	1
Digoxin	Prazosin	0.193	-1.506	None	12 (5/7)		#B4D1E6	0.215985675829979	1
Phenytoin	Sucralfate	0.204	-1.266	Moderate	37 (17/20)		#B4D1E6	0.665955833809102	1
Digoxin	Sulfasalazine	0.189	-1.578	Moderate	37 (15/22)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#B2D0E5	0.665955833809102	1
Rabeprazole	Itraconazole	0.189	1.826	Moderate	332 (220/112)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F8BABA	5.97560369796275	1
Telithromycin	Atorvastatin	0.119	-1.472	Major	45 (19/26)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#B4D1E6	0.809946284362421	1
Atenolol	Piroxicam	0.109	2.178	Moderate	117 (82/35)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F7B9B9	2.10586033934229	1
Venlafaxine	Propafenone	0.256	2.917	Moderate	120 (91/29)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#F7B7B7	2.15985675829979	1
Terbutaline	Rasagiline	0.052	-1.524	Moderate	87 (36/51)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#B4D1E6	1.56589614976735	1
Lithium cation	Etoricoxib	0.07	1.505	None	110 (68/42)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#F9BCBC	1.97986869510814	1
Propranolol	Rifampicin	0.157	-1.255	Moderate	78 (36/42)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#B4D1E6	1.40390689289486	1
Nortriptyline	Donepezil	0.217	1.343	Moderate	22 (13/9)		#F9BCBC	0.395973739021628	1
Warfarin	Primidone	0.131	1.115	Major	22 (12/10)	The metabolism of Warfarin can be increased when combined with Primidone.	#F9BCBC	0.395973739021628	1
Fludrocortisone	Rifampicin	0.146	-1.435	Moderate	14 (6/8)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#B4D1E6	0.251983288468309	1
Itraconazole	Solifenacin	0.146	1.465	Major	255 (156/99)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#F9BCBC	4.58969561138705	1
Galantamine	Clomipramine	0.227	2.055	Moderate	61 (42/19)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F8BABA	1.09792718546906	1
Rifampicin	Amiodarone	0.211	-1.506	Major	72 (30/42)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#B4D1E6	1.29591405497987	1
Erythromycin	Theophylline	0.29	-1.291	Moderate	66 (30/36)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#B4D1E6	1.18792121706488	1
Salbutamol	Doxepin	0.201	1.199	Moderate	71 (40/31)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F9BCBC	1.27791524866071	1
Fluconazole	Cyclophosphamide	0.483	1.223	None	44 (25/19)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#F9BCBC	0.791947478043256	1
Metoprolol	Propafenone	0.325	1.278	Moderate	19 (11/8)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#F9BCBC	0.341977320064133	1
Pantoprazole	Ketoconazole	0.276	-1.041	Moderate	122 (62/60)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#B4D1E6	2.19585437093812	1
Nortriptyline	Moclobemide	0.144	1.859	None	3 (2/1)	Moclobemide may increase the serotonergic activities of Nortriptyline.	#F8BABA	0.0539964189574947	1
Cimetidine	Donepezil	0.161	-1.793	Moderate	8 (3/5)	The metabolism of Donepezil can be decreased when combined with Cimetidine.	#B2D0E5	0.143990450553319	1
Phenytoin	Flurazepam	0.262	-1.076	Moderate	20 (10/10)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#B4D1E6	0.359976126383298	1
Colestipol	Digoxin	0.167	-1.883	Moderate	22 (8/14)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.395973739021628	1
Ketoconazole	Acenocoumarol	0.133	-2.317	None	82 (26/56)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#B1CFE5	1.47590211817152	1
Danazol	Acenocoumarol	0.169	1.239	None	28 (16/12)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	0.503966576936618	1
Tacrolimus	Felodipine	0.062	-1.23	Moderate	30 (14/16)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#B4D1E6	0.539964189574947	1
Nifedipine	Phenobarbital	0.361	1.37	Major	47 (28/19)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#F9BCBC	0.845943897000751	1
Simvastatin	Telithromycin	0.067	-1.775	Major	53 (20/33)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#B2D0E5	0.95393673491574	1
Glyburide	Rifampicin	0.162	-2.891	Moderate	59 (16/43)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#AFCEE4	1.06192957283073	1
Lovastatin	Itraconazole	0.059	1.593	Major	152 (96/56)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#F8BABA	2.73581856051307	1
Verapamil	Phenobarbital	0.295	1.735	Moderate	43 (28/15)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#F8BABA	0.773948671724091	1
Phenytoin	Disulfiram	0.195	-7.89	Moderate	25 (3/22)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#A2C4DE	0.449970157979123	1
Metoprolol	Hydralazine	0.26	-3.228	Minor	16 (4/12)	Hydralazine may increase the hypotensive activities of Metoprolol.	#AECDE3	0.287980901106639	1
Erythromycin	Quetiapine	0.099	2.202	Major	310 (218/92)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F7B9B9	5.57962995894112	1
Atenolol	Chlorpropamide	0.382	1.726	Moderate	20 (13/7)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#F8BABA	0.359976126383298	0.463476624881047
Disulfiram	Metronidazole	0.17	-2.468	Major	112 (34/78)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#B1CFE5	2.01586630774647	1
Hydrocortisone	Cholestyramine	0.25	1.215	Moderate	90 (51/39)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.61989256872484	1
Digoxin	Cyclophosphamide	0.186	1.001	Moderate	27 (14/13)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#F9BCBC	0.485967770617453	1
Cefoxitin	Acenocoumarol	0.034	-Inf	None	3 (0/3)	Cefoxitin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.0539964189574947	1
Atenolol	Clonidine	0.343	-1.998	Major	20 (7/13)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B2D0E5	0.359976126383298	1
Phenytoin	Rifampicin	0.151	-3.443	Major	21 (5/16)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#AECDE3	0.377974932702463	1
Phenytoin	Sulfadiazine	0.083	-Inf	Moderate	2 (0/2)	The metabolism of Sulfadiazine can be increased when combined with Phenytoin.	#1E61A5	0.0359976126383298	1
Chlorpropamide	Carvedilol	0.226	-1.076	Moderate	10 (5/5)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	0.179988063191649	1
Cyclosporine	Sulfasalazine	0.134	-2.51	Major	10 (3/7)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	0.179988063191649	1
Piroxicam	Carvedilol	0.127	-1.302	Moderate	42 (19/23)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#B4D1E6	0.755949865404926	1
Nabumetone	Warfarin	0.111	1.685	Major	45 (29/16)	Nabumetone may increase the anticoagulant activities of Warfarin.	#F8BABA	0.809946284362421	1
Carbamazepine	Itraconazole	0.112	1.461	Moderate	144 (88/56)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F9BCBC	2.59182810995975	1
Rifabutin	Tacrolimus	0.134	1.115	None	11 (6/5)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#F9BCBC	0.197986869510814	1
Trospium	Trihexyphenidyl	0.181	-3.228	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Trospium.	#AECDE3	0.0719952252766596	1
Warfarin	Naproxen	0.08	1.108	Major	320 (174/146)	Naproxen may increase the anticoagulant activities of Warfarin.	#F9BCBC	5.75961802213277	1
Clozapine	Bromazepam	0.333	-2.367	None	16 (5/11)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#B1CFE5	0.287980901106639	1
Clonidine	Doxepin	0.077	-Inf	Major	1 (0/1)	Doxepin may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.0179988063191649	1
Phenytoin	Doxycycline	0.074	-2.212	Moderate	55 (18/37)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#B1CFE5	0.98993434755407	1
Primidone	Methylprednisolone	0.193	-1.537	Moderate	34 (14/20)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#B2D0E5	0.611959414851607	1
Digoxin	Telithromycin	0.172	-1.614	Moderate	15 (6/9)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#B2D0E5	0.269982094787474	1
Nortriptyline	Salbutamol	0.126	2.101	Moderate	163 (113/50)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F7B9B9	2.93380543002388	1
Dihydroergotamine	Nitroglycerin	0.183	1.472	Moderate	124 (76/48)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#F9BCBC	2.23185198357645	1
Amitriptyline	Rifampicin	0.198	1.095	Minor	98 (53/45)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#F9BCBC	1.76388301927816	1
Celecoxib	Warfarin	0.108	1.536	Moderate	122 (76/46)	Celecoxib may increase the anticoagulant activities of Warfarin.	#F8BABA	2.19585437093812	1
Fluoxetine	Selegiline	0.358	1.394	Major	35 (21/14)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#F9BCBC	0.629958221170772	1
Testosterone	Warfarin	0.128	-Inf	Major	22 (0/22)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.395973739021628	1
Hydrocortisone	Rifampicin	0.236	-1.65	Moderate	76 (30/46)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#B2D0E5	1.36790928025653	1
Paroxetine	Frovatriptan	0.179	6.258	None	116 (101/15)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F2AEAE	2.08786153302313	1
Cyclosporine	Phenytoin	0.24	-1.793	Moderate	16 (6/10)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B2D0E5	0.287980901106639	1
Minocycline	Acenocoumarol	0.071	-1.513	None	154 (64/90)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	2.7718161731514	1
Phenytoin	Itraconazole	0.103	-1.383	Moderate	64 (28/36)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#B4D1E6	1.15192360442655	1
Metoprolol	Disopyramide	1	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Metoprolol.	#1E61A5	0.0179988063191649	1
Metoprolol	Primidone	0.322	-1.076	Moderate	10 (5/5)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#B4D1E6	0.179988063191649	1
Disulfiram	Acenocoumarol	0.166	-5.569	None	105 (17/88)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#A8C8E1	1.88987466351232	1
Itraconazole	Clarithromycin	0.539	1.581	Moderate	559 (352/207)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F8BABA	10.0613327324132	1
Celecoxib	Lithium cation	0.076	2.272	Major	124 (88/36)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F7B9B9	2.23185198357645	1
Midazolam	Clarithromycin	0.133	1.591	Moderate	179 (113/66)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F8BABA	3.22178633113052	1
Atomoxetine	Haloperidol	0.159	-4.519	Major	26 (5/21)	The metabolism of Haloperidol can be decreased when combined with Atomoxetine.	#ABCBE2	0.467968964298288	1
Ergotamine	Carvedilol	0.154	1.282	Moderate	69 (40/29)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F9BCBC	1.24191763602238	1
Theophylline	Propranolol	0.161	-1.148	Major	62 (30/32)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B4D1E6	1.11592599178822	1
Amitriptyline	Galantamine	0.203	2.788	Moderate	128 (96/32)		#F7B7B7	2.30384720885311	1
Cyclosporine	Clindamycin	0.092	-1.395	Moderate	62 (27/35)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#B4D1E6	1.11592599178822	1
Eletriptan	Dihydroergotamine	0.183	3.485	Major	19 (15/4)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#F6B6B6	0.341977320064133	1
Fluconazole	Cilostazol	0.082	-5.702	Major	63 (10/53)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#A8C8E1	1.13392479810739	1
Repaglinide	Rifampicin	0.125	-2.354	Moderate	51 (16/35)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#B1CFE5	0.917939122277411	1
Piroxicam	Alendronic acid	0.125	10.279	None	205 (188/17)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#EDA1A1	3.68975529542881	1
Betamethasone	Phenobarbital	0.037	-1.315	Moderate	20 (9/11)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.359976126383298	1
Labetalol	Ibuprofen	0.163	9.61	Moderate	601 (548/53)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#EDA3A3	10.8172825978181	1
Phenytoin	Triamcinolone	0.049	-1.205	Moderate	53 (25/28)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#B4D1E6	0.95393673491574	1
Haloperidol	Rifampicin	0.24	-1.377	Major	57 (25/32)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#B4D1E6	1.0259319601924	1
Eletriptan	Venlafaxine	0.151	10.921	Major	153 (141/12)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#EC9F9F	2.75381736683223	1
Methylphenidate	Rasagiline	0.188	-1.674	Moderate	46 (18/28)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#B2D0E5	0.827945090681586	1
Tolterodine	Itraconazole	0.11	1.813	Moderate	180 (119/61)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F8BABA	3.23978513744968	1
Naltrexone	Buprenorphine	0.316	-6.455	Major	14 (2/12)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#A5C6DF	0.251983288468309	1
Paroxetine	Moclobemide	0.299	1.195	None	16 (9/7)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#F9BCBC	0.287980901106639	1
Methylprednisolone	Itraconazole	0.369	1.196	Major	231 (130/101)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F9BCBC	4.15772425972709	1
Atomoxetine	Paroxetine	0.194	-1.531	Major	63 (26/37)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B4D1E6	1.13392479810739	1
Citalopram	Eletriptan	0.208	7.715	Major	186 (166/20)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#F0A9A9	3.34777797536467	1
Betamethasone	Acenocoumarol	0.066	1.122	None	117 (64/53)		#F9BCBC	2.10586033934229	1
Methadone	Rifampicin	0.319	-Inf	Major	5 (0/5)	The serum concentration of Methadone can be decreased when it is combined with Rifampicin.	#1E61A5	0.0899940315958246	1
Fluphenazine	Levofloxacin	0.13	-2.295	Moderate	47 (15/32)		#B1CFE5	0.845943897000751	1
Erythromycin	Verapamil	0.075	2.53	Major	134 (98/36)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F7B9B9	2.4118400467681	1
Itraconazole	Phenobarbital	0.067	1.41	Moderate	73 (44/29)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F9BCBC	1.31391286129904	1
Dextromethorphan	Rasagiline	0.078	-1.167	Major	123 (59/64)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#B4D1E6	2.21385317725728	1
Ergotamine	Clarithromycin	0.262	2.695	Major	234 (174/60)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F7B7B7	4.21172067868459	1
Cimetidine	Triazolam	0.714	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Ergotamine	Naratriptan	0.238	5.577	Major	14 (12/2)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#F3AFAF	0.251983288468309	0.0813787463141583
Cyclosporine	Rifampicin	0.231	-1.844	Major	19 (7/12)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#B2D0E5	0.341977320064133	1
Cyclosporine	Glyburide	0.152	-1.721	Moderate	39 (15/24)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#B2D0E5	0.701953446447432	1
Naratriptan	Escitalopram	0.227	3.187	Major	31 (24/7)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#F6B6B6	0.557962995894112	1
Captopril	Lithium cation	0.158	1.255	Moderate	47 (27/20)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#F9BCBC	0.845943897000751	1
Trospium	Amitriptyline	0.199	4.125	Moderate	87 (71/16)		#F5B4B4	1.56589614976735	1
Rifampicin	Dexamethasone	0.456	-1.514	Moderate	65 (27/38)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#B4D1E6	1.16992241074572	1
Verapamil	Nadolol	0.278	-1.614	Major	20 (8/12)	Verapamil may increase the hypotensive activities of Nadolol.	#B2D0E5	0.359976126383298	1
Metoprolol	Terbutaline	0.061	-1.116	Moderate	55 (27/28)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	0.98993434755407	1
Verapamil	Rifampicin	0.165	-1.703	Moderate	31 (12/19)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#B2D0E5	0.557962995894112	1
Rivastigmine	Doxepin	0.173	1.162	Moderate	9 (5/4)		#F9BCBC	0.161989256872484	1
Erythromycin	Warfarin	0.071	1.324	Major	80 (47/33)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#F9BCBC	1.43990450553319	1
Moxifloxacin	Sucralfate	0.319	1.037	Moderate	110 (58/52)		#F9BCBC	1.97986869510814	1
Erythromycin	Eplerenone	0.084	-3.062	Moderate	50 (13/37)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#AFCEE4	0.899940315958246	1
Ketoconazole	Budesonide	0.309	-1.087	Major	197 (98/99)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#B4D1E6	3.54576484487549	1
Acetylsalicylic acid	Heparin	0.135	-1.506	Moderate	12 (5/7)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#B4D1E6	0.215985675829979	1
Rifampicin	Propafenone	0.157	-2.367	Moderate	16 (5/11)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#B1CFE5	0.287980901106639	1
Trospium	Clomipramine	0.234	1.51	Moderate	21 (13/8)		#F9BCBC	0.377974932702463	1
Fentanyl	Itraconazole	0.154	1.989	Major	270 (184/86)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F8BABA	4.85967770617453	1
Pyridostigmine	Methylprednisolone	0.236	1.859	Moderate	51 (34/17)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#F8BABA	0.917939122277411	1
Ergotamine	Nitroglycerin	0.188	1.394	Moderate	115 (69/46)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#F9BCBC	2.06986272670397	1
Fluvoxamine	Warfarin	0.173	-1.166	Moderate	25 (12/13)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#B4D1E6	0.449970157979123	1
Gliclazide	Oxprenolol	0.392	1.549	None	16 (10/6)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#F8BABA	0.287980901106639	1
Warfarin	Rifampicin	0.145	-2.767	Major	25 (7/18)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#AFCEE4	0.449970157979123	1
Indomethacin	Sotalol	0.119	-4.088	Moderate	24 (5/19)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#ACCCE3	0.431971351659958	1
Cyclosporine	Carbamazepine	0.13	-1.076	Major	26 (13/13)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#B4D1E6	0.467968964298288	1
Ranolazine	Disopyramide	0.167	-Inf	Major	1 (0/1)	Ranolazine may increase the QTc-prolonging activities of Disopyramide.	#1E61A5	0.0179988063191649	1
Fludrocortisone	Phenobarbital	0.188	2.091	Moderate	13 (9/4)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#F7B9B9	0.233984482149144	0.795266373142083
Cyproheptadine	Donepezil	0.199	2.091	Moderate	13 (9/4)		#F7B9B9	0.233984482149144	1
Trospium	Olanzapine	0.161	1.936	Moderate	37 (25/12)		#F8BABA	0.665955833809102	1
Flutamide	Warfarin	0.128	-Inf	Moderate	6 (0/6)		#1E61A5	0.107992837914989	1
Lansoprazole	Ketoconazole	0.248	1.23	Moderate	79 (45/34)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#F9BCBC	1.42190569921403	1
Donepezil	Maprotiline	0.352	3.563	Moderate	29 (23/6)		#F6B6B6	0.521965383255782	1
Doxycycline	Methotrexate	0.158	1.878	Moderate	145 (97/48)		#F8BABA	2.60982691627891	1
Warfarin	Etoricoxib	0.113	-1.311	None	71 (32/39)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.27791524866071	1
Indomethacin	Lithium cation	0.103	1.104	Major	70 (38/32)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F9BCBC	1.25991644234154	1
Flurazepam	Itraconazole	0.151	1.433	None	61 (37/24)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#F9BCBC	1.09792718546906	1
Warfarin	Terbinafine	0.119	-2.367	Moderate	48 (15/33)		#B1CFE5	0.863942703319916	1
Phenytoin	Felodipine	0.18	1.549	Major	16 (10/6)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#F8BABA	0.287980901106639	1
Atenolol	Epinephrine	0.069	1.127	Moderate	104 (57/47)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F9BCBC	1.87187585719315	1
Megestrol acetate	Primidone	0.215	1.033	Moderate	19 (10/9)		#F9BCBC	0.341977320064133	1
Eletriptan	Sertraline	0.193	8.033	Major	135 (121/14)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#F0A7A7	2.42983885308726	1
Moxifloxacin	Sotalol	0.107	1.255	Major	47 (27/20)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	0.845943897000751	1
Galantamine	Trimipramine	0.16	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Erythromycin	Felodipine	0.137	-1.255	Moderate	26 (12/14)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#B4D1E6	0.467968964298288	1
Diltiazem	Buspirone	0.229	-1.435	Moderate	7 (3/4)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#B4D1E6	0.125991644234154	1
Triamcinolone	Warfarin	0.068	-1.043	Moderate	65 (33/32)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#B4D1E6	1.16992241074572	1
Fluoxetine	Frovatriptan	0.185	6.61	Major	73 (64/9)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#F2ACAC	1.31391286129904	1
Omeprazole	Chlordiazepoxide	0.116	2.788	Moderate	52 (39/13)		#F7B7B7	0.935937928596575	1
Amitriptyline	Clonidine	0.192	1.743	Major	23 (15/8)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#F8BABA	0.413972545340793	1
Ticlopidine	Theophylline	0.264	-1.076	Moderate	10 (5/5)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#B4D1E6	0.179988063191649	1
Clozapine	Rivastigmine	0.277	-1.793	Moderate	8 (3/5)		#B2D0E5	0.143990450553319	1
Diazepam	Ketoconazole	0.241	1.383	Moderate	199 (119/80)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F9BCBC	3.58176245751382	1
Tizanidine	Perindopril	0.125	1.107	Major	46 (25/21)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#F9BCBC	0.827945090681586	1
Perphenazine	Levofloxacin	0.08	1.423	Moderate	81 (49/32)		#F9BCBC	1.45790331185236	1
Epinephrine	Carvedilol	0.053	-1.565	Major	54 (22/32)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B2D0E5	0.971935541234905	1
Spironolactone	Cilazapril	0.208	-1.076	None	22 (11/11)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#B4D1E6	0.395973739021628	1
Labetalol	Repaglinide	0.166	-1.076	Moderate	12 (6/6)		#B4D1E6	0.215985675829979	1
Mercaptopurine	Acenocoumarol	0.181	-4.662	None	16 (3/13)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#ABCBE2	0.287980901106639	1
Digoxin	Bumetanide	0.265	2.417	Moderate	18 (13/5)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#F7B9B9	0.323978513744968	1
Ibuprofen	Oxprenolol	0.096	2.194	None	84 (59/25)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F7B9B9	1.51189973080985	1
Tacrolimus	Clarithromycin	0.308	1.153	Major	242 (134/108)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F9BCBC	4.35571112923791	1
Telithromycin	Acenocoumarol	0.081	1.007	None	25 (13/12)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#F9BCBC	0.449970157979123	1
Fluvoxamine	Zolmitriptan	0.117	1.943	Moderate	34 (23/11)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#F8BABA	0.611959414851607	1
Carteolol	Glyburide	0.048	-Inf	Moderate	1 (0/1)	Carteolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.0179988063191649	1
Cyproheptadine	Fluoxetine	0.276	2.207	Moderate	27 (19/8)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#F7B9B9	0.485967770617453	1
Thiethylperazine	Levofloxacin	0.439	1.288	None	272 (158/114)		#F9BCBC	4.89567531881286	1
Cilostazol	Itraconazole	0.088	-10.221	Major	42 (4/38)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#9ABEDB	0.755949865404926	1
Theophylline	Lithium cation	0.201	-1.315	Moderate	20 (9/11)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#B4D1E6	0.359976126383298	1
Cyclosporine	Lovastatin	0.178	-1.315	Major	20 (9/11)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#B4D1E6	0.359976126383298	1
Piroxicam	Acenocoumarol	0.148	-1.32	None	49 (22/27)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.881941509639081	1
Theophylline	Cimetidine	0.504	-Inf	Moderate	3 (0/3)	The metabolism of Theophylline can be decreased when combined with Cimetidine.	#1E61A5	0.0539964189574947	1
Fluvoxamine	Oxycodone	0.229	-1.315	Moderate	20 (9/11)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#B4D1E6	0.359976126383298	1
Eletriptan	Escitalopram	0.158	11.154	Major	156 (144/12)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#EB9E9E	2.80781378578973	1
Erythromycin	Carbamazepine	0.131	1.589	Major	84 (53/31)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F8BABA	1.51189973080985	1
Trospium	Imipramine	0.134	-1.076	Moderate	6 (3/3)		#B4D1E6	0.107992837914989	1
Flurbiprofen	Acenocoumarol	0.093	-1.524	None	29 (12/17)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.521965383255782	1
Carbamazepine	Felodipine	0.213	1.394	Moderate	20 (12/8)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#F9BCBC	0.359976126383298	1
Warfarin	Leflunomide	0.108	1.859	Moderate	24 (16/8)	Leflunomide may increase the anticoagulant activities of Warfarin.	#F8BABA	0.431971351659958	1
Sucralfate	Ibandronate	0.161	9.759	Moderate	115 (105/10)		#EDA3A3	2.06986272670397	1
Atenolol	Ampicillin	0.062	-1.324	Moderate	29 (13/16)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#B4D1E6	0.521965383255782	1
Citalopram	Moclobemide	0.168	1.084	None	13 (7/6)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#F9BCBC	0.233984482149144	1
Sotalol	Clarithromycin	0.054	1.611	Major	82 (52/30)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F8BABA	1.47590211817152	1
Warfarin	Mefenamic acid	0.044	-Inf	Major	2 (0/2)	Mefenamic acid may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0359976126383298	1
Citalopram	Frovatriptan	0.156	5.887	Major	88 (76/12)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F2AEAE	1.58389495608651	1
Itraconazole	Aripiprazole	0.082	1.394	Moderate	95 (57/38)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F9BCBC	1.70988660032067	1
Primidone	Dexamethasone	0.082	-1.998	Moderate	20 (7/13)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#B2D0E5	0.359976126383298	1
Dihydroergotamine	Nadolol	0.245	4.647	Moderate	36 (30/6)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F5B2B2	0.647957027489937	1
Alendronic acid	Flurbiprofen	0.126	8.598	Moderate	82 (74/8)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#EFA6A6	1.47590211817152	1
Venlafaxine	Frovatriptan	0.149	9.295	Major	77 (70/7)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#EEA4A4	1.3859080865757	1
Cimetidine	Nitrendipine	0.278	-2.152	None	3 (1/2)	The serum concentration of Nitrendipine can be increased when it is combined with Cimetidine.	#B1CFE5	0.0539964189574947	1
Norethisterone	Phenobarbital	0.143	7.9	Major	19 (17/2)	The metabolism of Norethisterone can be increased when combined with Phenobarbital.	#F0A9A9	0.341977320064133	1
Imipramine	Rasagiline	0.258	1.704	Major	17 (11/6)	Rasagiline may increase the serotonergic activities of Imipramine.	#F8BABA	0.305979707425803	1
Dihydroergotamine	Carvedilol	0.122	1.957	Moderate	59 (40/19)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F8BABA	1.06192957283073	1
Clodronic acid	Iron	0.252	-1.076	None	2 (1/1)		#B4D1E6	0.0359976126383298	1
Alprazolam	Josamycin	0.116	3.403	None	317 (249/68)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F6B6B6	5.70562160317528	1
Nortriptyline	Galantamine	0.224	1.627	Moderate	11 (7/4)		#F8BABA	0.197986869510814	1
Fluconazole	Flurazepam	0.122	2.366	None	78 (56/22)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#F7B9B9	1.40390689289486	1
Eprosartan	Lithium cation	0.159	1.239	Moderate	28 (16/12)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#F9BCBC	0.503966576936618	1
Fluconazole	Warfarin	0.093	1.382	Major	92 (55/37)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#F9BCBC	1.65589018136317	1
Tobramycin	Ceftriaxone	0.833	-2.152	Moderate	3 (1/2)		#B1CFE5	0.0539964189574947	1
Digoxin	Itraconazole	0.16	1.371	Major	151 (90/61)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#F9BCBC	2.7178197541939	1
Carbamazepine	Josamycin	0.104	-1.524	None	29 (12/17)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B4D1E6	0.521965383255782	1
Fluconazole	Celecoxib	0.254	2.788	Moderate	320 (240/80)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F7B7B7	5.75961802213277	1
Fluoxetine	Doxepin	0.227	5.577	Major	49 (42/7)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#F3AFAF	0.881941509639081	1
Cyclosporine	Piroxicam	0.053	-5.379	Moderate	6 (1/5)	Piroxicam may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	0.107992837914989	1
Quinapril	Lithium cation	0.14	-1.076	Moderate	16 (8/8)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#B4D1E6	0.287980901106639	1
Eplerenone	Lithium cation	0.104	-6.993	Moderate	15 (2/13)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#A3C5DF	0.269982094787474	1
Alprazolam	Telithromycin	0.135	2.169	Moderate	50 (35/15)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#F7B9B9	0.899940315958246	1
Cyclosporine	Bupropion	0.174	-10.759	Moderate	11 (1/10)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#99BDDA	0.197986869510814	1
Alendronic acid	Ketoprofen	0.129	12.238	Moderate	170 (158/12)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#EA9B9B	3.05979707425804	1
Dapsone	Trimethoprim	0.442	2.169	Moderate	10 (7/3)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Dapsone.	#F7B9B9	0.179988063191649	1
Trandolapril	Lithium cation	0.2	-1.614	Moderate	10 (4/6)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#B2D0E5	0.179988063191649	1
Tobramycin	Cefonicid	0.397	1.394	Moderate	5 (3/2)		#F9BCBC	0.0899940315958246	1
Erythromycin	Itraconazole	0.552	1.474	Major	150 (92/58)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F9BCBC	2.69982094787474	1
Lovastatin	Bezafibrate	0.218	1.975	None	25 (17/8)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#F8BABA	0.449970157979123	1
Ketoprofen	Acenocoumarol	0.062	-1.614	None	40 (16/24)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	0.719952252766596	1
Diltiazem	Triazolam	0.248	1.549	Moderate	16 (10/6)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#F8BABA	0.287980901106639	1
Cyclosporine	Clarithromycin	0.111	-1.134	Major	76 (37/39)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#B4D1E6	1.36790928025653	1
Tobramycin	Cefuroxime	0.478	-2.69	Moderate	14 (4/10)		#AFCEE4	0.251983288468309	1
Clozapine	Ciprofloxacin	0.098	-1.748	Major	42 (16/26)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B2D0E5	0.755949865404926	1
Trospium	Fluphenazine	0.241	-2.152	Moderate	3 (1/2)		#B1CFE5	0.0539964189574947	1
Levofloxacin	Josamycin	0.568	1.673	None	182 (117/65)		#F8BABA	3.27578275008801	1
Pyridostigmine	Hydrocortisone	0.161	1.573	Moderate	35 (22/13)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#F8BABA	0.629958221170772	1
Fluorouracil	Warfarin	0.06	-1.883	Major	11 (4/7)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#B2D0E5	0.197986869510814	1
Cimetidine	Nifedipine	0.139	-1.076	Moderate	8 (4/4)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#B4D1E6	0.143990450553319	1
Imipramine	Rivastigmine	0.242	2.124	Moderate	23 (16/7)		#F7B9B9	0.413972545340793	1
Ketoconazole	Rabeprazole	0.226	1.183	Moderate	50 (28/22)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#F9BCBC	0.899940315958246	1
Torasemide	Tobramycin	0.164	1.328	Major	17 (10/7)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#F9BCBC	0.305979707425803	1
Donepezil	Doxepin	0.224	2.479	Moderate	11 (8/3)		#F7B9B9	0.197986869510814	1
Codeine	Naltrexone	0.175	-2.152	Major	87 (29/58)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#B1CFE5	1.56589614976735	1
Repaglinide	Oxprenolol	0.227	-1.614	None	5 (2/3)		#B2D0E5	0.0899940315958246	1
Venlafaxine	Naratriptan	0.144	6.274	Major	31 (27/4)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#F2AEAE	0.557962995894112	1
Hydrocortisone	Primidone	0.115	-1.554	Moderate	22 (9/13)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#B2D0E5	0.395973739021628	1
Tetracycline	Insulin aspart	0.057	-1.291	Moderate	33 (15/18)		#B4D1E6	0.593960608532442	1
Labetalol	Salbutamol	0.165	5.164	Major	118 (100/18)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#F4B1B1	2.12385914566146	1
Trihexyphenidyl	Donepezil	0.263	2.231	Moderate	17 (12/5)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#F7B9B9	0.305979707425803	1
Fludrocortisone	Primidone	0.081	-2.152	Moderate	3 (1/2)	The serum concentration of Fludrocortisone can be decreased when it is combined with Primidone.	#B1CFE5	0.0539964189574947	1
Verapamil	Primidone	0.178	2.479	Moderate	22 (16/6)	The metabolism of Verapamil can be increased when combined with Primidone.	#F7B9B9	0.395973739021628	1
Cyclosporine	Ticlopidine	0.389	-1.614	Moderate	5 (2/3)	The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.	#B2D0E5	0.0899940315958246	1
Doxycycline	Digoxin	0.121	1.158	Moderate	128 (71/57)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#F9BCBC	2.30384720885311	1
Tizanidine	Quinapril	0.11	-1.076	Major	28 (14/14)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#B4D1E6	0.503966576936618	1
Cyclosporine	Itraconazole	0.267	-1.655	Major	33 (13/20)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#B2D0E5	0.593960608532442	1
Clarithromycin	Colchicine	0.198	-1.718	Major	187 (72/115)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#B2D0E5	3.36577678168384	1
Fluvoxamine	Ropinirole	0.198	1.487	Moderate	13 (8/5)	Fluvoxamine may increase the sedative activities of Ropinirole.	#F9BCBC	0.233984482149144	1
Theophylline	Acyclovir	0.132	-1.844	Minor	38 (14/24)		#B2D0E5	0.683954640128267	1
Lamotrigine	Rifampicin	0.058	-1.844	Moderate	19 (7/12)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#B2D0E5	0.341977320064133	1
Phenytoin	Fluorouracil	0.025	-2.69	Moderate	7 (2/5)	The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.	#AFCEE4	0.125991644234154	1
Disopyramide	Levofloxacin	0.08	-2.69	Major	7 (2/5)	Levofloxacin may increase the QTc-prolonging activities of Disopyramide.	#AFCEE4	0.125991644234154	1
Dextromethorphan	Selegiline	0.095	1.22	Major	37 (21/16)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#F9BCBC	0.665955833809102	1
Medroxyprogesterone acetate	Acenocoumarol	0.146	5.267	None	40 (34/6)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#F3AFAF	0.719952252766596	1
Amitriptyline	Pseudoephedrine	0.175	4.807	None	432 (362/70)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F4B1B1	7.77548432987924	1
Ketoconazole	Clonazepam	0.173	1.201	None	55 (31/24)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#F9BCBC	0.98993434755407	1
Rivastigmine	Pimozide	0.109	-1.435	Moderate	7 (3/4)		#B4D1E6	0.125991644234154	1
Erythromycin	Zafirlukast	0.249	2.324	Moderate	14 (10/4)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#F7B9B9	0.251983288468309	1
Donepezil	Pimozide	0.181	1.394	Moderate	10 (6/4)		#F9BCBC	0.179988063191649	1
Bromocriptine	Methotrimeprazine	0.221	1.394	Moderate	5 (3/2)	The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Bromocriptine.	#F9BCBC	0.0899940315958246	1
Fluoxetine	Josamycin	0.133	3.148	None	136 (105/31)		#F6B6B6	2.44783765940643	1
Ranolazine	Sotalol	0.413	-1.076	Major	8 (4/4)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.143990450553319	1
Imipramine	Terbutaline	0.113	1.859	Moderate	51 (34/17)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#F8BABA	0.917939122277411	1
Esomeprazole	Ketoconazole	0.258	1.01	Moderate	48 (25/23)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#F9BCBC	0.863942703319916	1
Labetalol	Salmeterol	0.188	2.272	Major	31 (22/9)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#F7B9B9	0.557962995894112	1
Halazepam	Ketoconazole	0.071	1.301	None	12 (7/5)		#F9BCBC	0.215985675829979	1
Trospium	Cetirizine	0.115	2.589	None	106 (78/28)		#F7B9B9	1.90787346983148	1
Meloxicam	Lithium cation	0.071	2.124	Major	46 (32/14)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#F7B9B9	0.827945090681586	1
Cyclosporine	Pyrazinamide	0.044	-4.304	Moderate	5 (1/4)	The serum concentration of Cyclosporine can be increased when it is combined with Pyrazinamide.	#ABCBE2	0.0899940315958246	1
Metoprolol	Piroxicam	0.158	1.162	Moderate	9 (5/4)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	0.161989256872484	1
Nortriptyline	Rasagiline	0.199	2.091	Major	13 (9/4)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#F7B9B9	0.233984482149144	1
Fluvoxamine	Dihydroergotamine	0.154	1.549	Major	16 (10/6)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#F8BABA	0.287980901106639	1
Haloperidol	Itraconazole	0.266	1.536	Moderate	130 (81/49)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#F8BABA	2.33984482149144	1
Glimepiride	Rifampicin	0.131	-3.873	Moderate	23 (5/18)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#ACCCE3	0.413972545340793	1
Cimetidine	Acenocoumarol	0.201	-2.421	None	13 (4/9)	Cimetidine may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.233984482149144	1
Citalopram	Josamycin	0.088	4.048	None	241 (196/45)		#F5B4B4	4.33771232291874	1
Propranolol	Epinephrine	0.134	2.021	Major	73 (50/23)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F8BABA	1.31391286129904	1
Oxcarbazepine	Felodipine	0.245	-1.291	Moderate	11 (5/6)		#B4D1E6	0.197986869510814	1
Warfarin	Isoniazid	0.158	-2.797	Moderate	18 (5/13)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#AFCEE4	0.323978513744968	1
Methotrexate	Ketoprofen	0.095	-1.076	Major	16 (8/8)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#B4D1E6	0.287980901106639	1
Cyclosporine	Nabumetone	0.089	-1.614	Moderate	10 (4/6)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	0.179988063191649	1
Tizanidine	Captopril	0.164	1.785	Major	73 (48/25)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F8BABA	1.31391286129904	1
Digoxin	Josamycin	0.086	1.859	None	72 (48/24)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#F8BABA	1.29591405497987	1
Frovatriptan	Sertraline	0.219	4.996	Major	51 (43/8)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#F4B1B1	0.917939122277411	1
Rifabutin	Simvastatin	0.065	-1.435	None	21 (9/12)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#B4D1E6	0.377974932702463	1
Bisoprolol	Chlorpropamide	0.227	2.014	Moderate	19 (13/6)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#F8BABA	0.341977320064133	1
Phenytoin	Capecitabine	0.104	-2.152	Moderate	6 (2/4)	The serum concentration of Phenytoin can be increased when it is combined with Capecitabine.	#B1CFE5	0.107992837914989	1
Carbamazepine	Doxepin	0.141	1.549	Moderate	8 (5/3)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#F8BABA	0.143990450553319	1
Dihydroergotamine	Oxprenolol	0.567	-Inf	None	1 (0/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Oxprenolol.	#1E61A5	0.0179988063191649	1
Epinephrine	Clomipramine	0.107	1.593	Major	38 (24/14)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#F8BABA	0.683954640128267	1
Estradiol	Ursodeoxycholic acid	0.207	10.968	None	64 (59/5)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#EC9F9F	1.15192360442655	1
Famotidine	Itraconazole	0.223	-1.524	Moderate	29 (12/17)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#B4D1E6	0.521965383255782	1
Erythromycin	Tacrolimus	0.243	1.093	Major	74 (40/34)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#F9BCBC	1.3319116676182	1
Dihydroergotamine	Clarithromycin	0.285	3.187	Major	155 (120/35)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#F6B6B6	2.78981497947056	1
Cyclosporine	Oxcarbazepine	0.181	-2.152	Moderate	12 (4/8)		#B1CFE5	0.215985675829979	1
Lovastatin	Josamycin	0.032	-1.076	None	28 (14/14)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#B4D1E6	0.503966576936618	1
Prednisolone	Phenobarbital	0.109	-1.565	Moderate	27 (11/16)	The serum concentration of Prednisolone can be decreased when it is combined with Phenobarbital.	#B2D0E5	0.485967770617453	1
Trimipramine	Donepezil	0.205	-1.076	Moderate	2 (1/1)		#B4D1E6	0.0359976126383298	1
Phenytoin	Estradiol	0.121	5.344	Moderate	27 (23/4)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#F3AFAF	0.485967770617453	1
Fluoxetine	Naratriptan	0.158	7.436	Major	36 (32/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#F0A9A9	0.647957027489937	1
Tetracycline	Amoxicillin	0.369	2.246	Moderate	410 (290/120)		#F7B9B9	7.37951059085761	1
Ceftriaxone	Acenocoumarol	0.07	-1.472	None	45 (19/26)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.809946284362421	1
Glipizide	Nadolol	0.335	-1.435	Moderate	7 (3/4)	Nadolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	0.125991644234154	1
Verapamil	Triazolam	0.378	2.788	Moderate	12 (9/3)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#F7B7B7	0.215985675829979	1
Fluconazole	Halazepam	0.114	2.788	None	60 (45/15)		#F7B7B7	1.07992837914989	1
Prazosin	Verapamil	0.551	3.253	Moderate	9 (7/2)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#F6B6B6	0.161989256872484	1
Ergotamine	Itraconazole	0.204	3.346	Major	92 (72/20)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#F6B6B6	1.65589018136317	1
Trazodone	Ketoconazole	0.137	1.348	Moderate	49 (29/20)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#F9BCBC	0.881941509639081	1
Rifampicin	Etoricoxib	0.223	1.144	None	58 (32/26)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#F9BCBC	1.04393076651156	1
Erythromycin	Cilostazol	0.128	-2.959	Major	30 (8/22)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#AFCEE4	0.539964189574947	1
Tacrolimus	Rifampicin	0.196	-1.937	Major	28 (10/18)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#B2D0E5	0.503966576936618	1
Clozapine	Modafinil	0.037	-Inf	Moderate	1 (0/1)	The metabolism of Clozapine can be decreased when combined with Modafinil.	#1E61A5	0.0179988063191649	1
Cimetidine	Clonazepam	0.167	1.394	Moderate	15 (9/6)		#F9BCBC	0.269982094787474	1
Disopyramide	Rivastigmine	0.102	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Doxycycline	Insulin detemir	0.074	1.042	Moderate	70 (37/33)		#F9BCBC	1.25991644234154	1
Cimetidine	Diazepam	0.245	1.627	Moderate	44 (28/16)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#F8BABA	0.791947478043256	1
Maprotiline	Rivastigmine	0.253	5.344	Moderate	27 (23/4)		#F3AFAF	0.485967770617453	1
Fluvoxamine	Ergotamine	0.198	2.324	Major	21 (15/6)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#F7B9B9	0.377974932702463	1
Colestipol	Hydrocortisone	0.289	1.239	Moderate	21 (12/9)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	0.377974932702463	1
Amitriptyline	Moclobemide	0.409	3.408	None	14 (11/3)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#F6B6B6	0.251983288468309	1
Donepezil	Zuclopenthixol	0.124	1.487	None	13 (8/5)		#F9BCBC	0.233984482149144	1
Frovatriptan	Escitalopram	0.154	11.021	Major	90 (83/7)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#EC9F9F	1.61989256872484	1
Moxifloxacin	Ziprasidone	0.11	2.002	Major	41 (28/13)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#F8BABA	0.737951059085761	1
Pyridostigmine	Dexamethasone	0.176	-1.195	Moderate	19 (9/10)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#B4D1E6	0.341977320064133	1
Gentamicin	Bumetanide	0.156	1.859	Major	3 (2/1)	The serum concentration of Gentamicin can be increased when it is combined with Bumetanide.	#F8BABA	0.0539964189574947	1
Theophylline	Rifampicin	0.129	-3.586	Moderate	13 (3/10)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#AECDE3	0.233984482149144	1
Doxycycline	Warfarin	0.08	-1.32	Moderate	49 (22/27)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#B4D1E6	0.881941509639081	1
Lidocaine	Labetalol	0.143	1.239	Moderate	7 (4/3)	The serum concentration of Lidocaine can be increased when it is combined with Labetalol.	#F9BCBC	0.125991644234154	1
Irbesartan	Drospirenone	0.038	1.394	Moderate	5 (3/2)	Irbesartan may increase the hyperkalemic activities of Drospirenone.	#F9BCBC	0.0899940315958246	1
Diazepam	Josamycin	0.21	2.541	None	280 (205/75)		#F7B9B9	5.03966576936618	1
Doxycycline	Iron	0.426	4.629	Moderate	311 (259/52)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F5B2B2	5.59762876526029	1
Trihexyphenidyl	Galantamine	0.338	-1.076	Moderate	6 (3/3)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#B4D1E6	0.107992837914989	1
Ranolazine	Verapamil	0.248	1.394	Major	20 (12/8)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#F9BCBC	0.359976126383298	1
Amikacin	Cefuroxime	0.62	-3.228	Moderate	8 (2/6)		#AECDE3	0.143990450553319	1
Doxycycline	Benzylpenicillin	0.852	-2.152	Moderate	9 (3/6)	The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Doxycycline.	#B1CFE5	0.161989256872484	1
Norethisterone	Primidone	0.436	2.788	None	4 (3/1)	The metabolism of Norethisterone can be increased when combined with Primidone.	#F7B7B7	0.0719952252766596	1
Indomethacin	Nadolol	0.294	2.672	Moderate	62 (46/16)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#F7B7B7	1.11592599178822	1
Piroxicam	Propranolol	0.142	3.464	Moderate	52 (41/11)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#F6B6B6	0.935937928596575	1
Fluvoxamine	Almotriptan	0.105	3.346	Major	23 (18/5)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#F6B6B6	0.413972545340793	1
Fluoxetine	Moclobemide	0.172	2.169	None	10 (7/3)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.	#F7B9B9	0.179988063191649	1
Doxycycline	Insulin glulisine	0.098	-1.572	Moderate	32 (13/19)		#B2D0E5	0.575961802213277	1
Perphenazine	Rivastigmine	0.201	1.301	Moderate	12 (7/5)		#F9BCBC	0.215985675829979	1
Colestipol	Raloxifene	0.259	5.577	Moderate	14 (12/2)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F3AFAF	0.251983288468309	1
Donepezil	Perphenazine	0.119	1.301	Moderate	12 (7/5)		#F9BCBC	0.215985675829979	1
Erythromycin	Dihydroergotamine	0.193	1.93	Major	40 (27/13)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#F8BABA	0.719952252766596	1
Lovastatin	Rifampicin	0.134	1.472	Major	31 (19/12)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#F9BCBC	0.557962995894112	1
Tenoxicam	Acenocoumarol	0.161	-2.152	None	18 (6/12)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.323978513744968	1
Imipramine	Galantamine	0.23	3.485	Moderate	19 (15/4)	The metabolism of Galantamine can be decreased when combined with Imipramine.	#F6B6B6	0.341977320064133	1
Cyclosporine	Primidone	0.093	1.239	Moderate	7 (4/3)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#F9BCBC	0.125991644234154	1
Nateglinide	Glucosamine	0.122	-1.076	None	4 (2/2)		#B4D1E6	0.0719952252766596	1
Sucralfate	Itraconazole	0.402	1.295	None	67 (39/28)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.20592002338405	1
Lovastatin	Danazol	0.417	-Inf	Major	2 (0/2)	The risk or severity of myopathy and rhabdomyolysis can be increased when Danazol is combined with Lovastatin.	#1E61A5	0.0359976126383298	1
Rifampicin	Fluvastatin	0.151	-3.497	Moderate	17 (4/13)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#AECDE3	0.305979707425803	1
Trospium	Trifluoperazine	0.357	-1.076	Moderate	2 (1/1)		#B4D1E6	0.0359976126383298	1
Torasemide	Amikacin	0.034	1.162	Major	9 (5/4)	The serum concentration of Amikacin can be increased when it is combined with Torasemide.	#F9BCBC	0.161989256872484	1
Sirolimus	Rifampicin	0.452	-Inf	Major	3 (0/3)	The metabolism of Sirolimus can be increased when combined with Rifampicin.	#1E61A5	0.0539964189574947	1
Fluconazole	Ranolazine	0.166	-1.761	Major	29 (11/18)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#B2D0E5	0.521965383255782	1
Ranitidine	Ketoconazole	0.246	1.261	Moderate	66 (38/28)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	1.18792121706488	1
Carbamazepine	Danazol	0.322	-Inf	Moderate	2 (0/2)	The metabolism of Carbamazepine can be decreased when combined with Danazol.	#1E61A5	0.0359976126383298	1
Trospium	Loratadine	0.126	3.031	None	98 (75/23)		#F7B7B7	1.76388301927816	1
Ethinylestradiol	Amoxicillin	0.117	1113.538	Moderate	29976 (29951/25)		#B32020	539.532218223287	1
Midazolam	Itraconazole	0.243	1.911	Major	55 (37/18)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#F8BABA	0.98993434755407	1
Halazepam	Itraconazole	0.174	2.401	None	43 (31/12)		#F7B9B9	0.773948671724091	1
Nortriptyline	Rivastigmine	0.218	5.112	Moderate	26 (22/4)		#F4B1B1	0.467968964298288	1
Lamotrigine	Norethisterone	0.126	36.714	Moderate	81 (79/2)		#CA5454	1.45790331185236	1
Pramipexole	Cimetidine	0.058	-Inf	Moderate	2 (0/2)	The serum concentration of Pramipexole can be increased when it is combined with Cimetidine.	#1E61A5	0.0359976126383298	1
Ranolazine	Clarithromycin	0.111	-2.152	Major	45 (15/30)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#B1CFE5	0.809946284362421	1
Fluconazole	Imipramine	0.112	3.36	Moderate	60 (47/13)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F6B6B6	1.07992837914989	1
Cyclosporine	Chloroquine	0.259	1.394	Moderate	5 (3/2)	Chloroquine may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	0.0899940315958246	1
Naratriptan	Sertraline	0.135	3.95	Major	21 (17/4)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#F5B4B4	0.377974932702463	1
Dextropropoxyphene	Acenocoumarol	0.177	2.272	None	31 (22/9)		#F7B9B9	0.557962995894112	1
Trospium	Potassium chloride	0.28	1.239	Major	7 (4/3)	Trospium may increase the ulcerogenic activities of Potassium Chloride.	#F9BCBC	0.125991644234154	1
Cyclosporine	Propafenone	0.386	-Inf	Minor	4 (0/4)	The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.	#1E61A5	0.0719952252766596	1
Methadone	Carbamazepine	0.183	-1.614	Major	5 (2/3)	The metabolism of Methadone can be increased when combined with Carbamazepine.	#B2D0E5	0.0899940315958246	1
Imipramine	Rifampicin	0.16	-2.69	Minor	7 (2/5)	The metabolism of Imipramine can be increased when combined with Rifampicin.	#AFCEE4	0.125991644234154	1
Dihydroergotamine	Isosorbide mononitrate	0.249	1.115	Moderate	22 (12/10)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#F9BCBC	0.395973739021628	1
Cyclobenzaprine	Rasagiline	0.083	1.058	Major	62 (33/29)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#F9BCBC	1.11592599178822	1
Amitriptyline	Epinephrine	0.162	4.985	Major	140 (118/22)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F4B1B1	2.51983288468309	1
Rivastigmine	Flavoxate	0.252	1.394	Moderate	5 (3/2)		#F9BCBC	0.0899940315958246	1
Theophylline	Sotalol	0.209	-1.076	Major	8 (4/4)	Sotalol may decrease the bronchodilatory activities of Theophylline.	#B4D1E6	0.143990450553319	1
Sotalol	Clonidine	0.242	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#1E61A5	0.0179988063191649	1
Rifampicin	Clomipramine	0.097	1.436	Minor	28 (17/11)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#F9BCBC	0.503966576936618	1
Terbutaline	Nadolol	0.155	1.51	Major	42 (26/16)		#F9BCBC	0.755949865404926	1
Warfarin	Itraconazole	0.078	1.01	Moderate	48 (25/23)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#F9BCBC	0.863942703319916	1
Clozapine	Donepezil	0.262	-1.614	Moderate	5 (2/3)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#B2D0E5	0.0899940315958246	1
Diltiazem	Sirolimus	0.275	-1.345	Moderate	9 (4/5)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#B4D1E6	0.161989256872484	1
Metoprolol	Lidocaine	0.077	3.187	Moderate	31 (24/7)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#F6B6B6	0.557962995894112	1
Amikacin	Ceftriaxone	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Ketoconazole	Solifenacin	0.18	-1.369	Major	25 (11/14)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#B4D1E6	0.449970157979123	1
Galantamine	Zuclopenthixol	0.202	1.549	None	8 (5/3)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#F8BABA	0.143990450553319	1
Primidone	Metronidazole	0.183	-1.076	Moderate	22 (11/11)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#B4D1E6	0.395973739021628	1
Repaglinide	Josamycin	0.059	1.291	None	43 (25/18)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#F9BCBC	0.773948671724091	1
Almotriptan	Itraconazole	0.193	4.78	Moderate	86 (72/14)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#F4B1B1	1.54789734344818	1
Alfuzosin	Ketoconazole	0.089	-Inf	Major	10 (0/10)	The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.	#1E61A5	0.179988063191649	1
Bumetanide	Ibuprofen	0.164	2.965	Moderate	88 (67/21)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#F7B7B7	1.58389495608651	1
Midazolam	Rifampicin	0.245	1.062	Minor	15 (8/7)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#F9BCBC	0.269982094787474	1
Clozapine	Ketazolam	0.527	-1.614	None	5 (2/3)	The risk or severity of adverse effects can be increased when Clozapine is combined with Ketazolam.	#B2D0E5	0.0899940315958246	1
Dextromethorphan	Terbinafine	0.448	1.553	Major	195 (122/73)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F8BABA	3.50976723223716	1
Spironolactone	Mitotane	0.325	1.859	Major	3 (2/1)	The therapeutic efficacy of Mitotane can be decreased when used in combination with Spironolactone.	#F8BABA	0.0539964189574947	1
Tenoxicam	Alendronic acid	0.176	14.5	None	83 (78/5)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#E79494	1.49390092449069	1
Phenytoin	Betamethasone	0.033	2.014	Moderate	19 (13/6)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#F8BABA	0.341977320064133	1
Galantamine	Perphenazine	0.172	1.859	Moderate	9 (6/3)		#F8BABA	0.161989256872484	1
Phenytoin	Sirolimus	0.142	-1.076	Major	4 (2/2)	The serum concentration of Sirolimus can be decreased when it is combined with Phenytoin.	#B4D1E6	0.0719952252766596	1
Erythromycin	Clozapine	0.099	-5.379	Moderate	6 (1/5)	The metabolism of Clozapine can be decreased when combined with Erythromycin.	#A8C8E1	0.107992837914989	1
Erythromycin	Ergotamine	0.194	2.401	Major	43 (31/12)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#F7B9B9	0.773948671724091	1
Fluconazole	Ergotamine	0.237	5.577	Moderate	119 (102/17)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#F3AFAF	2.14185795198062	1
Telithromycin	Amiodarone	0.081	-2.152	Major	6 (2/4)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#B1CFE5	0.107992837914989	1
Methotrexate	Sulindac	0.062	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Sulindac.	#1E61A5	0.0179988063191649	1
Rosiglitazone	Ketoconazole	0.096	-Inf	Moderate	4 (0/4)	The metabolism of Rosiglitazone can be decreased when combined with Ketoconazole.	#1E61A5	0.0719952252766596	1
Ketoconazole	Quetiapine	0.108	1.64	Major	47 (30/17)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#F8BABA	0.845943897000751	1
Phenytoin	Isoniazid	0.159	-2.51	Moderate	10 (3/7)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#B1CFE5	0.179988063191649	1
Galantamine	Pimozide	0.514	-1.076	Moderate	4 (2/2)	Galantamine may increase the QTc-prolonging activities of Pimozide.	#B4D1E6	0.0719952252766596	1
Clemastine	Donepezil	0.147	1.394	Moderate	10 (6/4)	The metabolism of Donepezil can be decreased when combined with Clemastine.	#F9BCBC	0.179988063191649	1
Sotalol	Terbutaline	0.095	1.014	Major	23 (12/11)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	0.413972545340793	1
Labetalol	Verapamil	0.109	2.324	Major	7 (5/2)	Verapamil may increase the hypotensive activities of Labetalol.	#F7B9B9	0.125991644234154	1
Rizatriptan	Moclobemide	0.07	-1.076	None	2 (1/1)	The serum concentration of Rizatriptan can be increased when it is combined with Moclobemide.	#B4D1E6	0.0359976126383298	1
Imipramine	Pseudoephedrine	0.116	2.873	None	45 (34/11)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F7B7B7	0.809946284362421	1
Cyclophosphamide	Warfarin	0.217	-1.614	Moderate	5 (2/3)		#B2D0E5	0.0899940315958246	1
Paroxetine	Naratriptan	0.154	8.133	Major	39 (35/4)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#F0A7A7	0.701953446447432	1
Dihydroergotamine	Isosorbide dinitrate	0.144	-2.152	Moderate	3 (1/2)	The metabolism of Isosorbide Dinitrate can be decreased when combined with Dihydroergotamine.	#B1CFE5	0.0539964189574947	1
Methadone	Primidone	0.119	-1.076	Major	2 (1/1)	The serum concentration of Methadone can be decreased when it is combined with Primidone.	#B4D1E6	0.0359976126383298	1
Cimetidine	Rivastigmine	0.122	-Inf	Moderate	2 (0/2)		#1E61A5	0.0359976126383298	1
Tetracycline	Acenocoumarol	0.051	1.352	None	54 (32/22)		#F9BCBC	0.971935541234905	1
Clozapine	Lisinopril	0.097	-1.721	Moderate	13 (5/8)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#B2D0E5	0.233984482149144	1
Fluconazole	Vincristine	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Vincristine can be decreased when combined with Fluconazole.	#1E61A5	0.0179988063191649	1
Warfarin	Disulfiram	0.111	-6.455	Moderate	14 (2/12)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#A5C6DF	0.251983288468309	1
Cyclosporine	Nicardipine	0.183	1.394	Moderate	10 (6/4)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#F9BCBC	0.179988063191649	1
Phenytoin	Clozapine	0.207	-1.076	Moderate	4 (2/2)	The serum concentration of Clozapine can be decreased when it is combined with Phenytoin.	#B4D1E6	0.0719952252766596	1
Piroxicam	Labetalol	0.171	-1.076	Moderate	2 (1/1)	Piroxicam may decrease the antihypertensive activities of Labetalol.	#B4D1E6	0.0359976126383298	1
Celecoxib	Rifampicin	0.22	1.223	Moderate	44 (25/19)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#F9BCBC	0.791947478043256	1
Trandolapril	Tizanidine	0.088	1.062	Major	15 (8/7)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#F9BCBC	0.269982094787474	1
Galantamine	Ketoconazole	0.1	1.115	Moderate	11 (6/5)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#F9BCBC	0.197986869510814	1
Trospium	Hydroxyzine	0.204	2.711	Moderate	47 (35/12)		#F7B7B7	0.845943897000751	1
Cyclosporine	Ketoprofen	0.063	-1.614	Moderate	5 (2/3)	Ketoprofen may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	0.0899940315958246	1
Tetracycline	Iron	0.499	4.433	Moderate	75 (62/13)		#F5B2B2	1.34991047393737	1
Eletriptan	Fluoxetine	0.141	19.984	Major	135 (129/6)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#E08585	2.42983885308726	1
Cyclosporine	Glipizide	0.413	-1.614	Moderate	5 (2/3)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#B2D0E5	0.0899940315958246	1
Triazolam	Clarithromycin	0.169	2.065	Moderate	29 (20/9)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#F8BABA	0.521965383255782	1
Erythromycin	Rifampicin	0.492	-1.345	Moderate	27 (12/15)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B4D1E6	0.485967770617453	1
Haloperidol	Ketoconazole	0.264	1.267	Major	26 (15/11)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#F9BCBC	0.467968964298288	1
Cyclosporine	Ethinylestradiol	0.116	32.531	Moderate	36 (35/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#CF5F5F	0.647957027489937	1
Erythromycin	Cabergoline	0.452	9.759	Major	69 (63/6)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#EDA3A3	1.24191763602238	1
Carbamazepine	Norethisterone	0.145	19.519	Major	44 (42/2)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#E18686	0.791947478043256	1
Fluconazole	Dihydroergotamine	0.309	3.452	Moderate	66 (52/14)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F6B6B6	1.18792121706488	1
Erythromycin	Midazolam	0.163	2.112	Moderate	36 (25/11)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#F7B9B9	0.647957027489937	1
Carbamazepine	Isotretinoin	0.058	-2.869	Moderate	11 (3/8)		#AFCEE4	0.197986869510814	1
Rifabutin	Acenocoumarol	0.079	-4.304	None	5 (1/4)	The metabolism of Acenocoumarol can be increased when combined with Rifabutin.	#ABCBE2	0.0899940315958246	1
Ergotamine	Isosorbide dinitrate	0.029	-1.076	Moderate	4 (2/2)		#B4D1E6	0.0719952252766596	1
Ketoconazole	Aripiprazole	0.088	-1.883	Moderate	11 (4/7)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#B2D0E5	0.197986869510814	1
Amitriptyline	Ketoconazole	0.149	2.523	Moderate	52 (38/14)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#F7B9B9	0.935937928596575	1
Doxycycline	Primidone	0.066	-8.607	Moderate	9 (1/8)	The serum concentration of Doxycycline can be decreased when it is combined with Primidone.	#9FC1DD	0.161989256872484	1
Prednisone	Estradiol	0.133	75.566	Moderate	1646 (1626/20)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	29.6260352013454	1
Digoxin	Minocycline	0.094	1.069	Moderate	43 (23/20)		#F9BCBC	0.773948671724091	1
Cyclosporine	Methylphenidate	0.15	1.239	Minor	21 (12/9)		#F9BCBC	0.377974932702463	1
Cimetidine	Carbamazepine	0.048	-1.076	Moderate	4 (2/2)	The serum concentration of Carbamazepine can be increased when it is combined with Cimetidine.	#B4D1E6	0.0719952252766596	1
Cimetidine	Clomipramine	0.189	-2.152	Moderate	3 (1/2)	The metabolism of Clomipramine can be decreased when combined with Cimetidine.	#B1CFE5	0.0539964189574947	1
Nortriptyline	Terbutaline	0.132	2.207	Moderate	27 (19/8)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#F7B9B9	0.485967770617453	1
Sucralfate	Ketoconazole	0.797	-1.883	Minor	11 (4/7)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.197986869510814	1
Haloperidol	Atropine	0.429	2.788	Moderate	4 (3/1)		#F7B7B7	0.0719952252766596	1
Fluvoxamine	Theophylline	0.297	1.859	Major	15 (10/5)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#F8BABA	0.269982094787474	1
Metoprolol	Phenobarbital	0.169	1.859	Moderate	9 (6/3)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#F8BABA	0.161989256872484	1
Eplerenone	Itraconazole	0.072	-3.766	Major	27 (6/21)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#ACCCE3	0.485967770617453	1
Phenytoin	Quazepam	0.016	-1.076	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Quazepam.	#B4D1E6	0.0359976126383298	1
Metoprolol	Dihydroergotamine	0.153	5.267	Moderate	20 (17/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#F3AFAF	0.359976126383298	1
Imipramine	Donepezil	0.235	3.95	Moderate	21 (17/4)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#F5B4B4	0.377974932702463	1
Trospium	Fexofenadine	0.05	2.324	None	7 (5/2)		#F7B9B9	0.125991644234154	1
Dihydroergotamine	Itraconazole	0.237	3.176	Major	53 (41/12)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#F6B6B6	0.95393673491574	1
Doxycycline	Ampicillin	0.802	-1.506	Moderate	12 (5/7)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#B4D1E6	0.215985675829979	1
Griseofulvin	Acenocoumarol	0.044	-Inf	None	10 (0/10)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.179988063191649	1
Salbutamol	Oxprenolol	0.09	1.859	None	18 (12/6)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#F8BABA	0.323978513744968	1
Imipramine	Ketoconazole	0.116	1.549	Moderate	8 (5/3)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#F8BABA	0.143990450553319	1
Doxycycline	Acitretin	0.186	-2.152	Major	12 (4/8)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#B1CFE5	0.215985675829979	1
Cyclosporine	Glimepiride	0.128	1.062	Moderate	15 (8/7)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#F9BCBC	0.269982094787474	1
Trospium	Maprotiline	0.187	5.577	Moderate	7 (6/1)		#F3AFAF	0.125991644234154	1
Minocycline	Iron	0.292	3.718	Moderate	100 (80/20)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F5B4B4	1.79988063191649	1
Fluvoxamine	Rizatriptan	0.17	7.25	Major	44 (39/5)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#F1ABAB	0.791947478043256	1
Rivastigmine	Periciazine	0.122	-2.152	None	3 (1/2)		#B1CFE5	0.0539964189574947	1
Donepezil	Periciazine	0.201	-2.152	None	3 (1/2)		#B1CFE5	0.0539964189574947	1
Fosinopril	Lithium cation	0.142	-1.614	Moderate	5 (2/3)	The serum concentration of Lithium can be increased when it is combined with Fosinopril.	#B2D0E5	0.0899940315958246	1
Felodipine	Itraconazole	0.06	2.091	Major	26 (18/8)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#F7B9B9	0.467968964298288	1
Rifampicin	Bupropion	0.351	-2.152	Moderate	12 (4/8)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#B1CFE5	0.215985675829979	1
Metoprolol	Telithromycin	1	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Telithromycin.	#1E61A5	0.0179988063191649	1
Ergotamine	Isosorbide mononitrate	0.147	1.162	Moderate	18 (10/8)		#F9BCBC	0.323978513744968	1
Salmeterol	Oxprenolol	0.159	1.239	None	7 (4/3)	Oxprenolol may decrease the bronchodilatory activities of Salmeterol.	#F9BCBC	0.125991644234154	1
Warfarin	Ofloxacin	0.065	-1.614	Major	10 (4/6)		#B2D0E5	0.179988063191649	1
Clonidine	Nadolol	0.223	1.859	Major	3 (2/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F8BABA	0.0539964189574947	1
Chlorthalidone	Lithium cation	0.11	2.633	Major	23 (17/6)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#F7B7B7	0.413972545340793	1
Warfarin	Meloxicam	0.068	-1.195	Major	19 (9/10)	Meloxicam may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.341977320064133	1
Buspirone	Verapamil	0.19	-Inf	Moderate	1 (0/1)	The metabolism of Buspirone can be decreased when combined with Verapamil.	#1E61A5	0.0179988063191649	1
Phenytoin	Mebendazole	0.057	-3.228	Moderate	12 (3/9)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#AECDE3	0.215985675829979	1
Metoprolol	Ergotamine	0.325	5.577	Moderate	21 (18/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#F3AFAF	0.377974932702463	1
Trospium	Desloratadine	0.173	2.272	None	31 (22/9)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#F7B9B9	0.557962995894112	1
Rifabutin	Atorvastatin	0.069	-1.076	Moderate	10 (5/5)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#B4D1E6	0.179988063191649	1
Erythromycin	Colchicine	0.271	-1.345	Major	45 (20/25)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#B4D1E6	0.809946284362421	1
Alprazolam	Aprepitant	0.19	-1.076	Moderate	2 (1/1)	The serum concentration of Alprazolam can be increased when it is combined with Aprepitant.	#B4D1E6	0.0359976126383298	1
Cyclosporine	Erythromycin	0.089	1.046	Major	17 (9/8)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#F9BCBC	0.305979707425803	1
Ofloxacin	Iron	0.488	1.436	None	28 (17/11)		#F9BCBC	0.503966576936618	1
Furosemide	Streptomycin	0.057	-Inf	Major	2 (0/2)	The serum concentration of Streptomycin can be increased when it is combined with Furosemide.	#1E61A5	0.0359976126383298	1
Clemastine	Rivastigmine	0.087	-1.076	Moderate	6 (3/3)		#B4D1E6	0.107992837914989	1
Methylprednisolone	Ketoconazole	0.407	-1.291	Major	22 (10/12)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#B4D1E6	0.395973739021628	1
Fluvoxamine	Rasagiline	0.146	-1.076	Major	8 (4/4)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#B4D1E6	0.143990450553319	1
Theophylline	Disulfiram	0.108	-2.152	Moderate	12 (4/8)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#B1CFE5	0.215985675829979	1
Carbamazepine	Ketoconazole	0.162	-1.291	Moderate	11 (5/6)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#B4D1E6	0.197986869510814	1
Clozapine	Norfloxacin	0.095	1.487	Major	13 (8/5)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#F9BCBC	0.233984482149144	1
Fluvoxamine	Cilostazol	0.25	-5.379	Major	6 (1/5)	The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine.	#A8C8E1	0.107992837914989	1
Clozapine	Halazepam	0.489	-1.076	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Halazepam.	#B4D1E6	0.0359976126383298	1
Fosinopril	Tizanidine	0.242	2.045	Major	16 (11/5)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#F8BABA	0.287980901106639	1
Ketoconazole	Tolterodine	0.116	1.328	Moderate	17 (10/7)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#F9BCBC	0.305979707425803	1
Benazepril	Tizanidine	0.092	-Inf	Major	2 (0/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Benazepril.	#1E61A5	0.0359976126383298	1
Theophylline	Terbinafine	0.122	-1.076	Moderate	22 (11/11)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#B4D1E6	0.395973739021628	1
Felodipine	Phenobarbital	0.042	1.394	Moderate	5 (3/2)	The metabolism of Felodipine can be increased when combined with Phenobarbital.	#F9BCBC	0.0899940315958246	1
Cyclosporine	Terbinafine	0.122	-1.076	Minor	16 (8/8)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#B4D1E6	0.287980901106639	1
Labetalol	Ergotamine	0.148	4.647	Moderate	6 (5/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#F5B2B2	0.107992837914989	1
Tizanidine	Donepezil	0.123	2.51	Moderate	37 (27/10)	Tizanidine may increase the bradycardic activities of Donepezil.	#F7B9B9	0.665955833809102	1
Fluvoxamine	Tizanidine	0.151	2.124	Major	23 (16/7)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#F7B9B9	0.413972545340793	1
Phenytoin	Phenylbutazone	0.064	-Inf	None	1 (0/1)	The metabolism of Phenylbutazone can be increased when combined with Phenytoin.	#1E61A5	0.0179988063191649	1
Lidocaine	Nadolol	0.109	2.231	Moderate	17 (12/5)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#F7B9B9	0.305979707425803	1
Carbamazepine	Dextropropoxyphene	0.133	-1.076	None	4 (2/2)	The metabolism of Dextropropoxyphene can be increased when combined with Carbamazepine.	#B4D1E6	0.0719952252766596	1
Phenytoin	Estriol	0.098	14.871	None	17 (16/1)		#E69393	0.305979707425803	1
Metoprolol	Glipizide	0.681	1.394	Moderate	5 (3/2)	Metoprolol may increase the hypoglycemic activities of Glipizide.	#F9BCBC	0.0899940315958246	1
Methadone	Naltrexone	0.196	-1.076	Major	2 (1/1)	The therapeutic efficacy of Methadone can be decreased when used in combination with Naltrexone.	#B4D1E6	0.0359976126383298	1
Codeine	Cimetidine	0.266	1.859	Moderate	30 (20/10)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#F8BABA	0.539964189574947	1
Cimetidine	Galantamine	0.059	-Inf	Moderate	1 (0/1)	The metabolism of Galantamine can be decreased when combined with Cimetidine.	#1E61A5	0.0179988063191649	1
Glimepiride	Ketoconazole	0.262	-1.255	None	13 (6/7)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#B4D1E6	0.233984482149144	1
Dextromethorphan	Moclobemide	0.025	-3.228	None	4 (1/3)	Moclobemide may increase the serotonergic activities of Dextromethorphan.	#AECDE3	0.0719952252766596	1
Terbutaline	Oxprenolol	0.052	-Inf	None	2 (0/2)	Oxprenolol may decrease the bronchodilatory activities of Terbutaline.	#1E61A5	0.0359976126383298	1
Indomethacin	Labetalol	0.082	2.169	Moderate	10 (7/3)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#F7B9B9	0.179988063191649	1
Ziprasidone	Amiodarone	0.152	-1.076	Major	10 (5/5)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#B4D1E6	0.179988063191649	1
Cimetidine	Midazolam	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Erythromycin	Sotalol	0.056	1.673	Major	14 (9/5)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#F8BABA	0.251983288468309	1
Pimozide	Clarithromycin	0.174	-1.435	Major	14 (6/8)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#B4D1E6	0.251983288468309	1
Carbamazepine	Isoniazid	0.238	1.461	Moderate	18 (11/7)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#F9BCBC	0.323978513744968	1
Citalopram	Naratriptan	0.143	10.534	Major	37 (34/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#EDA1A1	0.665955833809102	1
Epinephrine	Rasagiline	0.11	-1.793	Moderate	8 (3/5)	Rasagiline may increase the hypertensive activities of Epinephrine.	#B2D0E5	0.143990450553319	1
Rifabutin	Bupropion	0.138	-1.076	None	2 (1/1)	The metabolism of Bupropion can be increased when combined with Rifabutin.	#B4D1E6	0.0359976126383298	1
Phenytoin	Cimetidine	0.207	1.859	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Cimetidine is combined with Phenytoin.	#F8BABA	0.0539964189574947	1
Pseudoephedrine	Rasagiline	0.054	-1.291	Moderate	22 (10/12)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#B4D1E6	0.395973739021628	1
Propranolol	Isoprenaline	0.611	-1.076	Moderate	2 (1/1)		#B4D1E6	0.0359976126383298	1
Disopyramide	Carvedilol	0.497	-1.076	Major	2 (1/1)	Disopyramide may increase the bradycardic activities of Carvedilol.	#B4D1E6	0.0359976126383298	1
Piroxicam	Nadolol	0.256	-2.152	Moderate	3 (1/2)	Piroxicam may decrease the antihypertensive activities of Nadolol.	#B1CFE5	0.0539964189574947	1
Trospium	Clemastine	0.044	-1.076	Moderate	2 (1/1)		#B4D1E6	0.0359976126383298	1
Cyclosporine	Ketoconazole	0.33	-3.228	Major	4 (1/3)	The metabolism of Cyclosporine can be decreased when combined with Ketoconazole.	#AECDE3	0.0719952252766596	1
Gentamicin	Ceftriaxone	0.538	4.183	Moderate	11 (9/2)		#F5B4B4	0.197986869510814	1
Rifabutin	Clomipramine	0.03	-Inf	None	1 (0/1)	The metabolism of Clomipramine can be increased when combined with Rifabutin.	#1E61A5	0.0179988063191649	1
Perindopril	Lithium cation	0.111	-1.435	Moderate	7 (3/4)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B4D1E6	0.125991644234154	1
Lovastatin	Ketoconazole	0.091	1.859	Major	15 (10/5)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#F8BABA	0.269982094787474	1
Cimetidine	Ketoconazole	0.625	-1.076	Moderate	2 (1/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Cimetidine.	#B4D1E6	0.0359976126383298	1
Ziprasidone	Ketoconazole	0.099	1.394	Major	5 (3/2)	The metabolism of Ziprasidone can be decreased when combined with Ketoconazole.	#F9BCBC	0.0899940315958246	1
Clobazam	Clozapine	0.083	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Clobazam is combined with Clozapine.	#1E61A5	0.0179988063191649	1
Griseofulvin	Acetylsalicylic acid	0.069	1.394	Minor	35 (21/14)		#F9BCBC	0.629958221170772	1
Rifampicin	Itraconazole	0.455	-1.554	Major	22 (9/13)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B2D0E5	0.395973739021628	1
Eletriptan	Itraconazole	0.166	6.739	Major	33 (29/4)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#F2ACAC	0.593960608532442	1
Donepezil	Cyclobenzaprine	0.081	2.138	Moderate	66 (46/20)		#F7B9B9	1.18792121706488	1
Sirolimus	Clarithromycin	0.07	-1.255	Major	13 (6/7)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#B4D1E6	0.233984482149144	1
Theophylline	Isoniazid	0.198	-5.379	Moderate	6 (1/5)	The serum concentration of Theophylline can be increased when it is combined with Isoniazid.	#A8C8E1	0.107992837914989	1
Fluconazole	Chlordiazepoxide	0.267	-1.076	None	2 (1/1)	The metabolism of Chlordiazepoxide can be decreased when combined with Fluconazole.	#B4D1E6	0.0359976126383298	1
Phenytoin	Triazolam	0.034	1.859	Moderate	3 (2/1)	The serum concentration of Phenytoin can be increased when it is combined with Triazolam.	#F8BABA	0.0539964189574947	1
Betamethasone	Primidone	0.02	-2.152	Moderate	3 (1/2)	The serum concentration of Betamethasone can be decreased when it is combined with Primidone.	#B1CFE5	0.0539964189574947	1
Theophylline	Nadolol	0.142	-1.076	Major	6 (3/3)		#B4D1E6	0.107992837914989	1
Labetalol	Terbutaline	0.122	4.647	Major	18 (15/3)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#F5B2B2	0.323978513744968	1
Theophylline	Josamycin	0.43	1.673	None	14 (9/5)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#F8BABA	0.251983288468309	1
Tetracycline	Insulin detemir	0.039	-1.345	Moderate	9 (4/5)		#B4D1E6	0.161989256872484	1
Estradiol	Primidone	0.141	2.788	Moderate	4 (3/1)	The metabolism of Estradiol can be increased when combined with Primidone.	#F7B7B7	0.0719952252766596	1
Ergotamine	Ketoconazole	0.355	1.549	Major	8 (5/3)	The serum concentration of Ergotamine can be increased when it is combined with Ketoconazole.	#F8BABA	0.143990450553319	1
Tizanidine	Rivastigmine	0.136	1.51	Moderate	21 (13/8)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#F9BCBC	0.377974932702463	1
Galantamine	Periciazine	0.037	3.718	None	5 (4/1)		#F5B4B4	0.0899940315958246	1
Conjugated estrogens	Prednisone	0.205	8.055	Moderate	29 (26/3)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#F0A7A7	0.521965383255782	1
Fluconazole	Nortriptyline	0.127	3.904	Moderate	26 (21/5)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#F5B4B4	0.467968964298288	1
Digoxin	Oxytetracycline	0.125	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Warfarin	Tetracycline	0.038	-1.435	Moderate	7 (3/4)		#B4D1E6	0.125991644234154	1
Ampicillin	Warfarin	0.03	-Inf	Moderate	2 (0/2)	Ampicillin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0359976126383298	1
Ranolazine	Itraconazole	0.205	-Inf	Major	8 (0/8)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.143990450553319	1
Prednisolone	Acetylsalicylic acid	0.128	1.176	Moderate	145 (81/64)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#F9BCBC	2.60982691627891	1
Warfarin	Minocycline	0.082	1.062	Moderate	15 (8/7)	Minocycline may increase the anticoagulant activities of Warfarin.	#F9BCBC	0.269982094787474	1
Primidone	Felodipine	0.9	-Inf	Moderate	1 (0/1)	The metabolism of Felodipine can be increased when combined with Primidone.	#1E61A5	0.0179988063191649	1
Trimipramine	Pseudoephedrine	0.114	-1.076	None	2 (1/1)	Trimipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B4D1E6	0.0359976126383298	1
Phenytoin	Methadone	0.347	-1.076	Major	2 (1/1)	The serum concentration of Methadone can be decreased when it is combined with Phenytoin.	#B4D1E6	0.0359976126383298	1
Phenoxymethylpenicillin	Methotrexate	0.106	3.074	Major	56 (43/13)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#F7B7B7	1.00793315387324	1
Indomethacin	Bumetanide	0.158	1.394	Moderate	5 (3/2)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.	#F9BCBC	0.0899940315958246	1
Digoxin	Tetracycline	0.109	-7.531	Moderate	8 (1/7)		#A2C4DE	0.143990450553319	1
Labetalol	Formoterol	0.14	8.598	Major	41 (37/4)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#EFA6A6	0.737951059085761	1
Triamcinolone	Primidone	0.114	1.394	Moderate	10 (6/4)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#F9BCBC	0.179988063191649	1
Doxycycline	Phenoxymethylpenicillin	0.553	-1.169	Moderate	48 (23/25)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#B4D1E6	0.863942703319916	1
Amitriptyline	Isoprenaline	0.538	-1.076	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoprenaline.	#B4D1E6	0.0359976126383298	1
Tacrolimus	Ketoconazole	0.625	1.239	Major	14 (8/6)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#F9BCBC	0.251983288468309	1
Hydromorphone	Naltrexone	0.222	-Inf	Major	1 (0/1)	The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Naltrexone.	#1E61A5	0.0179988063191649	1
Moxifloxacin	Josamycin	0.685	3.146	None	57 (44/13)		#F6B6B6	1.0259319601924	1
Prednisone	Ethinylestradiol	0.134	635.383	Moderate	3423 (3418/5)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	61.6099140305015	1
Conjugated estrogens	Prednisolone	1	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be increased when it is combined with Conjugated estrogens.	#1E61A5	0.0179988063191649	1
Itraconazole	Ciclesonide	0.159	1.084	Moderate	13 (7/6)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#F9BCBC	0.233984482149144	1
Etidronic acid	Iron	0.204	1.859	None	3 (2/1)		#F8BABA	0.0539964189574947	1
Doxycycline	Aztreonam	1	-Inf	None	1 (0/1)		#1E61A5	0.0179988063191649	1
Chlorpropamide	Repaglinide	0.127	1.859	None	3 (2/1)	Chlorpropamide may increase the hypoglycemic activities of Repaglinide.	#F8BABA	0.0539964189574947	1
Rifampicin	Doxepin	0.375	-1.076	Minor	2 (1/1)	The metabolism of Doxepin can be increased when combined with Rifampicin.	#B4D1E6	0.0359976126383298	1
Ethinylestradiol	Itraconazole	0.174	484.252	Moderate	1044 (1042/2)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	18.7907537972082	1
Propranolol	Chlorpropamide	0.174	2.788	Moderate	4 (3/1)	Propranolol may increase the hypoglycemic activities of Chlorpropamide.	#F7B7B7	0.0719952252766596	1
Trifluoperazine	Levofloxacin	0.145	-1.076	Moderate	10 (5/5)		#B4D1E6	0.179988063191649	1
Erythromycin	Triazolam	0.182	2.788	Moderate	8 (6/2)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#F7B7B7	0.143990450553319	1
Piroxicam	Lithium cation	0.144	-1.076	Major	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Piroxicam.	#B4D1E6	0.0719952252766596	1
Fluvoxamine	Sumatriptan	0.139	5.887	Major	22 (19/3)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#F2AEAE	0.395973739021628	1
Oxycodone	Cimetidine	0.188	-1.076	Major	2 (1/1)	The metabolism of Oxycodone can be decreased when combined with Cimetidine.	#B4D1E6	0.0359976126383298	1
Chlorpropamide	Glucosamine	0.202	3.718	None	5 (4/1)		#F5B4B4	0.0899940315958246	1
Sirolimus	Itraconazole	0.271	-3.228	Major	4 (1/3)	The serum concentration of Sirolimus can be increased when it is combined with Itraconazole.	#AECDE3	0.0719952252766596	1
Clarithromycin	Everolimus	0.029	1.549	Major	16 (10/6)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#F8BABA	0.287980901106639	1
Cimetidine	Fentanyl	0.157	2.788	Moderate	8 (6/2)		#F7B7B7	0.143990450553319	1
Trospium	Ketotifen	0.228	3.718	None	5 (4/1)		#F5B4B4	0.0899940315958246	1
Enalapril	Drospirenone	0.144	34.7	Moderate	115 (112/3)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#CC5858	2.06986272670397	1
Sucralfate	Ofloxacin	0.233	1.394	Moderate	10 (6/4)		#F9BCBC	0.179988063191649	1
Cyproheptadine	Rivastigmine	0.242	3.718	Moderate	5 (4/1)		#F5B4B4	0.0899940315958246	1
Raloxifene	Estradiol	0.222	65.063	Moderate	71 (70/1)		#B32020	1.27791524866071	1
Isotretinoin	Acenocoumarol	0.167	-3.228	None	16 (4/12)		#AECDE3	0.287980901106639	1
Terbinafine	Rifampicin	0.481	-2.152	Minor	12 (4/8)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#B1CFE5	0.215985675829979	1
Imipramine	Terbinafine	0.138	2.788	Moderate	16 (12/4)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#F7B7B7	0.287980901106639	1
Cyclosporine	Roxithromycin	0.118	-1.076	None	2 (1/1)	The metabolism of Roxithromycin can be decreased when combined with Cyclosporine.	#B4D1E6	0.0359976126383298	1
Erythromycin	Ranolazine	0.142	-1.793	Major	8 (3/5)	The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.	#B2D0E5	0.143990450553319	1
Trospium	Glycopyrronium	0.179	-2.152	Moderate	3 (1/2)	Trospium may increase the anticholinergic activities of Glycopyrronium.	#B1CFE5	0.0539964189574947	1
Amitriptyline	Cimetidine	0.181	3.718	Moderate	10 (8/2)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#F5B4B4	0.179988063191649	1
Naltrexone	Fentanyl	0.211	-1.793	Major	8 (3/5)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#B2D0E5	0.143990450553319	1
Felodipine	Josamycin	0.05	2.324	None	7 (5/2)		#F7B9B9	0.125991644234154	1
Benzylpenicillin	Acenocoumarol	0.113	-3.228	None	4 (1/3)	Benzylpenicillin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	0.0719952252766596	1
Verapamil	Telithromycin	0.046	1.859	Moderate	3 (2/1)	The serum concentration of Verapamil can be increased when it is combined with Telithromycin.	#F8BABA	0.0539964189574947	1
Salbutamol	Moclobemide	0.079	2.479	None	11 (8/3)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#F7B9B9	0.197986869510814	1
Thiethylperazine	Bromocriptine	0.296	10.224	Moderate	12 (11/1)		#EDA1A1	0.215985675829979	1
Triazolam	Josamycin	0.505	-1.076	None	2 (1/1)	The serum concentration of Triazolam can be increased when it is combined with Josamycin.	#B4D1E6	0.0359976126383298	1
Trospium	Levocabastine	0.133	-1.076	None	2 (1/1)		#B4D1E6	0.0359976126383298	1
Warfarin	Mercaptopurine	0.02	-Inf	Moderate	1 (0/1)	Mercaptopurine may decrease the anticoagulant activities of Warfarin.	#1E61A5	0.0179988063191649	1
Midazolam	Josamycin	0.157	1.859	None	9 (6/3)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#F8BABA	0.161989256872484	1
Lovastatin	Telithromycin	0.02	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Telithromycin.	#1E61A5	0.0179988063191649	1
Griseofulvin	Phenobarbital	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Griseofulvin can be decreased when it is combined with Phenobarbital.	#1E61A5	0.0179988063191649	1
Tacrolimus	Danazol	0.155	2.788	Moderate	4 (3/1)	The serum concentration of Tacrolimus can be increased when it is combined with Danazol.	#F7B7B7	0.0719952252766596	1
Topiramate	Ethinylestradiol	0.148	492.617	Moderate	531 (530/1)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	9.55736615547657	1
Azithromycin	Disopyramide	0.049	1.394	Major	5 (3/2)	Azithromycin may increase the QTc-prolonging activities of Disopyramide.	#F9BCBC	0.0899940315958246	1
Tetracycline	Quinapril	0.012	-2.152	Moderate	3 (1/2)		#B1CFE5	0.0539964189574947	1
Rifampicin	Glipizide	0.113	1.859	Moderate	6 (4/2)	The serum concentration of Glipizide can be decreased when it is combined with Rifampicin.	#F8BABA	0.107992837914989	1
Triamcinolone	Rifampicin	0.266	-1.076	Moderate	14 (7/7)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#B4D1E6	0.251983288468309	1
Carbamazepine	Telithromycin	1	-Inf	Major	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Telithromycin.	#1E61A5	0.0179988063191649	1
Isoniazid	Ketoconazole	0.483	-Inf	Moderate	3 (0/3)	The serum concentration of Ketoconazole can be decreased when it is combined with Isoniazid.	#1E61A5	0.0539964189574947	1
Erythromycin	Pimozide	0.079	-1.076	Major	4 (2/2)	The serum concentration of Pimozide can be increased when it is combined with Erythromycin.	#B4D1E6	0.0719952252766596	1
Fluorouracil	Metronidazole	0.464	-2.69	Moderate	7 (2/5)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#AFCEE4	0.125991644234154	1
Erythromycin	Bromocriptine	0.426	5.577	Moderate	7 (6/1)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#F3AFAF	0.125991644234154	1
Piroxicam	Warfarin	0.052	-1.076	Major	4 (2/2)	Piroxicam may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.0719952252766596	1
Phenylbutazone	Gliclazide	0.292	1.394	None	5 (3/2)		#F9BCBC	0.0899940315958246	1
Ketoconazole	Cilostazol	0.063	-Inf	Major	3 (0/3)	The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole.	#1E61A5	0.0539964189574947	1
Phenylephrine	Imipramine	0.362	-1.076	Major	4 (2/2)	Imipramine may increase the vasopressor activities of Phenylephrine.	#B4D1E6	0.0719952252766596	1
Oxytetracycline	Amoxicillin	0.493	1.487	Moderate	13 (8/5)		#F9BCBC	0.233984482149144	1
Dextropropoxyphene	Warfarin	0.024	-Inf	None	1 (0/1)		#1E61A5	0.0179988063191649	1
Triazolam	Itraconazole	0.382	-1.076	Major	4 (2/2)	The serum concentration of Triazolam can be increased when it is combined with Itraconazole.	#B4D1E6	0.0719952252766596	1
Tetracycline	Insulin glulisine	0.064	-1.076	Moderate	4 (2/2)		#B4D1E6	0.0719952252766596	1
Morphine	Naltrexone	0.112	-Inf	Major	3 (0/3)	The therapeutic efficacy of Morphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.0539964189574947	1
Warfarin	Isotretinoin	0.095	-1.614	Moderate	5 (2/3)		#B2D0E5	0.0899940315958246	1
Erlotinib	Clarithromycin	0.147	-1.076	Moderate	2 (1/1)	The serum concentration of Erlotinib can be increased when it is combined with Clarithromycin.	#B4D1E6	0.0359976126383298	1
Atomoxetine	Terbinafine	0.208	-2.152	Moderate	6 (2/4)	The serum concentration of Atomoxetine can be increased when it is combined with Terbinafine.	#B1CFE5	0.107992837914989	1
Clozapine	Rifampicin	0.053	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be decreased when it is combined with Rifampicin.	#1E61A5	0.0179988063191649	1
Fluconazole	Triazolam	0.223	2.788	Major	8 (6/2)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#F7B7B7	0.143990450553319	1
Nortriptyline	Pseudoephedrine	0.17	2.479	None	11 (8/3)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F7B9B9	0.197986869510814	1
Ethinylestradiol	Cloxacillin	0.156	474.493	Moderate	1023 (1021/2)		#B32020	18.4127788645057	1
Ketoconazole	Pioglitazone	0.277	-1.076	Moderate	4 (2/2)	The metabolism of Pioglitazone can be decreased when combined with Ketoconazole.	#B4D1E6	0.0719952252766596	1
Lovastatin	Niacin	0.195	2.788	Major	4 (3/1)	The risk or severity of rhabdomyolysis can be increased when Niacin is combined with Lovastatin.	#F7B7B7	0.0719952252766596	1
Clemastine	Galantamine	0.113	6.506	Moderate	8 (7/1)	The metabolism of Galantamine can be decreased when combined with Clemastine.	#F2ACAC	0.143990450553319	1
Pimozide	Josamycin	0.178	-1.076	None	2 (1/1)		#B4D1E6	0.0359976126383298	1
Clozapine	Josamycin	0.091	-Inf	None	1 (0/1)		#1E61A5	0.0179988063191649	1
Sertraline	Moclobemide	0.138	6.506	None	8 (7/1)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#F2ACAC	0.143990450553319	1
Phenylbutazone	Acenocoumarol	0.038	-2.152	None	3 (1/2)	Phenylbutazone may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.0539964189574947	1
Tramadol	Moclobemide	0.124	5.112	None	13 (11/2)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#F4B1B1	0.233984482149144	1
Amitriptyline	Rifabutin	0.044	-1.076	None	2 (1/1)	The metabolism of Amitriptyline can be increased when combined with Rifabutin.	#B4D1E6	0.0359976126383298	1
Eletriptan	Clarithromycin	0.09	18.822	Major	85 (81/4)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#E18888	1.52989853712902	1
Prednisolone	Rifampicin	0.163	-1.614	Moderate	10 (4/6)	The serum concentration of Prednisolone can be decreased when it is combined with Rifampicin.	#B2D0E5	0.179988063191649	1
Warfarin	Ceftriaxone	0.192	1.859	Moderate	6 (4/2)	Ceftriaxone may increase the anticoagulant activities of Warfarin.	#F8BABA	0.107992837914989	1
Itraconazole	Josamycin	0.508	2.788	None	28 (21/7)		#F7B7B7	0.503966576936618	1
Pimozide	Itraconazole	0.054	-1.076	Major	4 (2/2)	The serum concentration of Pimozide can be increased when it is combined with Itraconazole.	#B4D1E6	0.0719952252766596	1
Rifabutin	Itraconazole	0.375	-1.076	None	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifabutin.	#B4D1E6	0.0359976126383298	1
Doxycycline	Rifabutin	1	-1.076	Moderate	2 (1/1)	The metabolism of Rifabutin can be decreased when combined with Doxycycline.	#B4D1E6	0.0359976126383298	1
Warfarin	Fludrocortisone	0.166	2.788	Moderate	4 (3/1)	Fludrocortisone may increase the anticoagulant activities of Warfarin.	#F7B7B7	0.0719952252766596	1
Oxytetracycline	Cloxacillin	0.556	-1.076	Moderate	2 (1/1)		#B4D1E6	0.0359976126383298	1
Nortriptyline	Terbinafine	0.063	3.253	Moderate	9 (7/2)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#F6B6B6	0.161989256872484	1
Galantamine	Tizanidine	0.087	2.479	Moderate	11 (8/3)	Galantamine may increase the bradycardic activities of Tizanidine.	#F7B9B9	0.197986869510814	1
Tetracycline	Cloxacillin	0.713	-1.883	Moderate	11 (4/7)		#B2D0E5	0.197986869510814	1
Tacrolimus	Telithromycin	0.256	-1.076	Major	2 (1/1)	The serum concentration of Tacrolimus can be increased when it is combined with Telithromycin.	#B4D1E6	0.0359976126383298	1
Bisoprolol	Isoprenaline	0.046	1.859	Moderate	3 (2/1)	Bisoprolol may decrease the bronchodilatory activities of Isoprenaline.	#F8BABA	0.0539964189574947	1
Atomoxetine	Propafenone	0.509	1.859	Moderate	3 (2/1)	The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.	#F8BABA	0.0539964189574947	1
Prednisone	Estriol	0.19	52.98	None	174 (171/3)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B42323	3.13179229953469	1
Sulindac	Furosemide	0.18	7.436	Moderate	9 (8/1)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#F0A9A9	0.161989256872484	1
Itraconazole	Quazepam	0.401	2.788	None	4 (3/1)	The metabolism of Quazepam can be decreased when combined with Itraconazole.	#F7B7B7	0.0719952252766596	1
Cyclobenzaprine	Rivastigmine	0.168	3.821	Moderate	46 (37/9)		#F5B4B4	0.827945090681586	1
Cimetidine	Propranolol	0.054	7.436	Moderate	9 (8/1)	The metabolism of Propranolol can be decreased when combined with Cimetidine.	#F0A9A9	0.161989256872484	1
Phenylbutazone	Glyburide	0.062	-Inf	Moderate	1 (0/1)		#1E61A5	0.0179988063191649	1
Ethinylestradiol	Etoricoxib	0.146	270.475	None	292 (291/1)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	5.25565144519615	1
Acetaminophen	Imatinib	0.121	3.718	Moderate	5 (4/1)	Acetaminophen may increase the hepatotoxic activities of Imatinib.	#F5B4B4	0.0899940315958246	1
Doxycycline	Ethinylestradiol	0.224	1014.977	Moderate	1093 (1092/1)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#B32020	19.6726953068472	1
Methotrexate	Tetracycline	0.052	8.83	Moderate	21 (19/2)		#EFA6A6	0.377974932702463	1
Ampicillin	Methotrexate	0.264	3.718	Major	5 (4/1)	The serum concentration of Methotrexate can be increased when it is combined with Ampicillin.	#F5B4B4	0.0899940315958246	1
Famotidine	Ketoconazole	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Famotidine.	#1E61A5	0.0179988063191649	1
Flurazepam	Ketoconazole	0.021	-1.076	None	2 (1/1)	The metabolism of Flurazepam can be decreased when combined with Ketoconazole.	#B4D1E6	0.0359976126383298	1
Trospium	Azelastine	0.363	1.859	None	3 (2/1)		#F8BABA	0.0539964189574947	1
Tamoxifen	Rifampicin	0.161	8.365	Moderate	10 (9/1)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#F0A7A7	0.179988063191649	1
Phenytoin	Prednisolone	0.295	1.239	Moderate	7 (4/3)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#F9BCBC	0.125991644234154	1
Erythromycin	Sirolimus	0.022	-1.076	Major	2 (1/1)	The metabolism of Sirolimus can be decreased when combined with Erythromycin.	#B4D1E6	0.0359976126383298	1
Cimetidine	Itraconazole	0.128	-1.076	Moderate	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Cimetidine.	#B4D1E6	0.0359976126383298	1
Dihydroergotamine	Ketoconazole	0.605	5.577	Major	7 (6/1)	The serum concentration of Dihydroergotamine can be increased when it is combined with Ketoconazole.	#F3AFAF	0.125991644234154	1
Rifampicin	Josamycin	0.733	-2.152	None	3 (1/2)	The metabolism of Rifampicin can be decreased when combined with Josamycin.	#B1CFE5	0.0539964189574947	1
Pseudoephedrine	Doxepin	0.276	-1.076	None	2 (1/1)	Doxepin may decrease the antihypertensive activities of Pseudoephedrine.	#B4D1E6	0.0359976126383298	1
Ampicillin	Minocycline	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Minocycline.	#1E61A5	0.0179988063191649	1
Prednisolone	Acenocoumarol	0.091	1.394	None	30 (18/12)		#F9BCBC	0.539964189574947	1
Erythromycin	Eletriptan	0.177	8.365	Major	10 (9/1)	The serum concentration of Eletriptan can be increased when it is combined with Erythromycin.	#F0A7A7	0.179988063191649	1
Rosiglitazone	Rifampicin	0.095	-1.076	Moderate	2 (1/1)	The metabolism of Rosiglitazone can be increased when combined with Rifampicin.	#B4D1E6	0.0359976126383298	1
Erythromycin	Everolimus	0.02	-1.076	Major	2 (1/1)	The serum concentration of Everolimus can be increased when it is combined with Erythromycin.	#B4D1E6	0.0359976126383298	1
Terbutaline	Doxepin	0.131	4.647	Moderate	6 (5/1)	The risk or severity of adverse effects can be increased when Doxepin is combined with Terbutaline.	#F5B2B2	0.107992837914989	1
Metoprolol	Rifampicin	0.014	-Inf	Moderate	1 (0/1)	The metabolism of Metoprolol can be increased when combined with Rifampicin.	#1E61A5	0.0179988063191649	1
Metoprolol	Epinephrine	0.116	3.718	Moderate	5 (4/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#F5B4B4	0.0899940315958246	1
Phenoxymethylpenicillin	Minocycline	0.437	1.487	Moderate	13 (8/5)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Minocycline.	#F9BCBC	0.233984482149144	1
Tetracycline	Isotretinoin	0.306	-1.076	Major	2 (1/1)		#B4D1E6	0.0359976126383298	1
Dihydroergotamine	Josamycin	0.166	3.718	None	5 (4/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Josamycin.	#F5B4B4	0.0899940315958246	1
Ergotamine	Josamycin	0.184	2.788	None	4 (3/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Josamycin.	#F7B7B7	0.0719952252766596	1
Fluconazole	Pimozide	0.104	3.718	Major	5 (4/1)	The serum concentration of Pimozide can be increased when it is combined with Fluconazole.	#F5B4B4	0.0899940315958246	1
Pyridostigmine	Triamcinolone	0.127	4.647	Moderate	6 (5/1)	The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.	#F5B2B2	0.107992837914989	1
Prednisolone	Ketoconazole	0.486	-2.152	Moderate	3 (1/2)	The serum concentration of Prednisolone can be increased when it is combined with Ketoconazole.	#B1CFE5	0.0539964189574947	1
Amitriptyline	Phenylephrine	0.305	1.859	Major	9 (6/3)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#F8BABA	0.161989256872484	1
Phenoxymethylpenicillin	Tetracycline	1	-2.152	None	3 (1/2)		#B1CFE5	0.0539964189574947	1
Pyridostigmine	Prednisolone	0.055	-1.076	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Prednisolone is combined with Pyridostigmine.	#B4D1E6	0.0359976126383298	1
Primidone	Prednisolone	0.025	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be decreased when it is combined with Primidone.	#1E61A5	0.0179988063191649	1
Betamethasone	Warfarin	0.015	-Inf	Moderate	1 (0/1)	Betamethasone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0179988063191649	1
Estradiol	Prednisolone	0.23	21.378	Moderate	24 (23/1)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#DE8080	0.431971351659958	1
Eplerenone	Ketoconazole	0.062	-Inf	Major	1 (0/1)	The serum concentration of Eplerenone can be increased when it is combined with Ketoconazole.	#1E61A5	0.0179988063191649	1
Prednisolone	Itraconazole	0.495	2.045	Moderate	16 (11/5)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#F8BABA	0.287980901106639	1
Phenylephrine	Clomipramine	0.053	2.788	Major	4 (3/1)	Clomipramine may increase the vasopressor activities of Phenylephrine.	#F7B7B7	0.0719952252766596	1
Galantamine	Cyclobenzaprine	0.086	4.183	Moderate	11 (9/2)		#F5B4B4	0.197986869510814	1
Trospium	Cyclobenzaprine	0.194	17.66	Moderate	20 (19/1)		#E38B8B	0.359976126383298	1
Warfarin	Prednisolone	0.5	-Inf	Moderate	1 (0/1)	Prednisolone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.0179988063191649	1
Phenoxymethylpenicillin	Ethinylestradiol	0.134	Inf	Moderate	868 (868/0)		#B32020	15.6229638850351	1
Prazosin	Oxprenolol	0.742	Inf	None	2 (2/0)	Oxprenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.0359976126383298	1
Trimipramine	Moclobemide	0.167	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Trimipramine.	#B32020	0.0179988063191649	1
Tizanidine	Ethinylestradiol	0.131	Inf	Major	500 (500/0)		#B32020	8.99940315958246	1
Amikacin	Bumetanide	0.065	Inf	Major	2 (2/0)	The serum concentration of Amikacin can be increased when it is combined with Bumetanide.	#B32020	0.0359976126383298	1
Ethinylestradiol	Minocycline	0.165	Inf	Moderate	306 (306/0)		#B32020	5.50763473366446	1
Ceftazidime	Gentamicin	1	Inf	Moderate	3 (3/0)		#B32020	0.0539964189574947	1
Amikacin	Cefotaxime	0.167	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Disopyramide	Sotalol	0.072	Inf	Major	2 (2/0)	Disopyramide may increase the bradycardic activities of Sotalol.	#B32020	0.0359976126383298	1
Procyclidine	Haloperidol	0.358	Inf	Moderate	3 (3/0)		#B32020	0.0539964189574947	1
Amikacin	Cefonicid	0.607	Inf	Moderate	5 (5/0)		#B32020	0.0899940315958246	1
Methadone	Cimetidine	0.526	Inf	Moderate	2 (2/0)	The metabolism of Methadone can be decreased when combined with Cimetidine.	#B32020	0.0359976126383298	1
Cefotaxime	Gentamicin	0.556	Inf	Moderate	3 (3/0)		#B32020	0.0539964189574947	1
Lamotrigine	Ethinylestradiol	0.145	Inf	Moderate	150 (150/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	2.69982094787474	1
Tolmetin	Methotrexate	0.021	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Tolmetin.	#B32020	0.0179988063191649	1
Tetracycline	Ethinylestradiol	0.196	Inf	None	134 (134/0)		#B32020	2.4118400467681	1
Cyclosporine	Sulfadiazine	0.021	Inf	Major	2 (2/0)	Sulfadiazine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0359976126383298	1
Gentamicin	Cefoxitin	1	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Tizanidine	Norethisterone	0.17	Inf	Major	84 (84/0)		#B32020	1.51189973080985	1
Raloxifene	Cholestyramine	0.103	Inf	Moderate	37 (37/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.665955833809102	1
Carbamazepine	Imatinib	0.103	Inf	Moderate	1 (1/0)	The serum concentration of Imatinib can be decreased when it is combined with Carbamazepine.	#B32020	0.0179988063191649	1
Meperidine	Chlorpromazine	1	Inf	Major	1 (1/0)	The metabolism of Pethidine can be decreased when combined with Chlorpromazine.	#B32020	0.0179988063191649	1
Metoprolol	Clonidine	0.435	Inf	Major	2 (2/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.0359976126383298	1
Oxcarbazepine	Ethinylestradiol	0.149	Inf	Major	70 (70/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Oxcarbazepine.	#B32020	1.25991644234154	1
Phenobarbital	Estriol	0.186	Inf	None	14 (14/0)		#B32020	0.251983288468309	1
Desogestrel	Lamotrigine	0.106	Inf	Moderate	64 (64/0)	Desogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.	#B32020	1.15192360442655	1
Fluvoxamine	Moclobemide	0.277	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Moclobemide.	#B32020	0.0359976126383298	1
Fluvoxamine	Eletriptan	0.148	Inf	Major	9 (9/0)	The serum concentration of Eletriptan can be increased when it is combined with Fluvoxamine.	#B32020	0.161989256872484	1
Donepezil	Flavoxate	0.213	Inf	Moderate	6 (6/0)		#B32020	0.107992837914989	1
Sucralfate	Clodronic acid	0.056	Inf	None	1 (1/0)		#B32020	0.0179988063191649	1
Rifabutin	Warfarin	0.391	Inf	None	2 (2/0)	The metabolism of Warfarin can be increased when combined with Rifabutin.	#B32020	0.0359976126383298	1
Fluvoxamine	Frovatriptan	0.35	Inf	Major	6 (6/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.107992837914989	1
Clozapine	Triazolam	0.216	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine.	#B32020	0.0179988063191649	1
Carbamazepine	Ethinylestradiol	0.108	Inf	Major	76 (76/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Carbamazepine.	#B32020	1.36790928025653	1
Phenytoin	Chlordiazepoxide	0.042	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Chlordiazepoxide.	#B32020	0.0179988063191649	1
Cimetidine	Doxepin	0.375	Inf	Moderate	1 (1/0)	The metabolism of Doxepin can be decreased when combined with Cimetidine.	#B32020	0.0179988063191649	1
Ethinylestradiol	Rifampicin	0.158	Inf	Major	48 (48/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Rifampicin.	#B32020	0.863942703319916	1
Fluvoxamine	Naratriptan	0.383	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Naratriptan.	#B32020	0.0539964189574947	1
Cyproheptadine	Galantamine	0.038	Inf	Moderate	3 (3/0)		#B32020	0.0539964189574947	1
Medroxyprogesterone acetate	Phenobarbital	0.153	Inf	Moderate	14 (14/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.251983288468309	1
Donepezil	Pipotiazine	0.069	Inf	None	2 (2/0)		#B32020	0.0359976126383298	1
Fluvoxamine	Methadone	0.167	Inf	Moderate	2 (2/0)	The metabolism of Methadone can be decreased when combined with Fluvoxamine.	#B32020	0.0359976126383298	1
Phenytoin	Telithromycin	0.047	Inf	Major	2 (2/0)	The metabolism of Telithromycin can be increased when combined with Phenytoin.	#B32020	0.0359976126383298	1
Phenytoin	Conjugated estrogens	0.188	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Phenytoin.	#B32020	0.0539964189574947	1
Verapamil	Oxprenolol	0.026	Inf	None	2 (2/0)	Verapamil may increase the hypotensive activities of Oxprenolol.	#B32020	0.0359976126383298	1
Phenytoin	Nisoldipine	0.167	Inf	Major	1 (1/0)	The metabolism of Nisoldipine can be increased when combined with Phenytoin.	#B32020	0.0179988063191649	1
Chlorpromazine	Bromocriptine	0.556	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Bromocriptine.	#B32020	0.0539964189574947	1
Interferon alfa-2b	Theophylline	0.051	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Interferon Alfa-2b. Recombinant.	#B32020	0.0179988063191649	1
Trospium	Zuclopenthixol	0.254	Inf	None	2 (2/0)		#B32020	0.0359976126383298	1
Donepezil	Promethazine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Disopyramide	Galantamine	0.704	Inf	Moderate	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.0179988063191649	1
Levonorgestrel	Carbamazepine	0.152	Inf	Major	46 (46/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Carbamazepine.	#B32020	0.827945090681586	1
Cimetidine	Flurazepam	0.139	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Ethinylestradiol	Ketoconazole	0.165	Inf	Moderate	36 (36/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Ketoconazole.	#B32020	0.647957027489937	1
Betamethasone	Pyridostigmine	0.049	Inf	Moderate	5 (5/0)	The risk or severity of adverse effects can be increased when Betamethasone is combined with Pyridostigmine.	#B32020	0.0899940315958246	1
Ranitidine	Procainamide	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Procainamide can be increased when it is combined with Ranitidine.	#B32020	0.0179988063191649	1
Acetylsalicylic acid	Paramethasone	0.505	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Paramethasone.	#B32020	0.0359976126383298	1
Chlorpropamide	Rifampicin	0.034	Inf	Moderate	1 (1/0)	The serum concentration of Chlorpropamide can be decreased when it is combined with Rifampicin.	#B32020	0.0179988063191649	1
Cilazapril	Lithium cation	0.052	Inf	None	3 (3/0)	The serum concentration of Lithium can be increased when it is combined with Cilazapril.	#B32020	0.0539964189574947	1
Phenytoin	Medroxyprogesterone acetate	0.152	Inf	Moderate	11 (11/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.197986869510814	1
Meperidine	Galantamine	0.083	Inf	None	1 (1/0)		#B32020	0.0179988063191649	1
Sotalol	Piroxicam	0.137	Inf	Moderate	3 (3/0)	Piroxicam may decrease the antihypertensive activities of Sotalol.	#B32020	0.0539964189574947	1
Atenolol	Isoprenaline	0.127	Inf	Moderate	2 (2/0)	Atenolol may decrease the bronchodilatory activities of Isoprenaline.	#B32020	0.0359976126383298	1
Morphine	Cimetidine	0.398	Inf	Moderate	3 (3/0)	The metabolism of Morphine can be decreased when combined with Cimetidine.	#B32020	0.0539964189574947	1
Imipramine	Clonidine	0.072	Inf	Major	1 (1/0)	Imipramine may decrease the antihypertensive activities of Clonidine.	#B32020	0.0179988063191649	1
Buspirone	Rifampicin	0.25	Inf	Major	1 (1/0)	The serum concentration of Buspirone can be decreased when it is combined with Rifampicin.	#B32020	0.0179988063191649	1
Conjugated estrogens	Ursodeoxycholic acid	0.053	Inf	None	4 (4/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Conjugated estrogens.	#B32020	0.0719952252766596	1
Galantamine	Flavoxate	0.37	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Digoxin	Penicillamine	0.301	Inf	Moderate	2 (2/0)	The serum concentration of Digoxin can be decreased when it is combined with Penicillamine.	#B32020	0.0359976126383298	1
Haloperidol	Rifabutin	0.26	Inf	None	2 (2/0)	The metabolism of Haloperidol can be increased when combined with Rifabutin.	#B32020	0.0359976126383298	1
Mefenamic acid	Lithium cation	0.045	Inf	Major	3 (3/0)	The serum concentration of Lithium can be increased when it is combined with Mefenamic acid.	#B32020	0.0539964189574947	1
Galantamine	Moclobemide	0.04	Inf	None	1 (1/0)		#B32020	0.0179988063191649	1
Ethinylestradiol	Ursodeoxycholic acid	0.121	Inf	None	37 (37/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.665955833809102	1
Dihydroergotamine	Telithromycin	0.062	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Telithromycin.	#B32020	0.0359976126383298	1
Griseofulvin	Estradiol	0.395	Inf	Moderate	6 (6/0)	The metabolism of Estradiol can be increased when combined with Griseofulvin.	#B32020	0.107992837914989	1
Midazolam	Ketoconazole	0.348	Inf	Major	5 (5/0)	The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.	#B32020	0.0899940315958246	1
Phenytoin	Norethisterone	0.153	Inf	None	8 (8/0)	The metabolism of Norethisterone can be increased when combined with Phenytoin.	#B32020	0.143990450553319	1
Sotalol	Ergotamine	0.138	Inf	Moderate	4 (4/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.0719952252766596	1
Bleomycin	Digoxin	0.028	Inf	Moderate	1 (1/0)	Digoxin may decrease the cardiotoxic activities of Bleomycin.	#B32020	0.0179988063191649	1
Ampicillin	Ethinylestradiol	0.322	Inf	Moderate	16 (16/0)		#B32020	0.287980901106639	1
Imatinib	Simvastatin	0.3	Inf	Moderate	2 (2/0)	The serum concentration of Simvastatin can be increased when it is combined with Imatinib.	#B32020	0.0359976126383298	1
Dihydroergotamine	Naratriptan	0.261	Inf	Major	2 (2/0)	Dihydroergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.0359976126383298	1
Nortriptyline	Epinephrine	0.17	Inf	Major	4 (4/0)	Nortriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.0719952252766596	1
Trospium	Doxepin	0.05	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Epinephrine	Doxepin	0.179	Inf	Major	2 (2/0)	Doxepin may decrease the antihypertensive activities of Epinephrine.	#B32020	0.0359976126383298	1
Cyclosporine	Modafinil	0.167	Inf	Moderate	1 (1/0)	The serum concentration of Cyclosporine can be decreased when it is combined with Modafinil.	#B32020	0.0179988063191649	1
Primidone	Estriol	0.168	Inf	None	3 (3/0)		#B32020	0.0539964189574947	1
Trifluoperazine	Rivastigmine	0.068	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Indomethacin	Oxprenolol	0.024	Inf	None	2 (2/0)	Indomethacin may decrease the antihypertensive activities of Oxprenolol.	#B32020	0.0359976126383298	1
Cimetidine	Halazepam	0.167	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Sulfadiazine	Methotrexate	1	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Sulfadiazine is combined with Methotrexate.	#B32020	0.0179988063191649	1
Fluphenazine	Bromocriptine	0.087	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Bromocriptine.	#B32020	0.0179988063191649	1
Modafinil	Ethinylestradiol	0.15	Inf	Moderate	7 (7/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Modafinil.	#B32020	0.125991644234154	1
Mitotane	Acenocoumarol	0.023	Inf	None	1 (1/0)	The serum concentration of Acenocoumarol can be decreased when it is combined with Mitotane.	#B32020	0.0179988063191649	1
Cimetidine	Ketazolam	0.257	Inf	None	2 (2/0)		#B32020	0.0359976126383298	1
Imatinib	Atorvastatin	0.03	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin.	#B32020	0.0179988063191649	1
Trifluoperazine	Donepezil	0.036	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Atomoxetine	Perphenazine	0.125	Inf	Moderate	1 (1/0)	The metabolism of Perphenazine can be decreased when combined with Atomoxetine.	#B32020	0.0179988063191649	1
Epinephrine	Nadolol	0.087	Inf	Major	5 (5/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.0899940315958246	1
Griseofulvin	Medroxyprogesterone acetate	0.124	Inf	Major	3 (3/0)	The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Griseofulvin.	#B32020	0.0539964189574947	1
Doxepin	Rasagiline	0.072	Inf	Major	1 (1/0)	Rasagiline may increase the serotonergic activities of Doxepin.	#B32020	0.0179988063191649	1
Levonorgestrel	Phenobarbital	0.16	Inf	Major	11 (11/0)	The metabolism of Levonorgestrel can be increased when combined with Phenobarbital.	#B32020	0.197986869510814	1
Benazepril	Lithium cation	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Benazepril.	#B32020	0.0179988063191649	1
Ethinylestradiol	Phenobarbital	0.151	Inf	Major	13 (13/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Phenobarbital.	#B32020	0.233984482149144	1
Cyclosporine	Flurbiprofen	0.467	Inf	Moderate	1 (1/0)	Flurbiprofen may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0179988063191649	1
Alendronic acid	Mefenamic acid	0.17	Inf	Moderate	9 (9/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.161989256872484	1
Labetalol	Epinephrine	0.167	Inf	Major	4 (4/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.0719952252766596	1
Theophylline	Ethinylestradiol	0.151	Inf	None	15 (15/0)	The serum concentration of Theophylline can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.269982094787474	1
Pseudoephedrine	Bromocriptine	0.405	Inf	Moderate	7 (7/0)	Bromocriptine may increase the hypertensive and vasoconstricting activities of Pseudoephedrine.	#B32020	0.125991644234154	1
Tizanidine	Cilazapril	0.065	Inf	None	3 (3/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Cilazapril.	#B32020	0.0539964189574947	1
Fluvoxamine	Selegiline	0.261	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Selegiline.	#B32020	0.0179988063191649	1
Dihydroergotamine	Sotalol	0.201	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.0359976126383298	1
Cimetidine	Warfarin	0.045	Inf	Moderate	1 (1/0)	Cimetidine may increase the anticoagulant activities of Warfarin.	#B32020	0.0179988063191649	1
Almotriptan	Ketoconazole	0.395	Inf	Moderate	4 (4/0)	The serum concentration of Almotriptan can be increased when it is combined with Ketoconazole.	#B32020	0.0719952252766596	1
Trospium	Chlorpromazine	0.024	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Imipramine	Epinephrine	0.062	Inf	Major	3 (3/0)	Imipramine may decrease the antihypertensive activities of Epinephrine.	#B32020	0.0539964189574947	1
Conjugated estrogens	Phenobarbital	0.455	Inf	Moderate	1 (1/0)	The metabolism of Conjugated estrogens can be increased when combined with Phenobarbital.	#B32020	0.0179988063191649	1
Cyclosporine	Tenoxicam	0.25	Inf	None	1 (1/0)	Tenoxicam may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0179988063191649	1
Galantamine	Doxepin	0.227	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Disopyramide	Clarithromycin	0.032	Inf	Major	2 (2/0)	Clarithromycin may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.0359976126383298	1
Dihydroergotamine	Labetalol	0.341	Inf	Moderate	3 (3/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.0539964189574947	1
Nimodipine	Cimetidine	0.095	Inf	Moderate	1 (1/0)	The serum concentration of Nimodipine can be increased when it is combined with Cimetidine.	#B32020	0.0179988063191649	1
Atomoxetine	Rasagiline	0.14	Inf	Moderate	1 (1/0)	Rasagiline may increase the central neurotoxic activities of Atomoxetine.	#B32020	0.0179988063191649	1
Cyclosporine	Mefenamic acid	0.21	Inf	Moderate	1 (1/0)	Mefenamic acid may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.0179988063191649	1
Ampicillin	Tetracycline	0.75	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Entacapone	Epinephrine	0.009	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Perphenazine	Bromocriptine	0.065	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Perphenazine can be decreased when used in combination with Bromocriptine.	#B32020	0.0179988063191649	1
Promethazine	Levofloxacin	0.25	Inf	Moderate	1 (1/0)	Promethazine may increase the QTc-prolonging activities of Levofloxacin.	#B32020	0.0179988063191649	1
Acitretin	Norethisterone	0.122	Inf	None	2 (2/0)		#B32020	0.0359976126383298	1
Formoterol	Oxprenolol	0.072	Inf	None	2 (2/0)	Oxprenolol may decrease the bronchodilatory activities of Formoterol.	#B32020	0.0359976126383298	1
Losartan	Drospirenone	0.141	Inf	Moderate	28 (28/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.503966576936618	1
Rivastigmine	Diphenhydramine	0.077	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Sucralfate	Etidronic acid	0.05	Inf	None	1 (1/0)		#B32020	0.0179988063191649	1
Methotrexate	Benzylpenicillin	0.009	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Benzylpenicillin.	#B32020	0.0179988063191649	1
Ketoconazole	Rifampicin	0.417	Inf	Major	2 (2/0)	The metabolism of Ketoconazole can be increased when combined with Rifampicin.	#B32020	0.0359976126383298	1
Methotrexate	Mefenamic acid	0.134	Inf	Major	2 (2/0)	The serum concentration of Methotrexate can be increased when it is combined with Mefenamic acid.	#B32020	0.0359976126383298	1
Tizanidine	Spirapril	0.083	Inf	None	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Spirapril.	#B32020	0.0179988063191649	1
Cyclosporine	Josamycin	0.185	Inf	None	2 (2/0)	The metabolism of Cyclosporine can be decreased when combined with Josamycin.	#B32020	0.0359976126383298	1
Warfarin	Flurbiprofen	0.016	Inf	Major	1 (1/0)	Flurbiprofen may increase the anticoagulant activities of Warfarin.	#B32020	0.0179988063191649	1
Buspirone	Clarithromycin	0.162	Inf	Moderate	2 (2/0)	The metabolism of Buspirone can be decreased when combined with Clarithromycin.	#B32020	0.0359976126383298	1
Lisinopril	Drospirenone	0.186	Inf	Moderate	18 (18/0)	Lisinopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.323978513744968	1
Buspirone	Itraconazole	0.143	Inf	Moderate	1 (1/0)	The metabolism of Buspirone can be decreased when combined with Itraconazole.	#B32020	0.0179988063191649	1
Prednisolone	Ethinylestradiol	0.214	Inf	Moderate	20 (20/0)	The serum concentration of Prednisolone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.359976126383298	1
Warfarin	Ketoconazole	0.187	Inf	Moderate	2 (2/0)	The serum concentration of Warfarin can be increased when it is combined with Ketoconazole.	#B32020	0.0359976126383298	1
Pseudoephedrine	Moclobemide	0.023	Inf	None	1 (1/0)	Moclobemide may increase the hypertensive activities of Pseudoephedrine.	#B32020	0.0179988063191649	1
Warfarin	Capecitabine	0.026	Inf	Major	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Capecitabine.	#B32020	0.0179988063191649	1
Ramipril	Drospirenone	0.244	Inf	Moderate	13 (13/0)	Ramipril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.233984482149144	1
Olmesartan	Drospirenone	0.225	Inf	Moderate	12 (12/0)	Olmesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.215985675829979	1
Medroxyprogesterone acetate	Warfarin	0.324	Inf	None	4 (4/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.	#B32020	0.0719952252766596	1
Nortriptyline	Rifampicin	0.013	Inf	Minor	1 (1/0)	The metabolism of Nortriptyline can be increased when combined with Rifampicin.	#B32020	0.0179988063191649	1
Lidocaine	Cimetidine	0.125	Inf	Moderate	1 (1/0)	The metabolism of Lidocaine can be decreased when combined with Cimetidine.	#B32020	0.0179988063191649	1
Ethinylestradiol	Acenocoumarol	0.143	Inf	None	27 (27/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.485967770617453	1
Acitretin	Minocycline	0.1	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Minocycline is combined with Acitretin.	#B32020	0.0179988063191649	1
Ethinylestradiol	Benzylpenicillin	0.094	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
Methylergometrine	Epinephrine	0.333	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Epinephrine.	#B32020	0.0359976126383298	1
Methylergometrine	Almotriptan	0.061	Inf	None	2 (2/0)	Methylergometrine may increase the vasoconstricting activities of Almotriptan.	#B32020	0.0359976126383298	1
Phenylephrine	Nortriptyline	0.333	Inf	Major	1 (1/0)	Nortriptyline may increase the vasopressor activities of Phenylephrine.	#B32020	0.0179988063191649	1
Carteolol	Ibuprofen	0.083	Inf	Moderate	1 (1/0)	Ibuprofen may decrease the antihypertensive activities of Carteolol.	#B32020	0.0179988063191649	1
Norethisterone	Pioglitazone	0.115	Inf	Minor	2 (2/0)	The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Norethisterone.	#B32020	0.0359976126383298	1
Conjugated estrogens	Raloxifene	0.176	Inf	Moderate	1 (1/0)		#B32020	0.0179988063191649	1
Medroxyprogesterone acetate	Primidone	0.016	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Primidone.	#B32020	0.0179988063191649	1
Phenytoin	Ethinylestradiol	0.308	Inf	Major	4 (4/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.0719952252766596	1
Bromocriptine	Josamycin	1	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Josamycin.	#B32020	0.0179988063191649	1
Warfarin	Ketoprofen	0.042	Inf	Major	1 (1/0)	Ketoprofen may increase the anticoagulant activities of Warfarin.	#B32020	0.0179988063191649	1
Phenytoin	Levonorgestrel	0.077	Inf	Major	3 (3/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Phenytoin.	#B32020	0.0539964189574947	1
Fluconazole	Quazepam	0.056	Inf	None	1 (1/0)	The metabolism of Quazepam can be decreased when combined with Fluconazole.	#B32020	0.0179988063191649	1
Phenylephrine	Rasagiline	0.011	Inf	Moderate	1 (1/0)	Rasagiline may increase the hypertensive activities of Phenylephrine.	#B32020	0.0179988063191649	1
Quinapril	Drospirenone	0.121	Inf	Moderate	2 (2/0)	Quinapril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0359976126383298	1
Captopril	Drospirenone	0.32	Inf	Moderate	4 (4/0)	Captopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0719952252766596	1
Betamethasone	Rifampicin	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Rifampicin.	#B32020	0.0179988063191649	1
Telmisartan	Drospirenone	0.141	Inf	Moderate	4 (4/0)	Telmisartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0719952252766596	1
Prednisolone	Estriol	0.513	Inf	None	2 (2/0)	The serum concentration of Prednisolone can be increased when it is combined with Estriol.	#B32020	0.0359976126383298	1
Norethisterone	Rifampicin	0.5	Inf	Major	1 (1/0)	The metabolism of Norethisterone can be increased when combined with Rifampicin.	#B32020	0.0179988063191649	1
Griseofulvin	Ethinylestradiol	0.111	Inf	Major	1 (1/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Griseofulvin.	#B32020	0.0179988063191649	1
Ethinylestradiol	Pioglitazone	0.208	Inf	Minor	2 (2/0)	The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.0359976126383298	1
Warfarin	Ethinylestradiol	0.242	Inf	Moderate	2 (2/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Warfarin.	#B32020	0.0359976126383298	1
Eprosartan	Drospirenone	0.235	Inf	Moderate	1 (1/0)	Eprosartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.0179988063191649	1
Raloxifene	Ethinylestradiol	0.52	Inf	Moderate	2 (2/0)		#B32020	0.0359976126383298	1
